<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000236589" datecreated="2016-06-29" datelastupdated="2021-02-19" numberofsubmissions="7" numberofsubmitters="6" recordtype="interpreted" variationid="236589" variationname="NM_000038.6(APC):c.3340C&gt;T (p.Arg1114Ter)" variationtype="single nucleotide variant" version="6">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="239564" variationid="236589">
      <genelist>
       <gene fullname="APC regulator of WNT signaling pathway" geneid="324" hgnc_id="HGNC:583" relationshiptype="within single gene" source="submitted" symbol="APC">
        <location>
         <cytogeneticlocation>
          5q22.2
         </cytogeneticlocation>
         <sequencelocation accession="NC_000005.10" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="5" display_start="112707498" display_stop="112846239" start="112707498" stop="112846239" strand="+">
         </sequencelocation>
         <sequencelocation accession="NC_000005.9" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="5" display_start="112043201" display_stop="112181935" start="112043201" stop="112181935" strand="+">
         </sequencelocation>
        </location>
        <omim>
         611731
        </omim>
        <haploinsufficiency clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APC" last_evaluated="2012-07-06">
         Sufficient evidence for dosage pathogenicity
        </haploinsufficiency>
        <triplosensitivity clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APC" last_evaluated="2012-07-06">
         No evidence available
        </triplosensitivity>
        <property>
         gene_acmg_incidental_2013
        </property>
        <property>
         gene_acmg_incidental_2016
        </property>
       </gene>
      </genelist>
      <name>
       NM_000038.6(APC):c.3340C&gt;T (p.Arg1114Ter)
      </name>
      <canonicalspdi>
       NC_000005.10:112838933:C:T
      </canonicalspdi>
      <varianttype>
       single nucleotide variant
      </varianttype>
      <location>
       <cytogeneticlocation>
        5q22.2
       </cytogeneticlocation>
       <sequencelocation accession="NC_000005.10" alternateallelevcf="T" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="5" display_start="112838934" display_stop="112838934" fordisplay="true" positionvcf="112838934" referenceallelevcf="C" start="112838934" stop="112838934" variantlength="1">
       </sequencelocation>
       <sequencelocation accession="NC_000005.9" alternateallelevcf="T" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="5" display_start="112174631" display_stop="112174631" positionvcf="112174631" referenceallelevcf="C" start="112174631" stop="112174631" variantlength="1">
       </sequencelocation>
      </location>
      <proteinchange>
       R1096*
      </proteinchange>
      <proteinchange>
       R1114*
      </proteinchange>
      <proteinchange>
       R1013*
      </proteinchange>
      <proteinchange>
       R1023*
      </proteinchange>
      <proteinchange>
       R1073*
      </proteinchange>
      <proteinchange>
       R1086*
      </proteinchange>
      <proteinchange>
       R1089*
      </proteinchange>
      <proteinchange>
       R1124*
      </proteinchange>
      <proteinchange>
       R1132*
      </proteinchange>
      <proteinchange>
       R954*
      </proteinchange>
      <proteinchange>
       R988*
      </proteinchange>
      <proteinchange>
       R831*
      </proteinchange>
      <proteinchange>
       R1055*
      </proteinchange>
      <hgvslist>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.112174631C&gt;T" sequenceaccession="NC_000005" sequenceaccessionversion="NC_000005.9" sequenceversion="9">
         <expression>
          NC_000005.9:g.112174631C&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.112838934C&gt;T" sequenceaccession="NC_000005" sequenceaccessionversion="NC_000005.10" sequenceversion="10">
         <expression>
          NC_000005.10:g.112838934C&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3340C&gt;T" maneselect="true" sequenceaccession="NM_000038" sequenceaccessionversion="NM_000038.6" sequenceversion="6">
         <expression>
          NM_000038.6:c.3340C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1114Ter" sequenceaccession="NP_000029" sequenceaccessionversion="NP_000029.2" sequenceversion="2">
         <expression>
          NP_000029.2:p.Arg1114Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3340C&gt;T" sequenceaccession="NM_001127510" sequenceaccessionversion="NM_001127510.3" sequenceversion="3">
         <expression>
          NM_001127510.3:c.3340C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1114Ter" sequenceaccession="NP_001120982" sequenceaccessionversion="NP_001120982.1" sequenceversion="1">
         <expression>
          NP_001120982.1:p.Arg1114Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3394C&gt;T" sequenceaccession="NM_001354896" sequenceaccessionversion="NM_001354896.2" sequenceversion="2">
         <expression>
          NM_001354896.2:c.3394C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1132Ter" sequenceaccession="NP_001341825" sequenceaccessionversion="NP_001341825.1" sequenceversion="1">
         <expression>
          NP_001341825.1:p.Arg1132Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3370C&gt;T" sequenceaccession="NM_001354897" sequenceaccessionversion="NM_001354897.2" sequenceversion="2">
         <expression>
          NM_001354897.2:c.3370C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1124Ter" sequenceaccession="NP_001341826" sequenceaccessionversion="NP_001341826.1" sequenceversion="1">
         <expression>
          NP_001341826.1:p.Arg1124Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3265C&gt;T" sequenceaccession="NM_001354898" sequenceaccessionversion="NM_001354898.2" sequenceversion="2">
         <expression>
          NM_001354898.2:c.3265C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1089Ter" sequenceaccession="NP_001341827" sequenceaccessionversion="NP_001341827.1" sequenceversion="1">
         <expression>
          NP_001341827.1:p.Arg1089Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3256C&gt;T" sequenceaccession="NM_001354899" sequenceaccessionversion="NM_001354899.2" sequenceversion="2">
         <expression>
          NM_001354899.2:c.3256C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1086Ter" sequenceaccession="NP_001341828" sequenceaccessionversion="NP_001341828.1" sequenceversion="1">
         <expression>
          NP_001341828.1:p.Arg1086Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3286C&gt;T" sequenceaccession="NM_001127511" sequenceaccessionversion="NM_001127511.3" sequenceversion="3">
         <expression>
          NM_001127511.3:c.3286C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1096Ter" sequenceaccession="NP_001120983" sequenceaccessionversion="NP_001120983.2" sequenceversion="2">
         <expression>
          NP_001120983.2:p.Arg1096Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3340C&gt;T" sequenceaccession="NM_001354895" sequenceaccessionversion="NM_001354895.2" sequenceversion="2">
         <expression>
          NM_001354895.2:c.3340C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1114Ter" sequenceaccession="NP_001341824" sequenceaccessionversion="NP_001341824.1" sequenceversion="1">
         <expression>
          NP_001341824.1:p.Arg1114Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3217C&gt;T" sequenceaccession="NM_001354900" sequenceaccessionversion="NM_001354900.2" sequenceversion="2">
         <expression>
          NM_001354900.2:c.3217C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1073Ter" sequenceaccession="NP_001341829" sequenceaccessionversion="NP_001341829.1" sequenceversion="1">
         <expression>
          NP_001341829.1:p.Arg1073Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3163C&gt;T" sequenceaccession="NM_001354901" sequenceaccessionversion="NM_001354901.2" sequenceversion="2">
         <expression>
          NM_001354901.2:c.3163C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1055Ter" sequenceaccession="NP_001341830" sequenceaccessionversion="NP_001341830.1" sequenceversion="1">
         <expression>
          NP_001341830.1:p.Arg1055Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3067C&gt;T" sequenceaccession="NM_001354902" sequenceaccessionversion="NM_001354902.2" sequenceversion="2">
         <expression>
          NM_001354902.2:c.3067C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1023Ter" sequenceaccession="NP_001341831" sequenceaccessionversion="NP_001341831.1" sequenceversion="1">
         <expression>
          NP_001341831.1:p.Arg1023Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.3037C&gt;T" sequenceaccession="NM_001354903" sequenceaccessionversion="NM_001354903.2" sequenceversion="2">
         <expression>
          NM_001354903.2:c.3037C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg1013Ter" sequenceaccession="NP_001341832" sequenceaccessionversion="NP_001341832.1" sequenceversion="1">
         <expression>
          NP_001341832.1:p.Arg1013Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.2962C&gt;T" sequenceaccession="NM_001354904" sequenceaccessionversion="NM_001354904.2" sequenceversion="2">
         <expression>
          NM_001354904.2:c.2962C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg988Ter" sequenceaccession="NP_001341833" sequenceaccessionversion="NP_001341833.1" sequenceversion="1">
         <expression>
          NP_001341833.1:p.Arg988Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.2860C&gt;T" sequenceaccession="NM_001354905" sequenceaccessionversion="NM_001354905.2" sequenceversion="2">
         <expression>
          NM_001354905.2:c.2860C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg954Ter" sequenceaccession="NP_001341834" sequenceaccessionversion="NP_001341834.1" sequenceversion="1">
         <expression>
          NP_001341834.1:p.Arg954Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.2491C&gt;T" sequenceaccession="NM_001354906" sequenceaccessionversion="NM_001354906.2" sequenceversion="2">
         <expression>
          NM_001354906.2:c.2491C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Arg831Ter" sequenceaccession="NP_001341835" sequenceaccessionversion="NP_001341835.1" sequenceversion="1">
         <expression>
          NP_001341835.1:p.Arg831Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.151414C&gt;T" sequenceaccession="NG_008481" sequenceaccessionversion="NG_008481.4" sequenceversion="4">
         <expression>
          NG_008481.4:g.151414C&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.151414C&gt;T" sequenceaccession="LRG_130" sequenceaccessionversion="LRG_130">
         <expression>
          LRG_130:g.151414C&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
      <xreflist>
       <xref db="ClinGen" id="CA10582306">
       </xref>
       <xref db="dbSNP" id="121913331" type="rs">
       </xref>
      </xreflist>
     </simpleallele>
     <reviewstatus>
      criteria provided, multiple submitters, no conflicts
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000228687" datelastevaluated="2018-12-18" interpretation="Pathogenic" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000038.6(APC):c.3340C&gt;T (p.Arg1114Ter) AND Familial adenomatous polyposis 1" version="6">
       <interpretedconditionlist traitsetid="6265">
        <interpretedcondition db="MedGen" id="C2713442">
         Familial adenomatous polyposis 1
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000424284" datelastevaluated="2015-07-14" interpretation="Likely pathogenic" reviewstatus="no assertion criteria provided" submissioncount="1" title="NM_000038.6(APC):c.3340C&gt;T (p.Arg1114Ter) AND Neoplasm of the large intestine" version="1">
       <interpretedconditionlist traitsetid="31428">
        <interpretedcondition db="MedGen" id="C0009404">
         Neoplasm of the large intestine
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000434269" datelastevaluated="2015-07-14" interpretation="Likely pathogenic" reviewstatus="no assertion criteria provided" submissioncount="1" title="NM_000038.6(APC):c.3340C&gt;T (p.Arg1114Ter) AND Lung adenocarcinoma" version="1">
       <interpretedconditionlist traitsetid="3349">
        <interpretedcondition db="MedGen" id="C0152013">
         Lung adenocarcinoma
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000491362" datelastevaluated="2019-10-18" interpretation="Pathogenic" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_000038.6(APC):c.3340C&gt;T (p.Arg1114Ter) AND Hereditary cancer-predisposing syndrome" version="2">
       <interpretedconditionlist traitsetid="13598">
        <interpretedcondition db="MedGen" id="C0027672">
         Hereditary cancer-predisposing syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000501152" datelastevaluated="2019-02-27" interpretation="Pathogenic" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_000038.6(APC):c.3340C&gt;T (p.Arg1114Ter) AND Familial multiple polyposis syndrome" version="4">
       <interpretedconditionlist traitsetid="8942">
        <interpretedcondition db="MedGen" id="C0032580">
         Familial multiple polyposis syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2019-10-18" numberofsubmissions="7" numberofsubmitters="6" type="Clinical significance">
       <description>
        Pathogenic
       </description>
       <citation type="general">
        <id source="PubMed">
         8187091
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         20223039
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         22987206
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         2281069
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         23159591
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         1316610
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         1338764
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         20924072
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         25157968
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         24664542
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         10646887
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         16134147
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         18433509
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         18948947
        </id>
       </citation>
       <citation type="general">
        <url>
         http://docm.genome.wustl.edu/variants/ENST00000257430:c.3340C&gt;T
        </url>
       </citation>
       <citation type="general">
        <id source="PubMed">
         21901162
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         20685668
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         23700467
        </id>
       </citation>
       <descriptionhistory dated="2018-05-29">
        <description>
         Pathogenic/Likely pathogenic
        </description>
       </descriptionhistory>
       <descriptionhistory dated="2017-03-07">
        <description>
         Pathogenic
        </description>
       </descriptionhistory>
       <conditionlist>
        <traitset id="8942" type="Disease">
         <trait id="6588" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Familial adenomatous polyposis
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Adenomatous polyposis coli
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Familial adenomatous polyposis of the colon
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Familial polyposis of the colon
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Polyposis, adenomatous intestinal
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Adenomatous polyposis of the colon
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Familial intestinal polyposis
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Familial multiple polyposis
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary polyposis coli
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Preferred">
            Familial multiple polyposis syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="72900001">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Familial polyposis
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            FAP
           </elementvalue>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            FPC
           </elementvalue>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            Familial adenomatous polyposis (FAP) is an inherited disorder characterized by cancer of the large intestine (colon) and rectum. People with the classic type of familial adenomatous polyposis may begin to develop multiple noncancerous (benign) growths (polyps) in the colon as early as their teenage years. Unless the colon is removed, these polyps will become malignant (cancerous). The average age at which an individual develops colon cancer in classic familial adenomatous polyposis is 39 years. Some people have a variant of the disorder, called attenuated familial adenomatous polyposis, in which polyp growth is delayed. The average age of colorectal cancer onset for attenuated familial adenomatous polyposis is 55 years.In people with classic familial adenomatous polyposis, the number of polyps increases with age, and hundreds to thousands of polyps can develop in the colon. Also of particular significance are noncancerous growths called desmoid tumors. These fibrous tumors usually occur in the tissue covering the intestines and may be provoked by surgery to remove the colon. Desmoid tumors tend to recur after they are surgically removed. In both classic familial adenomatous polyposis and its attenuated variant, benign and malignant tumors are sometimes found in other places in the body, including the duodenum (a section of the small intestine), stomach, bones, skin, and other tissues. People who have colon polyps as well as growths outside the colon are sometimes described as having Gardner syndrome.A milder type of familial adenomatous polyposis, called autosomal recessive familial adenomatous polyposis, has also been identified. People with the autosomal recessive type of this disorder have fewer polyps than those with the classic type. Fewer than 100 polyps typically develop, rather than hundreds or thousands. The autosomal recessive type of this disorder is caused by mutations in a different gene than the classic and attenuated types of familial adenomatous polyposis.
           </attribute>
           <xref db="Genetics Home Reference" id="familial-adenomatous-polyposis">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500599">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528534">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000529017">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552183">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552184">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528529">
           </xref>
          </attributeset>
          <citation abbrev="Decipher" type="review">
           <url>
            https://decipher.sanger.ac.uk/syndrome/49
           </url>
          </citation>
          <citation abbrev="Mallorca, 2008" type="practice guideline">
           <id source="PubMed">
            18194984
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="733">
          </xref>
          <xref db="MedGen" id="C0032580">
          </xref>
          <xref db="MONDO" id="MONDO:0021055">
          </xref>
          <xref db="OMIM" id="PS175100" type="Phenotypic series">
          </xref>
         </trait>
        </traitset>
        <traitset id="6265" type="Disease">
         <trait id="15929" type="Disease">
          <name>
           <elementvalue type="Alternate">
            POLYPOSIS, ADENOMATOUS INTESTINAL
           </elementvalue>
           <xref db="OMIM" id="175100" type="MIM">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            APC-Associated Polyposis Conditions
           </elementvalue>
           <xref db="GeneReviews" id="NBK1345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED
           </elementvalue>
           <xref db="OMIM" id="611731.0021" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="611731.0028" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="611731.0035" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="611731.0038" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="611731.0043" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="611731.0034" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="611731.0036" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="611731.0042" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="611731.0049" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Familial adenomatous polyposis 1
           </elementvalue>
           <xref db="MONDO" id="MONDO:0021056">
           </xref>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            FAP1
           </elementvalue>
           <xref db="OMIM" id="175100" type="MIM">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            APC-associated polyposis conditions include: familial adenomatous polyposis (FAP), attenuated FAP, and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colon cancer predisposition syndrome in which hundreds to thousands of adenomatous colonic polyps develop, beginning, on average, at age 16 years (range 7-36 years). By age 35 years, 95% of individuals with FAP have polyps; without colectomy, colon cancer is inevitable. The mean age of colon cancer diagnosis in untreated individuals is 39 years (range 34-43 years). Extracolonic manifestations are variably present and include: polyps of the gastric fundus and duodenum, osteomas, dental anomalies, congenital hypertrophy of the retinal pigment epithelium (CHRPE), soft tissue tumors, desmoid tumors, and associated cancers. Attenuated FAP is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of colon cancer at a later age than in FAP. Certain extracolonic manifestations, such as gastric and duodenal polyps or cancers, are variably present in attenuated FAP; risk management may be substantially different between FAP and attenuated FAP. GAPPS is characterized by gastric fundic gland polyposis, increased risk of gastric cancer, and limited colonic involvement in most individuals reported.
           </attribute>
           <xref db="GeneReviews" id="NBK1345">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000321103">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330056">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512645">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000515534">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520865">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558907">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500894">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501393">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508954">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520047">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520069">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520870">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000529017">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530028">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530118">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000172265">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512300">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000515899">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522559">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528912">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501794">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520077">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520868">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520869">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520872">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527984">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552290">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552303">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000591173">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301519
           </id>
           <id source="BookShelf">
            NBK1345
           </id>
          </citation>
          <citation abbrev="ASCRS, 2001" type="practice guideline">
           <id source="PubMed">
            11598466
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="EuroGenetest, 2011" type="Translational/Evidence-based">
           <id source="PubMed">
            21368914
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="ASCO/ESMO, 2015" type="practice guideline">
           <id source="PubMed">
            25452455
           </id>
          </citation>
          <citation abbrev="ACMG, 2014" type="practice guideline">
           <id source="PubMed">
            24310308
           </id>
          </citation>
          <citation abbrev="ACG, 2015" type="practice guideline">
           <id source="PubMed">
            25645574
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="MedGen" id="C2713442">
          </xref>
          <xref db="MONDO" id="MONDO:0021056">
          </xref>
          <xref db="OMIM" id="175100" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="13598" type="Disease">
         <trait id="18746" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Neoplastic Syndromes, Hereditary
           </elementvalue>
           <xref db="MeSH" id="D009386">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Hereditary cancer-predisposing syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="699346009">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Tumor predisposition
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Cancer predisposition
           </elementvalue>
           <xref db="Genetic Alliance" id="Hereditary+Cancer/3345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary Cancer Syndrome
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <citation abbrev="IARC, 2008" type="practice guideline">
           <id source="pmc">
            3075918
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="140162">
          </xref>
          <xref db="MedGen" id="C0027672">
          </xref>
          <xref db="MONDO" id="MONDO:0015356">
          </xref>
         </trait>
        </traitset>
        <traitset id="3349" type="Disease">
         <trait id="6499" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Adenocarcinoma of lung
           </elementvalue>
           <xref db="Genetic Alliance" id="Adenocarcinoma+of+Lung/222">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Lung adenocarcinoma
           </elementvalue>
           <xref db="Human Phenotype Ontology" id="HP:0030078">
           </xref>
           <xref db="MONDO" id="MONDO:0005061">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Adenocarcinoma of lung, somatic
           </elementvalue>
          </name>
          <attributeset>
           <attribute integervalue="5742" type="GARD id">
           </attribute>
           <xref db="Office of Rare Diseases" id="5742">
           </xref>
          </attributeset>
          <citation abbrev="CAP/IASLC/AMP, 2013" type="practice guideline">
           <id source="PubMed">
            23562183
           </id>
          </citation>
          <citation abbrev="ASCO/CAP/IASLC/AMP, 2014" type="practice guideline">
           <id source="PubMed">
            25311215
           </id>
          </citation>
          <citation abbrev="KCPSG, 2014" type="practice guideline">
           <id source="PubMed">
            24627688
           </id>
          </citation>
          <citation abbrev="NICE, 2013" type="practice guideline">
           <url>
            https://www.nice.org.uk/guidance/dg9
           </url>
          </citation>
          <xref db="MedGen" id="C0152013">
          </xref>
          <xref db="MeSH" id="C538231">
          </xref>
          <xref db="MONDO" id="MONDO:0005061">
          </xref>
          <xref db="Human Phenotype Ontology" id="HP:0030078" type="primary">
          </xref>
         </trait>
        </traitset>
        <traitset id="31428" type="Disease">
         <trait id="31583" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Neoplasm of the large intestine
           </elementvalue>
           <xref db="Human Phenotype Ontology" id="HP:0100834">
           </xref>
           <xref db="SNOMED CT" id="126837005">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Large intestine tumor
           </elementvalue>
           <xref db="Human Phenotype Ontology" id="HP:0100834">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Colorectal Neoplasms
           </elementvalue>
          </name>
          <citation abbrev="ESMO, 2012" type="practice guideline">
           <id source="PubMed">
            23012255
           </id>
          </citation>
          <xref db="MedGen" id="C0009404">
          </xref>
          <xref db="MeSH" id="D015179">
          </xref>
          <xref db="Human Phenotype Ontology" id="HP:0100834" type="primary">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2017-03-02" datelastupdated="2020-03-26" id="970272" submissiondate="2016-07-18">
       <clinvarsubmissionid localkey="ENST00000257430:c.3340C&gt;T|MeSH:D015179" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000504997" orgabbreviation="DoCM" organizationcategory="resource" orgid="505871" submittername="Database of Curated Mutations (DoCM)" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2015-07-14">
        <description>
         Likely pathogenic
        </description>
        <citation>
         <id source="PubMed">
          23700467
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21901162
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          25157968
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          2281069
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          8187091
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="ModeOfInheritance">
         Somatic mutation
        </attribute>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           somatic
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="T" assembly="GRCh37" chr="5" referenceallele="C" start="112174631" stop="112174631" variantlength="1">
         </sequencelocation>
        </location>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MeSH" id="D015179">
         </xref>
        </trait>
       </traitset>
       <citation>
        <url>
         http://docm.genome.wustl.edu/variants/ENST00000257430:c.3340C&gt;T
        </url>
       </citation>
       <studydescription>
        This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.
       </studydescription>
       <submissionnamelist>
        <submissionname>
         DoCM_7-13-16
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-03-02" datelastupdated="2020-03-26" id="970273" submissiondate="2016-07-18">
       <clinvarsubmissionid localkey="ENST00000257430:c.3340C&gt;T|MeSH:C538231" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000504998" orgabbreviation="DoCM" organizationcategory="resource" orgid="505871" submittername="Database of Curated Mutations (DoCM)" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2015-07-14">
        <description>
         Likely pathogenic
        </description>
        <citation>
         <id source="PubMed">
          25157968
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18948947
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="ModeOfInheritance">
         Somatic mutation
        </attribute>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           somatic
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="T" assembly="GRCh37" chr="5" referenceallele="C" start="112174631" stop="112174631" variantlength="1">
         </sequencelocation>
        </location>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MeSH" id="C538231">
         </xref>
        </trait>
       </traitset>
       <citation>
        <url>
         http://docm.genome.wustl.edu/variants/ENST00000257430:c.3340C&gt;T
        </url>
       </citation>
       <studydescription>
        This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.
       </studydescription>
       <submissionnamelist>
        <submissionname>
         DoCM_7-13-16
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-08-25" datelastupdated="2020-10-08" id="1147581" submissiondate="2017-10-30">
       <clinvarsubmissionid localkey="NM_000038.5:c.3340C&gt;T|MedGen:CN240755" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000591137" orgabbreviation="PLM-SHS" organizationcategory="laboratory" orgid="506152" submittername="Department of Pathology and Laboratory Medicine,Sinai Health System" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-08-31">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="APC">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000038.5:c.3340C&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MedGen" id="CN240755" type="CUI">
         </xref>
        </trait>
       </traitset>
       <studyname>
        Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         SHS20170111_update
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-06-29" datelastupdated="2020-03-26" id="537953" submissiondate="2019-03-28">
       <clinvarsubmissionid localkey="238355|MedGen:C2713442" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000282738" organizationcategory="laboratory" orgid="500031" submittername="Invitae" type="SCV" version="6">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2018-12-18">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          20685668
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          1338764
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          24664542
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          1316610
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20223039
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          16134147
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          23159591
         </id>
        </citation>
        <comment>
         This sequence change results in a premature translational stop signal in the last exon of the APC mRNA at codon 1114 (p.Arg1114*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 1730 amino acids of the APC protein. This variant is not present in population databases (ExAC no frequency). This variant has been reported in patients affected with familial adenomatous polyposis (FAP) and attenuated FAP (PMID: 1338764, 20685668, 20223039, 16134147). ClinVar contains an entry for this variant (Variation ID: 236589). Many truncation downstream of this variant has been determined to be pathogenic (PMID: 20223039, 1316610, 23159591, 24664542). This suggests that deletion of this region of the APC protein is causative of disease. Loss-of-function variants in APC are known to be pathogenic (PMID: 17963004, 20685668). For these reasons, this variant has been classified as Pathogenic.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Invitae Variant Classification Sherloc (09022015)
        </attribute>
        <citation>
         <id source="PubMed">
          28492532
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="APC">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000038.5:c.3340C&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Familial adenomatous polyposis 1
          </elementvalue>
         </name>
         <xref db="MedGen" id="C2713442" type="CUI">
         </xref>
        </trait>
       </traitset>
       <citation type="general">
        <id source="PubMed">
         28492532
        </id>
       </citation>
       <submissionnamelist>
        <submissionname>
         SUB5371970
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-06-19" datelastupdated="2021-02-03" id="2656043" submissiondate="2020-05-19">
       <clinvarsubmissionid localkey="Db4KrQBSZeoE7-orUyypkc4jdGwFj472knnGDdT0Yh4|MedGen:C0027672" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001347727" organizationcategory="laboratory" orgid="505849" submittername="Color Health, Inc" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-10-18">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <typeplatform>
           NGS
          </typeplatform>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="APC">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000038.5:c.3340C&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <comment>
        This variant changes 1 nucleotide in exon 16 of the APC gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in individuals affected with polyposis and familial adenomatous polyposis (PMID: 1338764, 20685668, 20223039, 16134147). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of APC function is a known mechanism of disease. Based on the available evidence, this variant is classified as Pathogenic.
       </comment>
       <submissionnamelist>
        <submissionname>
         Color Genomics - ClinVar Submission - May2020 - SUB747
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-06-21" datelastupdated="2021-02-10" id="2669474" submissiondate="2020-03-06">
       <clinvarsubmissionid localkey="NM_000038.5:c.3340C&gt;T|MedGen:CN240755" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001361155" orgabbreviation="IG" organizationcategory="laboratory" orgid="500026" submittername="Integrated Genetics/Laboratory Corporation of America" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-02-27">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          20223039
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18433509
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          10646887
         </id>
        </citation>
        <comment>
         Variant summary: APC c.3340C&gt;T (p.Arg1114X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (c.3927_3931delAAAGA, p.Glu1309fsX4; c.4393_4394dupAG, p.Ser1465fsX9; c.5582_5585delCTTT, p.Ser1861fsX1). The variant was absent in 245192 control chromosomes. c.3340C&gt;T has been reported in the literature in multiple individuals affected with Familial Adenomatous Polyposis (Ficari_2000, Friedl_2005, Kanter-Smoler_2008). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         LabCorp Variant Classification Summary - May 2015
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="APC">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000038.5:c.3340C&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Familial adenomatous polyposis
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN240755" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB6913290
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-06-23" datelastupdated="2020-12-07" id="1129531" submissiondate="2020-11-30">
       <clinvarsubmissionid localkey="a86809" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000579776" organizationcategory="laboratory" orgid="61756" submittername="Ambry Genetics" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-03-22">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          1338764
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20223039
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20924072
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22987206
         </id>
        </citation>
        <comment>
         The p.R1114* pathogenic mutation (also known as c.3340C&gt;T), located in coding exon 15 of the APC gene, results from a C to T substitution at nucleotide position 3340. This changes the amino acid from an arginine to a stop codon within coding exon 15. This mutation has been reported in multiple families with familial adenomatous polyposis (FAP) (Nagase H et al. Hum. Mutat. 1992;1:467-73; Friedl W et al. Hered Cancer Clin Pract. 2005 Sep;3:95-114; Rivera B et al. Ann. Oncol. 2011 Apr;22:903-9; Schwarzov&amp;aacute; L et al. Fam. Cancer, 2013 Mar;12:35-42). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Ambry Autosomal Dominant and X-Linked criteria (3/2017)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/uwtx4ijy/ad_xl_classificationscheme_03.2017_ambry.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="APC">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000038.5:c.3340C&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         NonExomeUpdate_081220AmbryReport
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="970273" mappingref="MeSH" mappingtype="XRef" mappingvalue="C538231" traittype="Disease">
       <medgen cui="C0152013" name="Lung adenocarcinoma">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="970272" mappingref="MeSH" mappingtype="XRef" mappingvalue="D015179" traittype="Disease">
       <medgen cui="C0009404" name="Neoplasm of the large intestine">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="537953" mappingref="Preferred" mappingtype="Name" mappingvalue="Familial adenomatous polyposis 1" traittype="Disease">
       <medgen cui="C2713442" name="Familial adenomatous polyposis 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2656043" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1129531" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1147581" mappingref="MedGen" mappingtype="XRef" mappingvalue="CN240755" traittype="Disease">
       <medgen cui="C0032580" name="Familial multiple polyposis syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2669474" mappingref="Preferred" mappingtype="Name" mappingvalue="Familial adenomatous polyposis" traittype="Disease">
       <medgen cui="C0032580" name="Familial multiple polyposis syndrome">
       </medgen>
      </traitmapping>
     </traitmappinglist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000055634" datecreated="2013-07-02" datelastupdated="2021-02-27" numberofsubmissions="14" numberofsubmitters="14" recordtype="interpreted" variationid="55634" variationname="NM_007294.4(BRCA1):c.5576C&gt;G (p.Pro1859Arg)" variationtype="single nucleotide variant" version="7">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="70301" variationid="55634">
      <genelist>
       <gene fullname="BRCA1 DNA repair associated" geneid="672" hgnc_id="HGNC:1100" relationshiptype="within single gene" source="submitted" symbol="BRCA1">
        <location>
         <cytogeneticlocation>
          17q21.31
         </cytogeneticlocation>
         <sequencelocation accession="NC_000017.11" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="17" display_start="43044295" display_stop="43125364" start="43044295" stop="43125364" strand="-">
         </sequencelocation>
         <sequencelocation accession="NC_000017.10" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="17" display_start="41196311" display_stop="41277499" start="41196311" stop="41277499" strand="-">
         </sequencelocation>
        </location>
        <omim>
         113705
        </omim>
        <haploinsufficiency clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA1" last_evaluated="2015-11-16">
         Sufficient evidence for dosage pathogenicity
        </haploinsufficiency>
        <triplosensitivity clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA1" last_evaluated="2015-11-16">
         No evidence available
        </triplosensitivity>
        <property>
         gene_acmg_incidental_2013
        </property>
        <property>
         gene_acmg_incidental_2016
        </property>
       </gene>
      </genelist>
      <name>
       NM_007294.4(BRCA1):c.5576C&gt;G (p.Pro1859Arg)
      </name>
      <canonicalspdi>
       NC_000017.11:43045693:G:C
      </canonicalspdi>
      <varianttype>
       single nucleotide variant
      </varianttype>
      <location>
       <cytogeneticlocation>
        17q21.31
       </cytogeneticlocation>
       <sequencelocation accession="NC_000017.11" alternateallelevcf="C" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="17" display_start="43045694" display_stop="43045694" fordisplay="true" positionvcf="43045694" referenceallelevcf="G" start="43045694" stop="43045694" variantlength="1">
       </sequencelocation>
       <sequencelocation accession="NC_000017.10" alternateallelevcf="C" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="17" display_start="41197711" display_stop="41197711" positionvcf="41197711" referenceallelevcf="G" start="41197711" stop="41197711" variantlength="1">
       </sequencelocation>
      </location>
      <othernamelist>
       <name>
        p.P1859R:CCC&gt;CGC
       </name>
       <name>
        5695C&gt;G
       </name>
      </othernamelist>
      <proteinchange>
       P1859R
      </proteinchange>
      <proteinchange>
       P1812R
      </proteinchange>
      <proteinchange>
       P755R
      </proteinchange>
      <proteinchange>
       P1880R
      </proteinchange>
      <hgvslist>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.41197711G&gt;C" sequenceaccession="NC_000017" sequenceaccessionversion="NC_000017.10" sequenceversion="10">
         <expression>
          NC_000017.10:g.41197711G&gt;C
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.43045694G&gt;C" sequenceaccession="NC_000017" sequenceaccessionversion="NC_000017.11" sequenceversion="11">
         <expression>
          NC_000017.11:g.43045694G&gt;C
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5576C&gt;G" maneselect="true" sequenceaccession="NM_007294" sequenceaccessionversion="NM_007294.4" sequenceversion="4">
         <expression>
          NM_007294.4:c.5576C&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Pro1859Arg" sequenceaccession="NP_009225" sequenceaccessionversion="NP_009225.1" sequenceversion="1">
         <expression>
          NP_009225.1:p.Pro1859Arg
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5435C&gt;G" sequenceaccession="NM_007297" sequenceaccessionversion="NM_007297.4" sequenceversion="4">
         <expression>
          NM_007297.4:c.5435C&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Pro1812Arg" sequenceaccession="NP_009228" sequenceaccessionversion="NP_009228.2" sequenceversion="2">
         <expression>
          NP_009228.2:p.Pro1812Arg
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.2264C&gt;G" sequenceaccession="NM_007298" sequenceaccessionversion="NM_007298.3" sequenceversion="3">
         <expression>
          NM_007298.3:c.2264C&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Pro755Arg" sequenceaccession="NP_009229" sequenceaccessionversion="NP_009229.2" sequenceversion="2">
         <expression>
          NP_009229.2:p.Pro755Arg
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.*90C&gt;G" sequenceaccession="NM_007299" sequenceaccessionversion="NM_007299.4" sequenceversion="4">
         <expression>
          NM_007299.4:c.*90C&gt;G
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001624" type="3 prime UTR variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5639C&gt;G" sequenceaccession="NM_007300" sequenceaccessionversion="NM_007300.4" sequenceversion="4">
         <expression>
          NM_007300.4:c.5639C&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Pro1880Arg" sequenceaccession="NP_009231" sequenceaccessionversion="NP_009231.2" sequenceversion="2">
         <expression>
          NP_009231.2:p.Pro1880Arg
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression sequenceaccession="LRG_292t1" sequenceaccessionversion="LRG_292t1">
         <expression>
          LRG_292t1:c.5576C&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Pro1859Arg">
         <expression>
          LRG_292p1:p.Pro1859Arg
         </expression>
        </proteinexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5576C&gt;G" sequenceaccession="NM_007294" sequenceaccessionversion="NM_007294.3" sequenceversion="3">
         <expression>
          NM_007294.3:c.5576C&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Pro1859Arg" sequenceaccession="NP_009225" sequenceaccessionversion="NP_009225.1" sequenceversion="1">
         <expression>
          NP_009225.1:p.Pro1859Arg
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.5753C&gt;G" sequenceaccession="NR_027676" sequenceaccessionversion="NR_027676.2" sequenceversion="2">
         <expression>
          NR_027676.2:n.5753C&gt;G
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001619" type="non-coding transcript variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.5695C&gt;G" sequenceaccession="U14680" sequenceaccessionversion="U14680.1" sequenceversion="1">
         <expression>
          U14680.1:n.5695C&gt;G
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.172290C&gt;G" sequenceaccession="NG_005905" sequenceaccessionversion="NG_005905.2" sequenceversion="2">
         <expression>
          NG_005905.2:g.172290C&gt;G
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression sequenceaccession="LRG_292" sequenceaccessionversion="LRG_292">
         <expression>
          LRG_292:g.172290C&gt;G
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
      <xreflist>
       <xref db="ClinGen" id="CA003729">
       </xref>
       <xref db="dbSNP" id="80357322" type="rs">
       </xref>
       <xref db="BRCA1-HCI" id="BRCA1_00098">
       </xref>
      </xreflist>
      <allelefrequencylist>
       <allelefrequency source="Trans-Omics for Precision Medicine (TOPMed)" value="0.00002">
       </allelefrequency>
       <allelefrequency source="Exome Aggregation Consortium (ExAC)" value="0.00002">
       </allelefrequency>
       <allelefrequency source="The Genome Aggregation Database (gnomAD), exomes" value="0.00004">
       </allelefrequency>
      </allelefrequencylist>
     </simpleallele>
     <reviewstatus>
      reviewed by expert panel
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000112706" datelastevaluated="2015-08-10" interpretation="Benign" reviewstatus="reviewed by expert panel" submissioncount="3" title="NM_007294.4(BRCA1):c.5576C&gt;G (p.Pro1859Arg) AND Breast-ovarian cancer, familial 1" version="2">
       <interpretedconditionlist traitsetid="1917">
        <interpretedcondition db="MedGen" id="C2676676">
         Breast-ovarian cancer, familial 1
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000162995" datelastevaluated="2016-04-25" interpretation="Benign/Likely benign" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_007294.4(BRCA1):c.5576C&gt;G (p.Pro1859Arg) AND Hereditary cancer-predisposing syndrome" version="4">
       <interpretedconditionlist traitsetid="13598">
        <interpretedcondition db="MedGen" id="C0027672">
         Hereditary cancer-predisposing syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000168527" datelastevaluated="2019-03-19" interpretation="Benign/Likely benign" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="5" title="NM_007294.4(BRCA1):c.5576C&gt;G (p.Pro1859Arg) AND not specified" version="10">
       <interpretedconditionlist traitsetid="9590">
        <interpretedcondition db="MedGen" id="CN169374">
         not specified
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000590490" datelastevaluated="2018-10-08" interpretation="Benign" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="3" title="NM_007294.4(BRCA1):c.5576C&gt;G (p.Pro1859Arg) AND not provided" version="4">
       <interpretedconditionlist traitsetid="9460">
        <interpretedcondition db="MedGen" id="CN517202">
         not provided
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV001084637" datelastevaluated="2019-12-31" interpretation="Likely benign" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_007294.4(BRCA1):c.5576C&gt;G (p.Pro1859Arg) AND Hereditary breast and ovarian cancer syndrome" version="1">
       <interpretedconditionlist traitsetid="7920">
        <interpretedcondition db="MedGen" id="C0677776">
         Hereditary breast and ovarian cancer syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2015-08-10" numberofsubmissions="14" numberofsubmitters="14" type="Clinical significance">
       <description>
        Benign
       </description>
       <citation type="general">
        <id source="PubMed">
         15385441
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         26689913
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         22753008
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         22516946
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         25085752
        </id>
       </citation>
       <citation type="general">
        <url>
         http://hci-exlovd.hci.utah.edu/variants.php?select_db=BRCA1&amp;action=search_all&amp;search_Variant%2FDNA=c.5576C%3EG
        </url>
       </citation>
       <citation type="general">
        <id source="PubMed">
         21990134
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         15172985
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         27272900
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         21965345
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         17924331
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         20516115
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         17305420
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         16267036
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         27802165
        </id>
       </citation>
       <conditionlist>
        <traitset id="13598" type="Disease">
         <trait id="18746" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Neoplastic Syndromes, Hereditary
           </elementvalue>
           <xref db="MeSH" id="D009386">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Hereditary cancer-predisposing syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="699346009">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Tumor predisposition
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Cancer predisposition
           </elementvalue>
           <xref db="Genetic Alliance" id="Hereditary+Cancer/3345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary Cancer Syndrome
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <citation abbrev="IARC, 2008" type="practice guideline">
           <id source="pmc">
            3075918
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="140162">
          </xref>
          <xref db="MedGen" id="C0027672">
          </xref>
          <xref db="MONDO" id="MONDO:0015356">
          </xref>
         </trait>
        </traitset>
        <traitset id="1917" type="Disease">
         <trait id="4711" type="Disease">
          <name>
           <elementvalue type="Alternate">
            BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
           </elementvalue>
           <xref db="OMIM" id="604370" type="MIM">
           </xref>
           <xref db="OMIM" id="113705.0003" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0005" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0006" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0008" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0010" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0015" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0023" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0026" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0028" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0030" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0033" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0004" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0012" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0017" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0019" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0020" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0025" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0029" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0032" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0035" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0037" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0041" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0007" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0009" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0013" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0014" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0024" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0036" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0038" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0040" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0001" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0002" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0016" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0018" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0021" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0027" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0031" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0034" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0042" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            OVARIAN CANCER, SUSCEPTIBILITY TO
           </elementvalue>
           <xref db="OMIM" id="602667.0001" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Breast-ovarian cancer, familial 1
           </elementvalue>
           <xref db="Genetic Alliance" id="Breast-ovarian+cancer%2C+familial+1/7865">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
           </elementvalue>
           <xref db="OMIM" id="604370">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Breast cancer, familial 1
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            BROVCA1
           </elementvalue>
           <xref db="OMIM" id="604370" type="MIM">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501743">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325409">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501817">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017876">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501743">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520866">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520867">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520870">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521908">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501746">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507864">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509692">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512645">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520872">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569406">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000514601">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000519030">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520069">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520869">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522161">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531275">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551440">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021517">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000320777">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000332529">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509983">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512320">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520865">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520871">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552304">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569423">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C2676676">
          </xref>
          <xref db="MONDO" id="MONDO:0011450">
          </xref>
          <xref db="OMIM" id="604370" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="9460" type="Disease">
         <trait id="17556" type="Disease">
          <name>
           <elementvalue type="Preferred">
            not provided
           </elementvalue>
           <xref db="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre" id="13DG0619">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN517202">
          </xref>
         </trait>
        </traitset>
        <traitset id="7920" type="Disease">
         <trait id="16761" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Hereditary breast and ovarian cancer syndrome
           </elementvalue>
           <xref db="MeSH" id="D061325">
           </xref>
           <xref db="Orphanet" id="145">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer
           </elementvalue>
           <xref db="CSER _CC_NCGL, University of Washington" id="UWMG_4506306">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer syndrome (HBOC)
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
          </symbol>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021468">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325401">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017876">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508566">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508956">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509985">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521499">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000523320">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551440">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551441">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552183">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552302">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558503">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000561859">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325409">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000502103">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509978">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000514601">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520887">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522161">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530028">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000592450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501981">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000503369">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509984">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512699">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521908">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017874">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021517">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508948">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509983">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521909">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522278">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522559">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530118">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551448">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558910">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000591268">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="ASCO, 2003" type="Position Statement">
           <id source="PubMed">
            12692171
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="Stratton and Rahman, 2008" type="review">
           <id source="PubMed">
            18163131
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C0677776">
          </xref>
          <xref db="MeSH" id="D061325">
          </xref>
          <xref db="MONDO" id="MONDO:0003582">
          </xref>
          <xref db="OMIM" id="PS604370" type="Phenotypic series">
          </xref>
         </trait>
        </traitset>
        <traitset id="9590" type="Disease">
         <trait id="16789" type="Disease">
          <name>
           <elementvalue type="Alternate">
            AllHighlyPenetrant
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Preferred">
            not specified
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN169374">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2017-01-04" datelastupdated="2020-04-18" id="952930" submissiondate="2016-11-23">
       <clinvarsubmissionid localkey="48443|OMIM:604370" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000489179" organizationcategory="laboratory" orgid="320494" submittername="Counsyl" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2016-09-01">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          27272900
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          17924331
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20516115
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21990134
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          25085752
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21965345
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          26689913
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Counsyl Autosomal Dominant Disease Classification criteria (2015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_(2015)_v1.pdf
         </url>
         <citationtext>
          Counsyl Autosomal Dominant Disease Classification criteria (2015)
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="604370" type="MIM">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         Counsyl2016
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-08-25" datelastupdated="2020-04-18" id="1148085" submissiondate="2017-04-19">
       <clinvarsubmissionid localkey="NM_007294.3:c.5576C&gt;G|not specified" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000591641" orgabbreviation="PLM-SHS" organizationcategory="laboratory" orgid="506152" submittername="Department of Pathology and Laboratory Medicine,Sinai Health System" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-11-26">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <genelocation>
          NM_007294.3:exon 24A
         </genelocation>
        </location>
        <othernamelist>
         <name>
          p.Pro1859Arg
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <studyname>
        The Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         SHS20170111
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-03-28" datelastupdated="2020-04-18" id="396026" submissiondate="2017-08-28">
       <clinvarsubmissionid localkey="1778355|not specified" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000219270" organizationcategory="laboratory" orgid="1050" submittername="CHEO Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-02-14">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          NM_007294.3:c.5576C&gt;G
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NC_000017.10:g.41197711G&gt;C
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <studyname>
        The Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         CHEO20170828_update
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-02-15" datelastupdated="2021-02-03" id="1338879" submissiondate="2017-10-26">
       <clinvarsubmissionid localkey="Db4KrQBSZeoE7-orUyypkTzDCVNLFor8cbznvXl9iwQ|MedGen:C0027672" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000683336" organizationcategory="laboratory" orgid="505849" submittername="Color Health, Inc" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2016-04-25">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <typeplatform>
           NGS
          </typeplatform>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3163908
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-03-15" datelastupdated="2021-02-10" id="1365627" submissiondate="2018-01-25">
       <clinvarsubmissionid localkey="NM_007294.3:c.5576C&gt;G|MedGen:CN221809" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000699275" orgabbreviation="IG" organizationcategory="laboratory" orgid="500026" submittername="Integrated Genetics/Laboratory Corporation of America" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-05-26">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          26689913
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21990134
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          27272900
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          25085752
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20516115
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22753008
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21965345
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          17924331
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          16267036
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15385441
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          17305420
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22516946
         </id>
        </citation>
        <comment>
         Variant summary: The BRCA1 c.5576C&gt;G (p.Pro1859Arg) variant involves the alteration of a non-conserved nucleotide and 2/4 in silico tools (SNPsandGO not captured due to low reliability index) predict a benign outcome. Multiple functional studies support these benign predictions, to which the variant was found to act comparable to wild type function for homology directed repair and transcription activation. This variant was found in 3/120890 control chromosomes at a frequency of 0.0000248, which does not exceed the estimated maximal expected allele frequency of a pathogenic BRCA1 variant (0.0010005). Multiple publications have cited the variant in affected individuals, although with limited information (ie, lack of co-occurrence and/or cosegregation data). BIC has cited the variant to co-occur with a pathogenic BRCA2 variant, c.5073_5074insA (classified as pathogenic by LCA). Furthermore, multipe publications have predicted the variant to be "neutral," along with multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Therefore, taking all available lines of evidence into consideration, the variant of interest has been classified as Benign.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         LabCorp Variant Classification Summary - May 2015
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf
         </url>
         <citationtext>
          LabCorp Variant Classification Summary - May 2015.docx
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <xreflist>
         <xref db="dbSNP" id="80357322" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MedGen" id="CN221809" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         2016-2017-variants
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-02-19" datelastupdated="2021-02-27" id="375670" submissiondate="2018-03-26">
       <clinvarsubmissionid localkey="GDX:7822|Not Provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000209995" orgabbreviation="GDX" organizationcategory="laboratory" orgid="26957" submittername="GeneDx" type="SCV" version="11">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-11-29">
        <description>
         Likely benign
        </description>
        <comment>
         This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         GeneDx Variant Classification (06012015)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="C" assembly="GRCh37" chr="17" referenceallele="G" start="41197711" stop="41197711" variantlength="1">
         </sequencelocation>
        </location>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3839901
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-02-07" datelastupdated="2020-10-06" id="2281207" submissiondate="2019-08-05">
       <clinvarsubmissionid localkey="2270376|MedGen:CN169374" submittedassembly="not applicable">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001156922" organizationcategory="laboratory" orgid="25969" submittername="ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-03-19">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ARUP Molecular Germline Variant Investigation Process
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NC_000017.10:g.41197711G&gt;C
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN169374" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         Aug 2019 ARUP
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2013-07-02" datelastupdated="2020-05-05" id="124999" submissiondate="2020-01-29">
       <clinvarsubmissionid localkey="759550|MedGen:C0677776" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000077069" organizationcategory="laboratory" orgid="500031" submittername="Invitae" type="SCV" version="8">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-12-31">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Invitae Variant Classification Sherloc (09022015)
        </attribute>
        <citation>
         <id source="PubMed">
          28492532
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary breast and ovarian cancer syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0677776" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB6897608
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-03-21" datelastupdated="2020-12-07" id="384482" submissiondate="2020-11-30">
       <clinvarsubmissionid localkey="a80352" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000213483" organizationcategory="laboratory" orgid="61756" submittername="Ambry Genetics" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-10-24">
        <description>
         Benign
        </description>
        <comment>
         This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Ambry Autosomal Dominant and X-Linked criteria (10/2015)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/aH4uL7vL/mid-7377_ambry_classification_scheme_oct_2015.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         NonExomeUpdate_081220AmbryReport
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2014-03-30" datelastupdated="2020-04-18" id="262480" submissiondate="2014-03-28">
       <clinvarsubmissionid localkey="U14680.1:n.5695C&gt;G|MedGen:C2676676">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000145582" organizationcategory="locus-specific database (LSDB)" orgid="504196" submittername="Breast Cancer Information Core (BIC) (BRCA1)" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2002-05-29">
        <description>
         Uncertain significance
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <geographicorigin>
           Ireland
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <geographicorigin>
           Western European
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European, Swedish
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western, Central/Eastern European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <genelocation>
          U14680.1:exon 24
         </genelocation>
        </location>
        <othernamelist>
         <name>
          P1859R
         </name>
        </othernamelist>
        <xreflist>
         <xref db="dbSNP" id="80357322" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          U14680.1:n.5695C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 1
          </elementvalue>
         </name>
         <xref db="MedGen" id="C2676676" type="CUI">
         </xref>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-09-26" datelastupdated="2020-04-18" id="455902" submissiondate="2015-08-17">
       <clinvarsubmissionid localkey="NM_007294.3:c.5576C&gt;G|OMIM:604370">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000244406" orgabbreviation="ENIGMA" organizationcategory="consortium" orgid="504863" submittername="Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        reviewed by expert panel
       </reviewstatus>
       <interpretation datelastevaluated="2015-08-10">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          21990134
         </id>
        </citation>
        <citation>
         <url>
          http://hci-exlovd.hci.utah.edu/variants.php?select_db=BRCA1&amp;action=search_all&amp;search_Variant%2FDNA=c.5576C%3EG
         </url>
        </citation>
        <comment>
         IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000104
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ENIGMA BRCA1/2 Classification Criteria (2015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf
         </url>
         <citationtext>
          ENIGMA BRCA1/2 Classification Criteria (2015)
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           curation
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          5695C&gt;G
         </name>
         <name>
          P1859R
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 1
          </elementvalue>
         </name>
         <xref db="OMIM" id="604370" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studydescription>
        ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/
       </studydescription>
       <submissionnamelist>
        <submissionname>
         ENIGMA_2015-08-17
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-08-04" datelastupdated="2020-04-18" id="1140450" submissiondate="2017-08-04">
       <clinvarsubmissionid localkey="287836|not specified" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000587523" organizationcategory="laboratory" orgid="506247" submittername="Research Molecular Genetics Laboratory,Women's College Hospital, University of Toronto" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2014-01-31">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           research
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          NM_007294.3:c.5576C&gt;G
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NC_000017.10:g.41197711G&gt;C
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <studyname>
        The Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         RMGL-WCRI-05152017
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-06-22" datelastupdated="2020-04-18" id="1518397" submissiondate="2018-03-09">
       <clinvarsubmissionid localkey="NM_007294.3:c.5576C&gt;G|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000778730" organizationcategory="laboratory" orgid="500068" submittername="Mayo Clinic Genetic Testing Laboratories,Mayo Clinic" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2017-09-18">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3765485
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-01-03" datelastupdated="2020-04-18" id="2238599" submissiondate="2020-03-06">
       <clinvarsubmissionid localkey="2559680|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001133642" organizationcategory="laboratory" orgid="500110" submittername="Quest Diagnostics Nichols Institute San Juan Capistrano" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2018-10-08">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          25085752
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          27802165
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          27272900
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20516115
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          17924331
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          17305420
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15172985
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21965345
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21990134
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22753008
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Quest Diagnostics Criteria
        </attribute>
        <citation>
         <id source="PubMed">
          26467025
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5576C&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB6975398
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="262480" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 1" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2281207" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="396026" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2238599" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="455902" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 1" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="375670" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="124999" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary breast and ovarian cancer syndrome" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="952930" mappingref="OMIM" mappingtype="XRef" mappingvalue="604370" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1365627" mappingref="MedGen" mappingtype="XRef" mappingvalue="CN221809" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="384482" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1140450" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1148085" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1518397" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1338879" mappingref="MedGen" mappingtype="XRef" mappingvalue="C0027672" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
     </traitmappinglist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000055628" datecreated="2013-07-02" datelastupdated="2021-02-27" numberofsubmissions="12" numberofsubmitters="12" recordtype="interpreted" variationid="55628" variationname="NM_007294.4(BRCA1):c.5558dup (p.Tyr1853Ter)" variationtype="Duplication" version="8">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="70295" variationid="55628">
      <genelist>
       <gene fullname="BRCA1 DNA repair associated" geneid="672" hgnc_id="HGNC:1100" relationshiptype="within single gene" source="submitted" symbol="BRCA1">
        <location>
         <cytogeneticlocation>
          17q21.31
         </cytogeneticlocation>
         <sequencelocation accession="NC_000017.11" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="17" display_start="43044295" display_stop="43125364" start="43044295" stop="43125364" strand="-">
         </sequencelocation>
         <sequencelocation accession="NC_000017.10" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="17" display_start="41196311" display_stop="41277499" start="41196311" stop="41277499" strand="-">
         </sequencelocation>
        </location>
        <omim>
         113705
        </omim>
        <haploinsufficiency clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA1" last_evaluated="2015-11-16">
         Sufficient evidence for dosage pathogenicity
        </haploinsufficiency>
        <triplosensitivity clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA1" last_evaluated="2015-11-16">
         No evidence available
        </triplosensitivity>
        <property>
         gene_acmg_incidental_2013
        </property>
        <property>
         gene_acmg_incidental_2016
        </property>
       </gene>
      </genelist>
      <name>
       NM_007294.4(BRCA1):c.5558dup (p.Tyr1853Ter)
      </name>
      <canonicalspdi>
       NC_000017.11:43045711:T:TT
      </canonicalspdi>
      <varianttype>
       Duplication
      </varianttype>
      <location>
       <cytogeneticlocation>
        17q21.31
       </cytogeneticlocation>
       <sequencelocation accession="NC_000017.11" alternateallelevcf="GT" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="17" display_start="43045711" display_stop="43045712" fordisplay="true" positionvcf="43045711" referenceallelevcf="G" start="43045711" stop="43045712" variantlength="1">
       </sequencelocation>
       <sequencelocation accession="NC_000017.10" alternateallelevcf="GT" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="17" display_start="41197728" display_stop="41197729" positionvcf="41197728" referenceallelevcf="G" start="41197728" stop="41197729" variantlength="1">
       </sequencelocation>
      </location>
      <othernamelist>
       <name>
        5677insA
       </name>
      </othernamelist>
      <proteinchange>
       Y1853*
      </proteinchange>
      <proteinchange>
       Y1806*
      </proteinchange>
      <proteinchange>
       Y1874*
      </proteinchange>
      <proteinchange>
       Y749*
      </proteinchange>
      <hgvslist>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.43045712dup" sequenceaccession="NC_000017" sequenceaccessionversion="NC_000017.11" sequenceversion="11">
         <expression>
          NC_000017.11:g.43045712dup
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.41197729dup" sequenceaccession="NC_000017" sequenceaccessionversion="NC_000017.10" sequenceversion="10">
         <expression>
          NC_000017.10:g.41197729dup
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5558dup" maneselect="true" sequenceaccession="NM_007294" sequenceaccessionversion="NM_007294.4" sequenceversion="4">
         <expression>
          NM_007294.4:c.5558dup
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Tyr1853Ter" sequenceaccession="NP_009225" sequenceaccessionversion="NP_009225.1" sequenceversion="1">
         <expression>
          NP_009225.1:p.Tyr1853Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5417dup" sequenceaccession="NM_007297" sequenceaccessionversion="NM_007297.4" sequenceversion="4">
         <expression>
          NM_007297.4:c.5417dup
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Tyr1806Ter" sequenceaccession="NP_009228" sequenceaccessionversion="NP_009228.2" sequenceversion="2">
         <expression>
          NP_009228.2:p.Tyr1806Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.2246dup" sequenceaccession="NM_007298" sequenceaccessionversion="NM_007298.3" sequenceversion="3">
         <expression>
          NM_007298.3:c.2246dup
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Tyr749Ter" sequenceaccession="NP_009229" sequenceaccessionversion="NP_009229.2" sequenceversion="2">
         <expression>
          NP_009229.2:p.Tyr749Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.*72dup" sequenceaccession="NM_007299" sequenceaccessionversion="NM_007299.4" sequenceversion="4">
         <expression>
          NM_007299.4:c.*72dup
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001624" type="3 prime UTR variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5621dup" sequenceaccession="NM_007300" sequenceaccessionversion="NM_007300.4" sequenceversion="4">
         <expression>
          NM_007300.4:c.5621dup
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Tyr1874Ter" sequenceaccession="NP_009231" sequenceaccessionversion="NP_009231.2" sequenceversion="2">
         <expression>
          NP_009231.2:p.Tyr1874Ter
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5558dupA" sequenceaccession="NM_007294" sequenceaccessionversion="NM_007294.3" sequenceversion="3">
         <expression>
          NM_007294.3:c.5558dupA
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001587" type="nonsense">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.5558_5559insA" sequenceaccession="U14680" sequenceaccessionversion="U14680.1" sequenceversion="1">
         <expression>
          U14680.1:c.5558_5559insA
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.5735dup" sequenceaccession="NR_027676" sequenceaccessionversion="NR_027676.2" sequenceversion="2">
         <expression>
          NR_027676.2:n.5735dup
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001619" type="non-coding transcript variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.5677_5678insA" sequenceaccession="U14680" sequenceaccessionversion="U14680.1" sequenceversion="1">
         <expression>
          U14680.1:n.5677_5678insA
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.172272dup" sequenceaccession="NG_005905" sequenceaccessionversion="NG_005905.2" sequenceversion="2">
         <expression>
          NG_005905.2:g.172272dup
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression sequenceaccession="LRG_292" sequenceaccessionversion="LRG_292">
         <expression>
          LRG_292:g.172272dup
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
      <xreflist>
       <xref db="Breast Cancer Information Core (BIC) (BRCA1)" id="5677&amp;base_change=ins A">
       </xref>
       <xref db="ClinGen" id="CA003713">
       </xref>
       <xref db="OMIM" id="113705.0019" type="Allelic variant">
       </xref>
       <xref db="dbSNP" id="80357629" type="rs">
       </xref>
      </xreflist>
      <allelefrequencylist>
       <allelefrequency source="Trans-Omics for Precision Medicine (TOPMed)" value="0.00002">
       </allelefrequency>
      </allelefrequencylist>
     </simpleallele>
     <reviewstatus>
      reviewed by expert panel
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000049050" datelastevaluated="2019-12-27" interpretation="Pathogenic" reviewstatus="criteria provided, single submitter" submissioncount="2" title="NM_007294.4(BRCA1):c.5558dup (p.Tyr1853Ter) AND Hereditary breast and ovarian cancer syndrome" version="9">
       <interpretedconditionlist traitsetid="7920">
        <interpretedcondition db="MedGen" id="C0677776">
         Hereditary breast and ovarian cancer syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000074357" datelastevaluated="2016-09-08" interpretation="Pathogenic" reviewstatus="reviewed by expert panel" submissioncount="5" title="NM_007294.4(BRCA1):c.5558dup (p.Tyr1853Ter) AND Breast-ovarian cancer, familial 1" version="12">
       <interpretedconditionlist traitsetid="1917">
        <interpretedcondition db="MedGen" id="C2676676">
         Breast-ovarian cancer, familial 1
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000163976" datelastevaluated="2020-01-15" interpretation="Pathogenic" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_007294.4(BRCA1):c.5558dup (p.Tyr1853Ter) AND Hereditary cancer-predisposing syndrome" version="6">
       <interpretedconditionlist traitsetid="13598">
        <interpretedcondition db="MedGen" id="C0027672">
         Hereditary cancer-predisposing syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000265181" datelastevaluated="2017-09-07" interpretation="Pathogenic" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="3" title="NM_007294.4(BRCA1):c.5558dup (p.Tyr1853Ter) AND not provided" version="3">
       <interpretedconditionlist traitsetid="9460">
        <interpretedcondition db="MedGen" id="CN517202">
         not provided
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2016-09-08" numberofsubmissions="12" numberofsubmitters="12" type="Clinical significance">
       <description>
        Pathogenic
       </description>
       <citation type="general">
        <id source="PubMed">
         12400015
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         10811118
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         25186627
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         11739404
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         20104584
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         9738006
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         24728189
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         24504028
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         18992264
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         7894493
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         21922593
        </id>
       </citation>
       <conditionlist>
        <traitset id="9460" type="Disease">
         <trait id="17556" type="Disease">
          <name>
           <elementvalue type="Preferred">
            not provided
           </elementvalue>
           <xref db="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre" id="13DG0619">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN517202">
          </xref>
         </trait>
        </traitset>
        <traitset id="7920" type="Disease">
         <trait id="16761" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Hereditary breast and ovarian cancer syndrome
           </elementvalue>
           <xref db="MeSH" id="D061325">
           </xref>
           <xref db="Orphanet" id="145">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer
           </elementvalue>
           <xref db="CSER _CC_NCGL, University of Washington" id="UWMG_4506306">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer syndrome (HBOC)
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
          </symbol>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021468">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325401">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017876">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508566">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508956">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509985">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521499">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000523320">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551440">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551441">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552183">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552302">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558503">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000561859">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325409">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000502103">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509978">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000514601">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520887">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522161">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530028">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000592450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501981">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000503369">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509984">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512699">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521908">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017874">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021517">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508948">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509983">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521909">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522278">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522559">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530118">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551448">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558910">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000591268">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="ASCO, 2003" type="Position Statement">
           <id source="PubMed">
            12692171
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="Stratton and Rahman, 2008" type="review">
           <id source="PubMed">
            18163131
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C0677776">
          </xref>
          <xref db="MeSH" id="D061325">
          </xref>
          <xref db="MONDO" id="MONDO:0003582">
          </xref>
          <xref db="OMIM" id="PS604370" type="Phenotypic series">
          </xref>
         </trait>
        </traitset>
        <traitset id="13598" type="Disease">
         <trait id="18746" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Neoplastic Syndromes, Hereditary
           </elementvalue>
           <xref db="MeSH" id="D009386">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Hereditary cancer-predisposing syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="699346009">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Tumor predisposition
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Cancer predisposition
           </elementvalue>
           <xref db="Genetic Alliance" id="Hereditary+Cancer/3345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary Cancer Syndrome
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <citation abbrev="IARC, 2008" type="practice guideline">
           <id source="pmc">
            3075918
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="140162">
          </xref>
          <xref db="MedGen" id="C0027672">
          </xref>
          <xref db="MONDO" id="MONDO:0015356">
          </xref>
         </trait>
        </traitset>
        <traitset id="1917" type="Disease">
         <trait id="4711" type="Disease">
          <name>
           <elementvalue type="Alternate">
            BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
           </elementvalue>
           <xref db="OMIM" id="604370" type="MIM">
           </xref>
           <xref db="OMIM" id="113705.0003" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0005" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0006" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0008" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0010" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0015" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0023" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0026" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0028" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0030" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0033" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0004" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0012" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0017" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0019" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0020" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0025" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0029" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0032" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0035" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0037" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0041" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0007" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0009" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0013" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0014" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0024" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0036" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0038" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0040" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0001" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0002" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0016" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0018" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0021" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0027" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0031" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0034" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0042" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            OVARIAN CANCER, SUSCEPTIBILITY TO
           </elementvalue>
           <xref db="OMIM" id="602667.0001" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Breast-ovarian cancer, familial 1
           </elementvalue>
           <xref db="Genetic Alliance" id="Breast-ovarian+cancer%2C+familial+1/7865">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
           </elementvalue>
           <xref db="OMIM" id="604370">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Breast cancer, familial 1
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            BROVCA1
           </elementvalue>
           <xref db="OMIM" id="604370" type="MIM">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501743">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325409">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501817">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017876">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501743">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520866">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520867">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520870">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521908">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501746">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507864">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509692">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512645">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520872">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569406">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000514601">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000519030">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520069">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520869">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522161">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531275">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551440">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021517">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000320777">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000332529">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509983">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512320">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520865">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520871">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552304">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569423">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C2676676">
          </xref>
          <xref db="MONDO" id="MONDO:0011450">
          </xref>
          <xref db="OMIM" id="604370" type="MIM">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2017-01-04" datelastupdated="2020-03-26" id="952227" submissiondate="2016-11-23">
       <clinvarsubmissionid localkey="48433|OMIM:604370" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000488476" organizationcategory="laboratory" orgid="320494" submittername="Counsyl" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2016-04-07">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          25186627
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20104584
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          11739404
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          12400015
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18992264
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          10811118
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          9738006
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          24504028
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          7894493
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Counsyl Autosomal Dominant Disease Classification criteria (2015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_(2015)_v1.pdf
         </url>
         <citationtext>
          Counsyl Autosomal Dominant Disease Classification criteria (2015)
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5558dupA
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="604370" type="MIM">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         Counsyl2016
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2011-01-25" datelastupdated="2020-03-26" id="39536" submissiondate="2010-12-30">
       <clinvarsubmissionid localkey="113705.0019_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1" title="BRCA1, TYR1853TER_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000039536" organizationcategory="resource" orgid="3" submittername="OMIM" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="1994-12-01">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           Friedman et al. (1994) studied 63 breast cancer patients and 10 ovarian cancer patients in 10 families with cancer linked to chromosome 17q21 (604370). They identified a 1-bp (A) insertion at nucleotide 5677 in exon 24 of the BRCA1 gene, leading to a premature termination codon in place of tyrosine-1853 and a truncated protein.
          </attribute>
          <citation>
           <id source="PubMed">
            7894493
           </id>
          </citation>
          <xref db="OMIM" id="604370" type="MIM">
          </xref>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <name>
         BRCA1, TYR1853TER
        </name>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name type="NonHGVS">
          TYR1853TER
         </name>
        </othernamelist>
        <xreflist>
         <xref db="OMIM" id="113705.0019" type="Allelic variant">
         </xref>
        </xreflist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2019-03-12" datelastupdated="2020-08-01" id="1738839" submissiondate="2018-08-31">
       <clinvarsubmissionid localkey="2840201|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000888951" organizationcategory="laboratory" orgid="500110" submittername="Quest Diagnostics Nichols Institute San Juan Capistrano" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-09-07">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Quest Diagnostics Criteria
        </attribute>
        <citation>
         <id source="PubMed">
          26467025
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <xreflist>
         <xref db="dbSNP" id="80357629" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5558dup
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB4481696
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-11-28" datelastupdated="2021-02-27" id="642372" submissiondate="2019-01-29">
       <clinvarsubmissionid localkey="GDX:7820|Not Provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000329130" orgabbreviation="GDX" organizationcategory="laboratory" orgid="26957" submittername="GeneDx" type="SCV" version="6">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-08-11">
        <description>
         Pathogenic
        </description>
        <comment>
         This duplication of one nucleotide is denoted BRCA1 c.5558dupA at the cDNA level and p.Tyr1853Ter (Y1853X) at the protein level. The normal sequence, with the base that is duplicated in braces, is ACCT[A]CCTG. The duplication creates a nonsense variant, which changes a Tyrosine to a premature stop codon, and is predicted to cause loss of normal protein function through protein truncation, causing the loss of the last 11 amino acids. BRCA1 c.5558dupA, previously reported as BRCA1 c.5677dupA, has been reported in association with breast and/or ovarian cancer and was shown to segregate with disease in at least one family (Friedman 1994, Borg 2010). Functional assays including those measuring transcription activity and proteolytic stability all confirm the pathogenic nature of this variant (Monteiro 1996, Williams 2010). In addition, this nonsense variant has been reported in public databases (LOVD and BIC), albeit due to different amino acid changes (c.5558C&gt;A and c.5559C&gt;A). It was shown to be functionally abnormal, decreasing formation in the nucleus, showing lack of transcription, and failing to suppress VEGF activity (Hayes 2000, Kawai 2002, Millot 2011). Based on currently available evidence, we consider this variant to be pathogenic.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         GeneDx Variant Classification (06012015)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="TT" assembly="GRCh37" chr="17" referenceallele="T" start="41197728" stop="41197729" variantlength="2">
         </sequencelocation>
        </location>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5558dupA
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Not Provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB5098196
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2013-07-02" datelastupdated="2020-04-15" id="124993" submissiondate="2020-02-06">
       <clinvarsubmissionid localkey="1123179|MedGen:C0677776" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000077063" organizationcategory="laboratory" orgid="500031" submittername="Invitae" type="SCV" version="8">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-12-27">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          11739404
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          24504028
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          12400015
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21922593
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          10811118
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20104584
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          7894493
         </id>
        </citation>
        <comment>
         This sequence change results in a premature translational stop signal in the last exon of the BRCA1 mRNA at codon 1853 (p.Tyr1853*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 11 amino acids of the BRCA1 protein. This variant is not present in population databases (ExAC no frequency). This variant has been observed in several individuals affected with breast and/or ovarian cancer (PMID: 24504028, 20104584), and has been reported to segregate with breast cancer in a single family (PMID: 7894493). This variant is also known as (c.5677insA, Y1853_L1854delinsX) in the literature. ClinVar contains an entry for this variant (Variation ID: 55628). Experimental studies have shown that this nonsense change induces a delocalization of BRCA1 in the cytoplasm, impairs the formation of nuclear foci, reduces transcriptional activation, and shows a pronounced enlargement of the unfolded chromatin structure (PMID: 21922593, 10811118, 11739404, 12400015). For these reasons, this variant has been classified as Pathogenic.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Invitae Variant Classification Sherloc (09022015)
        </attribute>
        <citation>
         <id source="PubMed">
          28492532
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5558dup
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary breast and ovarian cancer syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0677776" type="CUI">
         </xref>
        </trait>
       </traitset>
       <citation type="general">
        <id source="PubMed">
         28492532
        </id>
       </citation>
       <submissionnamelist>
        <submissionname>
         SUB6933801
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-03-21" datelastupdated="2020-12-07" id="385575" submissiondate="2020-11-30">
       <clinvarsubmissionid localkey="a63786" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000214576" organizationcategory="laboratory" orgid="61756" submittername="Ambry Genetics" type="SCV" version="5">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-10-09">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          10811118
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20104584
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          24728189
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          7894493
         </id>
        </citation>
        <comment>
         The c.5558dupA pathogenic mutation (also known as p.Y1853*), located in coding exon 22 of the BRCA1 gene, results from a duplication of A at position 5558. This changes the amino acid from a tyrosine to a stop codon within coding exon 22. This mutation has been identified in multiple individuals with Hereditary Breast and Ovarian Cancer (HBOC) syndrome (Friedman et al. Nat. Genet. 1994 Dec;8(4):399-404; Borg et al. Hum. Mutat. 2010 Mar;31(3):E1200-40; Song H et al. Hum. Mol. Genet. 2014 Sep;23(17):4703-9), and has been shown to cause loss of function in functional assays (Hayes et al. Cancer Res. 2000 May;60(9):2411-8). Of note, this alteration is also designated as 5677insA in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Ambry Autosomal Dominant and X-Linked criteria (3/2017)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/uwtx4ijy/ad_xl_classificationscheme_03.2017_ambry.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5558dupA
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         NonExomeUpdate_081220AmbryReport
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2014-03-30" datelastupdated="2020-03-26" id="262475" submissiondate="2014-03-28">
       <clinvarsubmissionid localkey="U14680.1:n.5677_5678insA|MedGen:C2676676">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000145577" organizationcategory="locus-specific database (LSDB)" orgid="504196" submittername="Breast Cancer Information Core (BIC) (BRCA1)" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2002-05-29">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="4" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Central/Eastern European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="7" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <genelocation>
          U14680.1:exon 24
         </genelocation>
        </location>
        <othernamelist>
         <name>
          5677insA
         </name>
        </othernamelist>
        <xreflist>
         <xref db="dbSNP" id="80357629" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          U14680.1:n.5677_5678insA
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 1
          </elementvalue>
         </name>
         <xref db="MedGen" id="C2676676" type="CUI">
         </xref>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2012-11-07" datelastupdated="2020-03-26" id="89482" submissiondate="2015-08-20">
       <clinvarsubmissionid localkey="SCRP_var_311" title="NM_007294.3:c.5558_5559insA AND Breast-ovarian cancer, familial 1">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000053867" orgabbreviation="SCRP" organizationcategory="consortium" orgid="500037" submittername="Sharing Clinical Reports Project (SCRP)" type="SCV" version="6">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2012-05-01">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
          <numbertested>
           8
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="VariantAlleles">
           8
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name type="nucleotide change">
          5677insA
         </name>
         <name type="nucleotide change">
          5677INSA
         </name>
        </othernamelist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 1
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-09-23" datelastupdated="2020-03-26" id="581338" submissiondate="2016-09-13">
       <clinvarsubmissionid localkey="NM_007294.3:c.5558dupA|OMIM:604370" submittedassembly="not applicable">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000300281" orgabbreviation="ENIGMA" organizationcategory="consortium" orgid="504863" submittername="Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        reviewed by expert panel
       </reviewstatus>
       <interpretation datelastevaluated="2016-09-08">
        <description>
         Pathogenic
        </description>
        <comment>
         Variant allele predicted to encode a truncated non-functional protein.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ENIGMA BRCA1/2 Classification Criteria (2015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf
         </url>
         <citationtext>
          ENIGMA BRCA1/2 Classification Criteria (2015)
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           curation
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5558dupA
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="604370" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studydescription>
        ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/
       </studydescription>
       <submissionnamelist>
        <submissionname>
         ENIGMA_2016-09-13
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-08-04" datelastupdated="2020-03-26" id="1140449" submissiondate="2017-08-04">
       <clinvarsubmissionid localkey="287830|Orphanet:ORPHA145" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000587522" organizationcategory="laboratory" orgid="506247" submittername="Research Molecular Genetics Laboratory,Women's College Hospital, University of Toronto" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2014-01-31">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           research
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          NM_007294.3:c.5558_5559insA
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NC_000017.10:g.41197728_41197729insT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="Orphanet" id="ORPHA145">
         </xref>
        </trait>
       </traitset>
       <studyname>
        The Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         RMGL-WCRI-05152017
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2019-05-17" datelastupdated="2021-02-03" id="1772642" submissiondate="2020-05-19">
       <clinvarsubmissionid localkey="Db4KrQBSZeoE7-orUyypkTx0GUITPy2ys_gNqKyiGIs|MedGen:C0027672" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000904687" organizationcategory="laboratory" orgid="505849" submittername="Color Health, Inc" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2020-01-15">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <typeplatform>
           NGS
          </typeplatform>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.3:c.5558dup
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <comment>
        This variant is located in the BRCA1 protein. Splice site prediction tools suggest that this variant may not impact RNA splicing. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Pathogenic.
       </comment>
       <submissionnamelist>
        <submissionname>
         Color Genomics - ClinVar Submission - May2020 - SUB747
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-12-09" datelastupdated="2020-12-12" id="2862723" submissiondate="2020-11-26">
       <clinvarsubmissionid localkey="NM_007294.4:c.5558dup|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001449857" orgabbreviation="KLINGEN-KUS" organizationcategory="laboratory" orgid="505315" submittername="Clinical Genetics Karolinska University Hospital,Karolinska University Hospital" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2016-05-25">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA1">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_007294.4:c.5558dup
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB8639822
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="1738839" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="89482" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 1" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1772642" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="262475" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 1" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="39536" mappingref="Preferred" mappingtype="Name" mappingvalue="BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2862723" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="385575" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="952227" mappingref="OMIM" mappingtype="XRef" mappingvalue="604370" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="581338" mappingref="OMIM" mappingtype="XRef" mappingvalue="604370" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="124993" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary breast and ovarian cancer syndrome" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1140449" mappingref="Orphanet" mappingtype="XRef" mappingvalue="ORPHA145" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="642372" mappingref="Preferred" mappingtype="Name" mappingvalue="Not Provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
     </traitmappinglist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000127898" datecreated="2014-05-13" datelastupdated="2021-02-27" numberofsubmissions="8" numberofsubmitters="7" recordtype="interpreted" variationid="127898" variationname="NM_002878.3(RAD51D):c.973G&gt;A (p.Gly325Ser)" variationtype="single nucleotide variant" version="10">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="133355" variationid="127898">
      <genelist>
       <gene fullname="RAD51 paralog D" geneid="5892" hgnc_id="HGNC:9823" relationshiptype="within multiple genes by overlap" source="submitted" symbol="RAD51D">
        <location>
         <cytogeneticlocation>
          17q12
         </cytogeneticlocation>
         <sequencelocation accession="NC_000017.11" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="17" display_start="35092221" display_stop="35119860" start="35092221" stop="35119860" strand="-">
         </sequencelocation>
         <sequencelocation accession="NC_000017.10" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="17" display_start="33426810" display_stop="33446887" start="33426810" stop="33446887" strand="-">
         </sequencelocation>
        </location>
        <omim>
         602954
        </omim>
        <haploinsufficiency clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD51D" last_evaluated="2019-10-09">
         Some evidence for dosage pathogenicity
        </haploinsufficiency>
        <triplosensitivity clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD51D" last_evaluated="2019-10-09">
         No evidence available
        </triplosensitivity>
       </gene>
       <gene fullname="RAD51L3-RFFL readthrough" geneid="100529207" relationshiptype="within multiple genes by overlap" source="calculated" symbol="RAD51L3-RFFL">
        <location>
         <cytogeneticlocation>
          17q12
         </cytogeneticlocation>
         <sequencelocation accession="NC_000017.11" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="17" display_start="35009112" display_stop="35121522" start="35009112" stop="35121522" strand="-">
         </sequencelocation>
        </location>
       </gene>
      </genelist>
      <name>
       NM_002878.3(RAD51D):c.973G&gt;A (p.Gly325Ser)
      </name>
      <canonicalspdi>
       NC_000017.11:35100966:C:T
      </canonicalspdi>
      <varianttype>
       single nucleotide variant
      </varianttype>
      <location>
       <cytogeneticlocation>
        17q12
       </cytogeneticlocation>
       <sequencelocation accession="NC_000017.11" alternateallelevcf="T" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="17" display_start="35100967" display_stop="35100967" fordisplay="true" positionvcf="35100967" referenceallelevcf="C" start="35100967" stop="35100967" variantlength="1">
       </sequencelocation>
       <sequencelocation accession="NC_000017.10" alternateallelevcf="T" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="17" display_start="33427986" display_stop="33427986" positionvcf="33427986" referenceallelevcf="C" start="33427986" stop="33427986" variantlength="1">
       </sequencelocation>
      </location>
      <othernamelist>
       <name>
        p.G325S:GGT&gt;AGT
       </name>
      </othernamelist>
      <proteinchange>
       G325S
      </proteinchange>
      <proteinchange>
       G213S
      </proteinchange>
      <proteinchange>
       G345S
      </proteinchange>
      <hgvslist>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.33427986C&gt;T" sequenceaccession="NC_000017" sequenceaccessionversion="NC_000017.10" sequenceversion="10">
         <expression>
          NC_000017.10:g.33427986C&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.35100967C&gt;T" sequenceaccession="NC_000017" sequenceaccessionversion="NC_000017.11" sequenceversion="11">
         <expression>
          NC_000017.11:g.35100967C&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1033G&gt;A" sequenceaccession="NM_001142571" sequenceaccessionversion="NM_001142571.2" sequenceversion="2">
         <expression>
          NM_001142571.2:c.1033G&gt;A
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Gly345Ser" sequenceaccession="NP_001136043" sequenceaccessionversion="NP_001136043.1" sequenceversion="1">
         <expression>
          NP_001136043.1:p.Gly345Ser
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.973G&gt;A" sequenceaccession="NM_002878" sequenceaccessionversion="NM_002878.3" sequenceversion="3">
         <expression>
          NM_002878.3:c.973G&gt;A
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Gly325Ser" sequenceaccession="NP_002869" sequenceaccessionversion="NP_002869.3" sequenceversion="3">
         <expression>
          NP_002869.3:p.Gly325Ser
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.637G&gt;A" sequenceaccession="NM_133629" sequenceaccessionversion="NM_133629.3" sequenceversion="3">
         <expression>
          NM_133629.3:c.637G&gt;A
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Gly213Ser" sequenceaccession="NP_598332" sequenceaccessionversion="NP_598332.1" sequenceversion="1">
         <expression>
          NP_598332.1:p.Gly213Ser
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression sequenceaccession="LRG_516t1" sequenceaccessionversion="LRG_516t1">
         <expression>
          LRG_516t1:c.973G&gt;A
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Gly325Ser" sequenceaccession="LRG_516p1" sequenceaccessionversion="LRG_516p1">
         <expression>
          LRG_516p1:p.Gly325Ser
         </expression>
        </proteinexpression>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.999G&gt;A" sequenceaccession="NR_037711" sequenceaccessionversion="NR_037711.2" sequenceversion="2">
         <expression>
          NR_037711.2:n.999G&gt;A
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001619" type="non-coding transcript variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.864G&gt;A" sequenceaccession="NR_037712" sequenceaccessionversion="NR_037712.2" sequenceversion="2">
         <expression>
          NR_037712.2:n.864G&gt;A
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001619" type="non-coding transcript variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.23903G&gt;A" sequenceaccession="NG_031858" sequenceaccessionversion="NG_031858.1" sequenceversion="1">
         <expression>
          NG_031858.1:g.23903G&gt;A
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression sequenceaccession="LRG_516" sequenceaccessionversion="LRG_516">
         <expression>
          LRG_516:g.23903G&gt;A
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
      <xreflist>
       <xref db="ClinGen" id="CA287999">
       </xref>
       <xref db="dbSNP" id="587780106" type="rs">
       </xref>
      </xreflist>
      <allelefrequencylist>
       <allelefrequency source="Trans-Omics for Precision Medicine (TOPMed)" value="0.00003">
       </allelefrequency>
       <allelefrequency source="The Genome Aggregation Database (gnomAD), exomes" value="0.00001">
       </allelefrequency>
      </allelefrequencylist>
     </simpleallele>
     <reviewstatus>
      criteria provided, multiple submitters, no conflicts
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000115824" datelastevaluated="2020-11-04" interpretation="Uncertain significance" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_002878.3(RAD51D):c.973G&gt;A (p.Gly325Ser) AND not specified" version="6">
       <interpretedconditionlist traitsetid="9590">
        <interpretedcondition db="MedGen" id="CN169374">
         not specified
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000554021" datelastevaluated="2019-11-27" interpretation="Uncertain significance" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_002878.3(RAD51D):c.973G&gt;A (p.Gly325Ser) AND Breast-ovarian cancer, familial 4" version="5">
       <interpretedconditionlist traitsetid="7625">
        <interpretedcondition db="MedGen" id="C3280345">
         Breast-ovarian cancer, familial 4
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000571425" datelastevaluated="2020-06-24" interpretation="Uncertain significance" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_002878.3(RAD51D):c.973G&gt;A (p.Gly325Ser) AND Hereditary cancer-predisposing syndrome" version="5">
       <interpretedconditionlist traitsetid="13598">
        <interpretedcondition db="MedGen" id="C0027672">
         Hereditary cancer-predisposing syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000656968" datelastevaluated="2019-09-04" interpretation="Uncertain significance" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_002878.3(RAD51D):c.973G&gt;A (p.Gly325Ser) AND not provided" version="2">
       <interpretedconditionlist traitsetid="9460">
        <interpretedcondition db="MedGen" id="CN517202">
         not provided
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000709426" datelastevaluated="2018-07-02" interpretation="Uncertain significance" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_002878.3(RAD51D):c.973G&gt;A (p.Gly325Ser) AND Hereditary breast and ovarian cancer syndrome" version="1">
       <interpretedconditionlist traitsetid="7920">
        <interpretedcondition db="MedGen" id="C0677776">
         Hereditary breast and ovarian cancer syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2020-11-04" numberofsubmissions="8" numberofsubmitters="7" type="Clinical significance">
       <description>
        Uncertain significance
       </description>
       <citation type="general">
        <id source="PubMed">
         25186627
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         25980754
        </id>
       </citation>
       <conditionlist>
        <traitset id="7920" type="Disease">
         <trait id="16761" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer
           </elementvalue>
           <xref db="CSER _CC_NCGL, University of Washington" id="UWMG_4506306">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer syndrome (HBOC)
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Preferred">
            Hereditary breast and ovarian cancer syndrome
           </elementvalue>
           <xref db="MeSH" id="D061325">
           </xref>
           <xref db="Orphanet" id="145">
           </xref>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021468">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325401">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017876">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508566">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508956">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509985">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521499">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000523320">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551440">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551441">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552183">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552302">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558503">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000561859">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325409">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000502103">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509978">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000514601">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520887">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522161">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530028">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000592450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501981">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000503369">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509984">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512699">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521908">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017874">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021517">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508948">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509983">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521909">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522278">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522559">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530118">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551448">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558910">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000591268">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="ASCO, 2003" type="Position Statement">
           <id source="PubMed">
            12692171
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="Stratton and Rahman, 2008" type="review">
           <id source="PubMed">
            18163131
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C0677776">
          </xref>
          <xref db="MeSH" id="D061325">
          </xref>
          <xref db="MONDO" id="MONDO:0003582">
          </xref>
          <xref db="OMIM" id="PS604370" type="Phenotypic series">
          </xref>
         </trait>
        </traitset>
        <traitset id="7625" type="Disease">
         <trait id="16581" type="Disease">
          <name>
           <elementvalue type="Alternate">
            BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4
           </elementvalue>
           <xref db="OMIM" id="614291" type="MIM">
           </xref>
           <xref db="OMIM" id="602954.0004" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="602954.0002" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="602954.0005" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="602954.0003" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="602954.0006" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="602954.0001" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Breast-ovarian cancer, familial 4
           </elementvalue>
           <xref db="Genetic Alliance" id="Breast-ovarian+cancer%2C+familial+4/7868">
           </xref>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            BROVCA4
           </elementvalue>
           <xref db="OMIM" id="614291" type="MIM">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            Ovarian cancer is a disease that affects women. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumor. The ovaries are the female reproductive organs in which egg cells are produced. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.The most common form of ovarian cancer begins in epithelial cells, which are the cells that line the surfaces and cavities of the body. These cancers can arise in the epithelial cells on the surface of the ovary. However, researchers suggest that many or even most ovarian cancers begin in epithelial cells on the fringes (fimbriae) at the end of one of the fallopian tubes, and the cancerous cells migrate to the ovary.Cancer can also begin in epithelial cells that form the lining of the abdomen (the peritoneum). This form of cancer, called primary peritoneal cancer, resembles epithelial ovarian cancer in its origin, symptoms, progression, and treatment. Primary peritoneal cancer often spreads to the ovaries. It can also occur even if the ovaries have been removed. Because cancers that begin in the ovaries, fallopian tubes, and peritoneum are so similar and spread easily from one of these structures to the others, they are often difficult to distinguish. These cancers are so closely related that they are generally considered collectively by experts.In about 10 percent of cases, ovarian cancer develops not in epithelial cells but in germ cells, which are precursors to egg cells, or in hormone-producing ovarian cells called granulosa cells.In its early stages, ovarian cancer usually does not cause noticeable symptoms. As the cancer progresses, signs and symptoms can include pain or a feeling of heaviness in the pelvis or lower abdomen, bloating, feeling full quickly when eating, back pain, vaginal bleeding between menstrual periods or after menopause, or changes in urinary or bowel habits. However, these changes can occur as part of many different conditions. Having one or more of these symptoms does not mean that a woman has ovarian cancer.In some cases, cancerous tumors can invade surrounding tissue and spread to other parts of the body. If ovarian cancer spreads, cancerous tumors most often appear in the abdominal cavity or on the surfaces of nearby organs such as the bladder or colon. Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers.Some ovarian cancers cluster in families. These cancers are described as hereditary and are associated with inherited gene mutations. Hereditary ovarian cancers tend to develop earlier in life than non-inherited (sporadic) cases.Because it is often diagnosed at a late stage, ovarian cancer can be difficult to treat; it leads to the deaths of about 14,000 women annually in the United States, more than any other gynecological cancer. However, when it is diagnosed and treated early, the 5-year survival rate is high.
           </attribute>
           <xref db="Genetics Home Reference" id="ovarian-cancer">
           </xref>
          </attributeset>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C3280345">
          </xref>
          <xref db="MONDO" id="MONDO:0013669">
          </xref>
          <xref db="OMIM" id="614291" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="13598" type="Disease">
         <trait id="18746" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Neoplastic Syndromes, Hereditary
           </elementvalue>
           <xref db="MeSH" id="D009386">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Hereditary cancer-predisposing syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="699346009">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Tumor predisposition
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Cancer predisposition
           </elementvalue>
           <xref db="Genetic Alliance" id="Hereditary+Cancer/3345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary Cancer Syndrome
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <citation abbrev="IARC, 2008" type="practice guideline">
           <id source="pmc">
            3075918
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="140162">
          </xref>
          <xref db="MedGen" id="C0027672">
          </xref>
          <xref db="MONDO" id="MONDO:0015356">
          </xref>
         </trait>
        </traitset>
        <traitset id="9460" type="Disease">
         <trait id="17556" type="Disease">
          <name>
           <elementvalue type="Preferred">
            not provided
           </elementvalue>
           <xref db="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre" id="13DG0619">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN517202">
          </xref>
         </trait>
        </traitset>
        <traitset id="9590" type="Disease">
         <trait id="16789" type="Disease">
          <name>
           <elementvalue type="Alternate">
            AllHighlyPenetrant
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Preferred">
            not specified
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN169374">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2017-09-27" datelastupdated="2020-08-01" id="1165867" submissiondate="2017-08-01">
       <clinvarsubmissionid localkey="NM_002878.3:c.973G&gt;A|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000602172" organizationcategory="laboratory" orgid="500110" submittername="Quest Diagnostics Nichols Institute San Juan Capistrano" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-03-06">
        <description>
         Uncertain significance
        </description>
        <citation>
         <id source="PubMed">
          25980754
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Quest Diagnostics Criteria
        </attribute>
        <citation>
         <id source="PubMed">
          26467025
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="RAD51D">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          p.Gly325Ser
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NM_002878.3:c.973G&gt;A
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB2915479
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-10-05" datelastupdated="2020-04-18" id="1611738" submissiondate="2018-08-20">
       <clinvarsubmissionid localkey="NC_000017.10:g.33427986C&gt;T|MedGen:C0677776" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000839168" organizationcategory="laboratory" orgid="500035" submittername="Mendelics" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2018-07-02">
        <description>
         Uncertain significance
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Mendelics Assertion Criteria 2017
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="RAD51D">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NC_000017.10:g.33427986C&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary breast and ovarian cancer syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0677776" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB4427121
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2019-05-29" datelastupdated="2021-02-10" id="1794757" submissiondate="2020-12-02">
       <clinvarsubmissionid localkey="NM_002878.3:c.973G&gt;A|MedGen:CN169374" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000918137" orgabbreviation="IG" organizationcategory="laboratory" orgid="500026" submittername="Integrated Genetics/Laboratory Corporation of America" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2020-11-04">
        <description>
         Uncertain significance
        </description>
        <citation>
         <id source="PubMed">
          25980754
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          25186627
         </id>
        </citation>
        <comment>
         Variant summary: RAD51D c.973G&gt;A (p.Gly325Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251494 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.973G&gt;A has been reported in the literature in an individual affected with breast cancer and an individual being tested for Lynch syndrome (Tung 2014, Yurgelun 2015). These reports do not provide unequivocal conclusions about association of the variant with Hereditary Breast and Ovarian Cancer. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         LabCorp Variant Classification Summary - May 2015
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="RAD51D">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_002878.3:c.973G&gt;A
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN169374" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB8677443
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-12-28" datelastupdated="2020-12-08" id="1299232" submissiondate="2020-11-30">
       <clinvarsubmissionid localkey="a00106" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000663814" organizationcategory="laboratory" orgid="61756" submittername="Ambry Genetics" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2020-06-24">
        <description>
         Uncertain significance
        </description>
        <comment>
         The p.G325S variant (also known as c.973G&gt;A), located in coding exon 10 of the RAD51D gene, results from a G to A substitution at nucleotide position 973. The glycine at codon 325 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Ambry Autosomal Dominant and X-Linked criteria (2/2020)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/izn1iuef/variant_classificationscheme_02.2020_ambry.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="RAD51D">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_002878.3:c.973G&gt;A
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         NonExomeUpdate_081220AmbryReport
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2019-03-12" datelastupdated="2021-01-27" id="1738504" submissiondate="2020-12-31">
       <clinvarsubmissionid localkey="NM_002878.3:c.973G&gt;A|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000888616" organizationcategory="laboratory" orgid="500110" submittername="Quest Diagnostics Nichols Institute San Juan Capistrano" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-09-04">
        <description>
         Uncertain significance
        </description>
        <citation>
         <id source="PubMed">
          25980754
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Quest Diagnostics criteria
        </attribute>
        <citation>
         <id source="PubMed">
          26467025
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="RAD51D">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_002878.3:c.973G&gt;A
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB8819638
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2014-05-13" datelastupdated="2021-02-27" id="270388" submissiondate="2019-01-29">
       <clinvarsubmissionid localkey="GDX:52315|Not Provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000149733" orgabbreviation="GDX" organizationcategory="laboratory" orgid="26957" submittername="GeneDx" type="SCV" version="15">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2018-03-08">
        <description>
         Uncertain significance
        </description>
        <comment>
         This variant is denoted RAD51D c.973G&gt;A at the cDNA level, p.Gly325Ser (G325S) at the protein level, and results in the change of a Glycine to a Serine (GGT&gt;AGT). This variant has been observed in at least one individual undergoing cancer panel testing due to a history suggestive of Lynch syndrome (Yurgelun 2015). RAD51D Gly325Ser was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is located in the RAD51C Binding Domain (Miller 2004). In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether RAD51D Gly325Ser is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         GeneDx Variant Classification (06012015)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="RAD51D">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="T" assembly="GRCh37" chr="17" referenceallele="C" start="33427986" stop="33427986" variantlength="1">
         </sequencelocation>
        </location>
        <attributeset>
         <attribute type="HGVS">
          NM_002878.3:c.973G&gt;A
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Not Provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB5098196
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-12-20" datelastupdated="2020-04-18" id="1249978" submissiondate="2020-02-06">
       <clinvarsubmissionid localkey="489332|MedGen:C3280345" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000651798" organizationcategory="laboratory" orgid="500031" submittername="Invitae" type="SCV" version="5">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-11-27">
        <description>
         Uncertain significance
        </description>
        <citation>
         <id source="PubMed">
          25186627
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          25980754
         </id>
        </citation>
        <comment>
         This sequence change replaces glycine with serine at codon 325 of the RAD51D protein (p.Gly325Ser). The glycine residue is weakly conserved and there is a small physicochemical difference between glycine and serine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in an individual affected with breast cancer (PMID: 25186627) and in an individual undergoing Lynch syndrome testing (PMID: 25980754). ClinVar contains an entry for this variant (Variation ID: 127898). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Invitae Variant Classification Sherloc (09022015)
        </attribute>
        <citation>
         <id source="PubMed">
          28492532
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="RAD51D">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_002878.3:c.973G&gt;A
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 4
          </elementvalue>
         </name>
         <xref db="MedGen" id="C3280345" type="CUI">
         </xref>
        </trait>
       </traitset>
       <citation type="general">
        <id source="PubMed">
         28492532
        </id>
       </citation>
       <submissionnamelist>
        <submissionname>
         SUB6933801
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-02-15" datelastupdated="2021-02-03" id="1342051" submissiondate="2020-05-19">
       <clinvarsubmissionid localkey="Db4KrQBSZeoE7-orUyypkfemWwgh_b-oEyo2_fGWK8M|MedGen:C0027672" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000686508" organizationcategory="laboratory" orgid="505849" submittername="Color Health, Inc" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-11-15">
        <description>
         Uncertain significance
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <typeplatform>
           NGS
          </typeplatform>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="RAD51D">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_002878.3:c.973G&gt;A
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <comment>
        This missense variant replaces glycine with serine at codon 325 of the RAD51D protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold &lt;= 0.5, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in individuals affected with breast cancer (PMID: 25186627) and Lynch syndromeassociated cancer and/or polyps (PMID: 25980754). This variant has also been identified in 2/251494 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
       </comment>
       <submissionnamelist>
        <submissionname>
         Color Genomics - ClinVar Submission - May2020 - SUB747
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="1342051" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1738504" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1165867" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1611738" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary breast and ovarian cancer syndrome" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1249978" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 4" traittype="Disease">
       <medgen cui="C3280345" name="Breast-ovarian cancer, familial 4">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="270388" mappingref="Preferred" mappingtype="Name" mappingvalue="Not Provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1299232" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1794757" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
     </traitmappinglist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000464706" datecreated="2017-12-20" datelastupdated="2021-01-25" numberofsubmissions="2" numberofsubmitters="2" recordtype="interpreted" variationid="464706" variationname="NM_001128425.1(MUTYH):c.1626C&gt;T (p.His542=)" variationtype="single nucleotide variant" version="5">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="447962" variationid="464706">
      <genelist>
       <gene fullname="mutY DNA glycosylase" geneid="4595" hgnc_id="HGNC:7527" relationshiptype="within single gene" source="submitted" symbol="MUTYH">
        <location>
         <cytogeneticlocation>
          1p34.1
         </cytogeneticlocation>
         <sequencelocation accession="NC_000001.11" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="1" display_start="45329242" display_stop="45340447" start="45329242" stop="45340447" strand="-">
         </sequencelocation>
         <sequencelocation accession="NC_000001.10" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="1" display_start="45794913" display_stop="45806141" start="45794913" stop="45806141" strand="-">
         </sequencelocation>
        </location>
        <omim>
         604933
        </omim>
        <property>
         gene_acmg_incidental_2013
        </property>
        <property>
         gene_acmg_incidental_2016
        </property>
       </gene>
      </genelist>
      <name>
       NM_001128425.1(MUTYH):c.1626C&gt;T (p.His542=)
      </name>
      <canonicalspdi>
       NC_000001.11:45329329:G:A
      </canonicalspdi>
      <varianttype>
       single nucleotide variant
      </varianttype>
      <location>
       <cytogeneticlocation>
        1p34.1
       </cytogeneticlocation>
       <sequencelocation accession="NC_000001.11" alternateallelevcf="A" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="1" display_start="45329330" display_stop="45329330" fordisplay="true" positionvcf="45329330" referenceallelevcf="G" start="45329330" stop="45329330" variantlength="1">
       </sequencelocation>
       <sequencelocation accession="NC_000001.10" alternateallelevcf="A" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="1" display_start="45795002" display_stop="45795002" positionvcf="45795002" referenceallelevcf="G" start="45795002" stop="45795002" variantlength="1">
       </sequencelocation>
      </location>
      <hgvslist>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.45795002G&gt;A" sequenceaccession="NC_000001" sequenceaccessionversion="NC_000001.10" sequenceversion="10">
         <expression>
          NC_000001.10:g.45795002G&gt;A
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.45329330G&gt;A" sequenceaccession="NC_000001" sequenceaccessionversion="NC_000001.11" sequenceversion="11">
         <expression>
          NC_000001.11:g.45329330G&gt;A
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1584C&gt;T" sequenceaccession="NM_001048171" sequenceaccessionversion="NM_001048171.1" sequenceversion="1">
         <expression>
          NM_001048171.1:c.1584C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His528=" sequenceaccession="NP_001041636" sequenceaccessionversion="NP_001041636.1" sequenceversion="1">
         <expression>
          NP_001041636.1:p.His528=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1545C&gt;T" sequenceaccession="NM_001048172" sequenceaccessionversion="NM_001048172.1" sequenceversion="1">
         <expression>
          NM_001048172.1:c.1545C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His515=" sequenceaccession="NP_001041637" sequenceaccessionversion="NP_001041637.1" sequenceversion="1">
         <expression>
          NP_001041637.1:p.His515=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1542C&gt;T" sequenceaccession="NM_001048173" sequenceaccessionversion="NM_001048173.1" sequenceversion="1">
         <expression>
          NM_001048173.1:c.1542C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His514=" sequenceaccession="NP_001041638" sequenceaccessionversion="NP_001041638.1" sequenceversion="1">
         <expression>
          NP_001041638.1:p.His514=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1542C&gt;T" sequenceaccession="NM_001048174" sequenceaccessionversion="NM_001048174.1" sequenceversion="1">
         <expression>
          NM_001048174.1:c.1542C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His514=" sequenceaccession="NP_001041639" sequenceaccessionversion="NP_001041639.1" sequenceversion="1">
         <expression>
          NP_001041639.1:p.His514=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1626C&gt;T" sequenceaccession="NM_001128425" sequenceaccessionversion="NM_001128425.1" sequenceversion="1">
         <expression>
          NM_001128425.1:c.1626C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His542=" sequenceaccession="NP_001121897" sequenceaccessionversion="NP_001121897.1" sequenceversion="1">
         <expression>
          NP_001121897.1:p.His542=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1587C&gt;T" sequenceaccession="NM_001293190" sequenceaccessionversion="NM_001293190.1" sequenceversion="1">
         <expression>
          NM_001293190.1:c.1587C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His529=" sequenceaccession="NP_001280119" sequenceaccessionversion="NP_001280119.1" sequenceversion="1">
         <expression>
          NP_001280119.1:p.His529=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1575C&gt;T" sequenceaccession="NM_001293191" sequenceaccessionversion="NM_001293191.1" sequenceversion="1">
         <expression>
          NM_001293191.1:c.1575C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His525=" sequenceaccession="NP_001280120" sequenceaccessionversion="NP_001280120.1" sequenceversion="1">
         <expression>
          NP_001280120.1:p.His525=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1266C&gt;T" sequenceaccession="NM_001293192" sequenceaccessionversion="NM_001293192.1" sequenceversion="1">
         <expression>
          NM_001293192.1:c.1266C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His422=" sequenceaccession="NP_001280121" sequenceaccessionversion="NP_001280121.1" sequenceversion="1">
         <expression>
          NP_001280121.1:p.His422=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1542C&gt;T" sequenceaccession="NM_001293195" sequenceaccessionversion="NM_001293195.1" sequenceversion="1">
         <expression>
          NM_001293195.1:c.1542C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His514=" sequenceaccession="NP_001280124" sequenceaccessionversion="NP_001280124.1" sequenceversion="1">
         <expression>
          NP_001280124.1:p.His514=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1266C&gt;T" sequenceaccession="NM_001293196" sequenceaccessionversion="NM_001293196.1" sequenceversion="1">
         <expression>
          NM_001293196.1:c.1266C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His422=" sequenceaccession="NP_001280125" sequenceaccessionversion="NP_001280125.1" sequenceversion="1">
         <expression>
          NP_001280125.1:p.His422=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1197C&gt;T" sequenceaccession="NM_001350650" sequenceaccessionversion="NM_001350650.1" sequenceversion="1">
         <expression>
          NM_001350650.1:c.1197C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His399=" sequenceaccession="NP_001337579" sequenceaccessionversion="NP_001337579.1" sequenceversion="1">
         <expression>
          NP_001337579.1:p.His399=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1197C&gt;T" sequenceaccession="NM_001350651" sequenceaccessionversion="NM_001350651.1" sequenceversion="1">
         <expression>
          NM_001350651.1:c.1197C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His399=" sequenceaccession="NP_001337580" sequenceaccessionversion="NP_001337580.1" sequenceversion="1">
         <expression>
          NP_001337580.1:p.His399=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1617C&gt;T" sequenceaccession="NM_012222" sequenceaccessionversion="NM_012222.2" sequenceversion="2">
         <expression>
          NM_012222.2:c.1617C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His539=" sequenceaccession="NP_036354" sequenceaccessionversion="NP_036354.1" sequenceversion="1">
         <expression>
          NP_036354.1:p.His539=
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001819" type="synonymous variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.1626C&gt;T" sequenceaccession="LRG_220t1" sequenceaccessionversion="LRG_220t1">
         <expression>
          LRG_220t1:c.1626C&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.His542=" sequenceaccession="LRG_220p1" sequenceaccessionversion="LRG_220p1">
         <expression>
          LRG_220p1:p.His542=
         </expression>
        </proteinexpression>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.1980C&gt;T" sequenceaccession="NR_146882" sequenceaccessionversion="NR_146882.1" sequenceversion="1">
         <expression>
          NR_146882.1:n.1980C&gt;T
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001619" type="non-coding transcript variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.1794C&gt;T" sequenceaccession="NR_146883" sequenceaccessionversion="NR_146883.1" sequenceversion="1">
         <expression>
          NR_146883.1:n.1794C&gt;T
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001619" type="non-coding transcript variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.16141C&gt;T" sequenceaccession="NG_008189" sequenceaccessionversion="NG_008189.1" sequenceversion="1">
         <expression>
          NG_008189.1:g.16141C&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.16141C&gt;T" sequenceaccession="LRG_220" sequenceaccessionversion="LRG_220">
         <expression>
          LRG_220:g.16141C&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
      <xreflist>
       <xref db="ClinGen" id="CA417701976">
       </xref>
       <xref db="dbSNP" id="1209611812" type="rs">
       </xref>
      </xreflist>
      <allelefrequencylist>
       <allelefrequency source="The Genome Aggregation Database (gnomAD), exomes" value="0.00000">
       </allelefrequency>
      </allelefrequencylist>
     </simpleallele>
     <reviewstatus>
      criteria provided, multiple submitters, no conflicts
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000549534" datelastevaluated="2019-12-31" interpretation="Likely benign" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_001128425.1(MUTYH):c.1626C&gt;T (p.His542=) AND MYH-associated polyposis" version="4">
       <interpretedconditionlist traitsetid="1473">
        <interpretedcondition db="MedGen" id="C1837991">
         MYH-associated polyposis
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000561413" datelastevaluated="2017-04-03" interpretation="Likely benign" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_001128425.1(MUTYH):c.1626C&gt;T (p.His542=) AND Hereditary cancer-predisposing syndrome" version="1">
       <interpretedconditionlist traitsetid="13598">
        <interpretedcondition db="MedGen" id="C0027672">
         Hereditary cancer-predisposing syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2019-12-31" numberofsubmissions="2" numberofsubmitters="2" type="Clinical significance">
       <description>
        Likely benign
       </description>
       <conditionlist>
        <traitset id="1473" type="Disease">
         <trait id="1532" type="Disease">
          <name>
           <elementvalue type="Alternate">
            COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE
           </elementvalue>
           <xref db="OMIM" id="608456" type="MIM">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE
           </elementvalue>
           <xref db="OMIM" id="608456" type="MIM">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            MYH-associated polyposis
           </elementvalue>
           <citation abbrev="Lindor, 2011" type="review">
            <id source="PubMed">
             21325953
            </id>
           </citation>
           <xref db="Genetic Alliance" id="MYH-associated+polyposis/8937">
           </xref>
           <xref db="OMIM" id="608456" type="MIM">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            FAP type 2
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            MUTYH-associated polyposis
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            FAP2
           </elementvalue>
           <xref db="OMIM" id="608456" type="MIM">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            MAP
           </elementvalue>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            MUTYH polyposis (also referred to as MUTYH-associated polyposis, or MAP) is characterized by a greatly increased lifetime risk of colorectal cancer (CRC). Although typically associated with ten to a few hundred colonic adenomatous polyps, CRC develops in some individuals in the absence of polyposis. Serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps can also occur. Duodenal adenomas are common, with an increased risk of duodenal cancer. The risk for malignancies of the ovary and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer. Additional reported features include thyroid nodules, benign adrenal lesions, jawbone cysts, and congenital hypertrophy of the retinal pigment epithelium.
           </attribute>
           <xref db="GeneReviews" id="NBK107219">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute integervalue="10805" type="GARD id">
           </attribute>
           <xref db="Office of Rare Diseases" id="10805">
           </xref>
          </attributeset>
          <citation abbrev="EuroGenetest, 2010" type="Translational/Evidence-based">
           <id source="pmc">
            2987420
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            23035301
           </id>
           <id source="BookShelf">
            NBK107219
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <citation abbrev="ASCO/ESMO, 2015" type="practice guideline">
           <id source="PubMed">
            25452455
           </id>
          </citation>
          <citation abbrev="ACMG, 2014" type="practice guideline">
           <id source="PubMed">
            24310308
           </id>
          </citation>
          <citation abbrev="ACG, 2015" type="practice guideline">
           <id source="PubMed">
            25645574
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="220460">
          </xref>
          <xref db="Orphanet" id="247798">
          </xref>
          <xref db="MedGen" id="C1837991">
          </xref>
          <xref db="MONDO" id="MONDO:0012041">
          </xref>
          <xref db="OMIM" id="608456" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="13598" type="Disease">
         <trait id="18746" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Hereditary cancer-predisposing syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="699346009">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Tumor predisposition
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Cancer predisposition
           </elementvalue>
           <xref db="Genetic Alliance" id="Hereditary+Cancer/3345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Neoplastic Syndromes, Hereditary
           </elementvalue>
           <xref db="MeSH" id="D009386">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary Cancer Syndrome
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <citation abbrev="IARC, 2008" type="practice guideline">
           <id source="pmc">
            3075918
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="140162">
          </xref>
          <xref db="MedGen" id="C0027672">
          </xref>
          <xref db="MONDO" id="MONDO:0015356">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2017-12-20" datelastupdated="2020-05-05" id="1231801" submissiondate="2020-01-29">
       <clinvarsubmissionid localkey="2021906|MedGen:C1837991" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000639299" organizationcategory="laboratory" orgid="500031" submittername="Invitae" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-12-31">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Invitae Variant Classification Sherloc (09022015)
        </attribute>
        <citation>
         <id source="PubMed">
          28492532
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="MUTYH">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_001128425.1:c.1626C&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           MYH-associated polyposis
          </elementvalue>
         </name>
         <xref db="MedGen" id="C1837991" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB6897608
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-12-28" datelastupdated="2020-12-08" id="1301918" submissiondate="2020-11-30">
       <clinvarsubmissionid localkey="a123952" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000666500" organizationcategory="laboratory" orgid="61756" submittername="Ambry Genetics" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-04-03">
        <description>
         Likely benign
        </description>
        <comment>
         In silico models in agreement (benign) ;Synonymous alterations with insufficient evidence to classify as benign
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Ambry Autosomal Dominant and X-Linked criteria (3/2017)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/uwtx4ijy/ad_xl_classificationscheme_03.2017_ambry.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="MUTYH">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_001128425.1:c.1626C&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         NonExomeUpdate_081220AmbryReport
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="1301918" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1231801" mappingref="Preferred" mappingtype="Name" mappingvalue="MYH-associated polyposis" traittype="Disease">
       <medgen cui="C1837991" name="MYH-associated polyposis">
       </medgen>
      </traitmapping>
     </traitmappinglist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000037003" datecreated="2012-08-24" datelastupdated="2021-01-25" numberofsubmissions="1" numberofsubmitters="1" recordtype="interpreted" variationid="37003" variationname="CDKN2A, 5-BP DUP, NT19" variationtype="Duplication" version="1">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="45669" variationid="37003">
      <genelist>
       <gene fullname="cyclin dependent kinase inhibitor 2A" geneid="1029" hgnc_id="HGNC:1787" relationshiptype="asserted, but not computed" source="submitted" symbol="CDKN2A">
        <location>
         <cytogeneticlocation>
          9p21.3
         </cytogeneticlocation>
         <sequencelocation accession="NC_000009.12" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="9" display_start="21967752" display_stop="21995324" start="21967752" stop="21995324" strand="-">
         </sequencelocation>
         <sequencelocation accession="NC_000009.11" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="9" display_start="21967750" display_stop="21994489" start="21967750" stop="21994489" strand="-">
         </sequencelocation>
        </location>
        <omim>
         600160
        </omim>
       </gene>
      </genelist>
      <name>
       CDKN2A, 5-BP DUP, NT19
      </name>
      <varianttype>
       Duplication
      </varianttype>
      <location>
       <cytogeneticlocation>
        9p21
       </cytogeneticlocation>
      </location>
      <othernamelist>
       <name>
        5-BP DUP, NT19
       </name>
      </othernamelist>
      <xreflist>
       <xref db="OMIM" id="600160.0022" type="Allelic variant">
       </xref>
      </xreflist>
     </simpleallele>
     <reviewstatus>
      no assertion criteria provided
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000030680" datelastevaluated="2012-06-01" interpretation="Pathogenic" reviewstatus="no assertion criteria provided" submissioncount="1" title="CDKN2A, 5-BP DUP, NT19 AND Melanoma-pancreatic cancer syndrome" version="6">
       <interpretedconditionlist traitsetid="2587">
        <interpretedcondition db="MedGen" id="C1838547">
         Melanoma-pancreatic cancer syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2012-06-01" numberofsubmissions="1" numberofsubmitters="1" type="Clinical significance">
       <description>
        Pathogenic
       </description>
       <citation type="general">
        <id source="PubMed">
         22636603
        </id>
       </citation>
       <conditionlist>
        <traitset id="2587" type="Disease">
         <trait id="2742" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Melanoma-pancreatic cancer syndrome
           </elementvalue>
           <xref db="Genetic Alliance" id="Melanoma-pancreatic+cancer+syndrome/8812">
           </xref>
           <xref db="MONDO" id="MONDO:0011713">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            Melanoma-pancreatic cancer syndrome is an inherited cancer predisposition syndrome in which mutation carriers have an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer (summary by Harinck et al., 2012).
For background and phenotypic information on malignant melanoma and pancreatic cancer, see 155600 and 260350, respectively.
           </attribute>
           <xref db="OMIM" id="606719" type="MIM">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325625">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501426">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000502978">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530028">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569524">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
          </attributeset>
          <citation abbrev="CAPS, 2013" type="practice guideline">
           <id source="pmc">
            3585492
           </id>
          </citation>
          <citation abbrev="ACG, 2015" type="practice guideline">
           <id source="PubMed">
            25645574
           </id>
          </citation>
          <xref db="Orphanet" id="404560">
          </xref>
          <xref db="MedGen" id="C1838547">
          </xref>
          <xref db="MONDO" id="MONDO:0011713">
          </xref>
          <xref db="OMIM" id="606719" type="MIM">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2012-08-24" datelastupdated="2019-03-31" id="88208" submissiondate="2012-08-22">
       <clinvarsubmissionid localkey="600160.0022_MELANOMA-PANCREATIC CANCER SYNDROME" title="CDKN2A, 5-BP DUP, NT19_MELANOMA-PANCREATIC CANCER SYNDROME">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000053341" organizationcategory="resource" orgid="3" submittername="OMIM" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2012-06-01">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           In 3 members of a family of Indonesian descent with pancreatic cancer (606719), Harinck et al. (2012) identified a heterozygous 5-bp duplication (19_23dup) in the CDKN2A gene, resulting in a frameshift and premature termination. Although there were no cases of melanoma in this family, Harinck et al. (2012) noted that the dark skin of the individuals may have offered protection from developing melanoma.
          </attribute>
          <citation>
           <id source="PubMed">
            22636603
           </id>
          </citation>
          <xref db="OMIM" id="606719" type="MIM">
          </xref>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="CDKN2A">
         </gene>
        </genelist>
        <name>
         CDKN2A, 5-BP DUP, NT19
        </name>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name type="NonHGVS">
          5-BP DUP, NT19
         </name>
        </othernamelist>
        <xreflist>
         <xref db="OMIM" id="600160.0022" type="Allelic variant">
         </xref>
        </xreflist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           MELANOMA-PANCREATIC CANCER SYNDROME
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="88208" mappingref="Preferred" mappingtype="Name" mappingvalue="MELANOMA-PANCREATIC CANCER SYNDROME" traittype="Disease">
       <medgen cui="C1838547" name="Melanoma-pancreatic cancer syndrome">
       </medgen>
      </traitmapping>
     </traitmappinglist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000228361" datecreated="2016-05-26" datelastupdated="2021-02-06" numberofsubmissions="1" numberofsubmitters="1" recordtype="interpreted" variationid="228361" variationname="NM_198159.2(MITF):c.(?_938)-102_*(78_?)del" variationtype="Deletion" version="1">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="228973" variationid="228361">
      <genelist>
       <gene fullname="melanocyte inducing transcription factor" geneid="4286" hgnc_id="HGNC:7105" relationshiptype="within single gene" source="submitted" symbol="MITF">
        <location>
         <cytogeneticlocation>
          3p13
         </cytogeneticlocation>
         <sequencelocation accession="NC_000003.12" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="3" display_start="69739464" display_stop="69968332" start="69739464" stop="69968332" strand="+">
         </sequencelocation>
         <sequencelocation accession="NC_000003.11" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="3" display_start="69788585" display_stop="70017487" start="69788585" stop="70017487" strand="+">
         </sequencelocation>
        </location>
        <omim>
         156845
        </omim>
        <haploinsufficiency clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MITF" last_evaluated="2012-05-31">
         Sufficient evidence for dosage pathogenicity
        </haploinsufficiency>
        <triplosensitivity clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MITF" last_evaluated="2012-05-31">
         No evidence available
        </triplosensitivity>
       </gene>
      </genelist>
      <name>
       NM_198159.2(MITF):c.(?_938)-102_*(78_?)del
      </name>
      <varianttype>
       Deletion
      </varianttype>
      <location>
       <cytogeneticlocation>
        3p13
       </cytogeneticlocation>
       <sequencelocation accession="NC_000003.12" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="3" display_start="69956353" display_stop="69965326" fordisplay="true" innerstart="69956353" innerstop="69965326" variantlength="8974">
       </sequencelocation>
       <sequencelocation accession="NC_000003.11" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="3" display_start="70005504" display_stop="70014477" innerstart="70005504" innerstop="70014477" variantlength="8974">
       </sequencelocation>
      </location>
      <hgvslist>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.(?_69956353)_(69965326_?)del" sequenceaccession="NC_000003" sequenceaccessionversion="NC_000003.12" sequenceversion="12">
         <expression>
          NC_000003.12:g.(?_69956353)_(69965326_?)del
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.(?_70005504)_(70014477_?)del" sequenceaccession="NC_000003" sequenceaccessionversion="NC_000003.11" sequenceversion="11">
         <expression>
          NC_000003.11:g.(?_70005504)_(70014477_?)del
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
     </simpleallele>
     <reviewstatus>
      criteria provided, single submitter
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000223260" datelastevaluated="2015-08-04" interpretation="Pathogenic" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_198159.2(MITF):c.(?_938)-102_*(78_?)del AND Rare genetic deafness" version="1">
       <interpretedconditionlist traitsetid="40993">
        <interpretedcondition db="MedGen" id="CN826980">
         Rare genetic deafness
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2015-08-04" numberofsubmissions="1" numberofsubmitters="1" type="Clinical significance">
       <description>
        Pathogenic
       </description>
       <citation type="general">
        <id source="PubMed">
         17318840
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         17627390
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         20127975
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         23512835
        </id>
       </citation>
       <conditionlist>
        <traitset id="40993" type="Disease">
         <trait id="38576" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Rare genetic deafness
           </elementvalue>
           <xref db="Orphanet" id="96210">
           </xref>
          </name>
          <xref db="Orphanet" id="96210">
          </xref>
          <xref db="MedGen" id="CN826980">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2016-05-26" datelastupdated="2020-10-07" id="507753" submissiondate="2019-03-21">
       <clinvarsubmissionid localkey="60517123|Orphanet:ORPHA96210" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000271395" organizationcategory="laboratory" orgid="21766" submittername="Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-08-04">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          17318840
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          17627390
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          23512835
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          20127975
         </id>
        </citation>
        <comment>
         The deletion of exons 8-10 in MITF has not been previously reported in individua ls with Waardenburg syndrome or in large population studies. This variant leads to a copy number loss of at least the last 3 exons of the MITF gene (exons 8 thr ough 10), and is predicted to lead to a truncated or absent protein. Haploinsuff iciency due to heterozygous loss of function variants in the MITF gene is an est ablished disease mechanism in Waardenburg syndrome type 2 (WS2). In summary, thi s variant meets our criteria to be classified as pathogenic for Waardenburg synd rome in an autosomal dominant manner based upon its predicted impact to the prot ein. It should be noted that exact breakpoints of the detected deletion could no t be determined due to limitations of the testing methodology.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="ModeOfInheritance">
         Autosomal dominant inheritance
        </attribute>
       </attributeset>
       <attributeset>
        <attribute type="AssertionMethod">
         LMM Criteria
        </attribute>
        <citation>
         <id source="PubMed">
          24033266
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
          <familydata numfamilieswithvariant="1">
          </familydata>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="MITF">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <genelocation>
          NM_198159.2:EXON 8-10
         </genelocation>
        </location>
        <othernamelist>
         <name>
          NM_198159.2:c.(?_938-102)_(*78_?)del
         </name>
         <name>
          p.?
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NC_000003.11:g.(?_70005504)_(70014477_?)del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="Orphanet" id="ORPHA96210">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB5348977
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="507753" mappingref="Orphanet" mappingtype="XRef" mappingvalue="ORPHA96210" traittype="Disease">
       <medgen cui="CN826980" name="Rare genetic deafness">
       </medgen>
      </traitmapping>
     </traitmappinglist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000037734" datecreated="2012-11-07" datelastupdated="2021-02-27" numberofsubmissions="29" numberofsubmitters="28" recordtype="interpreted" variationid="37734" variationname="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys)" variationtype="single nucleotide variant" version="10">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="46290" variationid="37734">
      <genelist>
       <gene fullname="BRCA2 DNA repair associated" geneid="675" hgnc_id="HGNC:1101" relationshiptype="within single gene" source="submitted" symbol="BRCA2">
        <location>
         <cytogeneticlocation>
          13q13.1
         </cytogeneticlocation>
         <sequencelocation accession="NC_000013.11" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="13" display_start="32315508" display_stop="32400268" start="32315508" stop="32400268" strand="+">
         </sequencelocation>
         <sequencelocation accession="NC_000013.10" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="13" display_start="32889616" display_stop="32973808" start="32889616" stop="32973808" strand="+">
         </sequencelocation>
        </location>
        <omim>
         600185
        </omim>
        <haploinsufficiency clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA2" last_evaluated="2012-07-06">
         Sufficient evidence for dosage pathogenicity
        </haploinsufficiency>
        <triplosensitivity clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA2" last_evaluated="2012-07-06">
         No evidence available
        </triplosensitivity>
        <property>
         gene_acmg_incidental_2013
        </property>
        <property>
         gene_acmg_incidental_2016
        </property>
       </gene>
      </genelist>
      <name>
       NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys)
      </name>
      <canonicalspdi>
       NC_000013.11:32319133:A:G
      </canonicalspdi>
      <varianttype>
       single nucleotide variant
      </varianttype>
      <location>
       <cytogeneticlocation>
        13q13.1
       </cytogeneticlocation>
       <sequencelocation accession="NC_000013.11" alternateallelevcf="G" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="13" display_start="32319134" display_stop="32319134" fordisplay="true" positionvcf="32319134" referenceallelevcf="A" start="32319134" stop="32319134" variantlength="1">
       </sequencelocation>
       <sequencelocation accession="NC_000013.10" alternateallelevcf="G" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="13" display_start="32893271" display_stop="32893271" positionvcf="32893271" referenceallelevcf="A" start="32893271" stop="32893271" variantlength="1">
       </sequencelocation>
      </location>
      <othernamelist>
       <name>
        p.Y42C:TAT&gt;TGT
       </name>
       <name>
        353A&gt;G
       </name>
      </othernamelist>
      <proteinchange>
       Y42C
      </proteinchange>
      <hgvslist>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.32893271A&gt;G" sequenceaccession="NC_000013" sequenceaccessionversion="NC_000013.10" sequenceversion="10">
         <expression>
          NC_000013.10:g.32893271A&gt;G
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.32319134A&gt;G" sequenceaccession="NC_000013" sequenceaccessionversion="NC_000013.11" sequenceversion="11">
         <expression>
          NC_000013.11:g.32319134A&gt;G
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.125A&gt;G" maneselect="true" sequenceaccession="NM_000059" sequenceaccessionversion="NM_000059.4" sequenceversion="4">
         <expression>
          NM_000059.4:c.125A&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Tyr42Cys" sequenceaccession="NP_000050" sequenceaccessionversion="NP_000050.3" sequenceversion="3">
         <expression>
          NP_000050.3:p.Tyr42Cys
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.125A&gt;G" sequenceaccession="NM_000059" sequenceaccessionversion="NM_000059.3" sequenceversion="3">
         <expression>
          NM_000059.3:c.125A&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Tyr42Cys" sequenceaccession="NP_000050" sequenceaccessionversion="NP_000050.2" sequenceversion="2">
         <expression>
          NP_000050.2:p.Tyr42Cys
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression sequenceaccession="LRG_293t1" sequenceaccessionversion="LRG_293t1">
         <expression>
          LRG_293t1:c.125A&gt;G
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Tyr42Cys">
         <expression>
          LRG_293p1:p.Tyr42Cys
         </expression>
        </proteinexpression>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.353A&gt;G" sequenceaccession="U43746" sequenceaccessionversion="U43746.1" sequenceversion="1">
         <expression>
          U43746.1:n.353A&gt;G
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.8655A&gt;G" sequenceaccession="NG_012772" sequenceaccessionversion="NG_012772.3" sequenceversion="3">
         <expression>
          NG_012772.3:g.8655A&gt;G
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.1230T&gt;C" sequenceaccession="NG_017006" sequenceaccessionversion="NG_017006.2" sequenceversion="2">
         <expression>
          NG_017006.2:g.1230T&gt;C
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression sequenceaccession="LRG_293" sequenceaccessionversion="LRG_293">
         <expression>
          LRG_293:g.8655A&gt;G
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
      <xreflist>
       <xref db="ClinGen" id="CA011360">
       </xref>
       <xref db="dbSNP" id="4987046" type="rs">
       </xref>
      </xreflist>
      <allelefrequencylist>
       <allelefrequency source="The Genome Aggregation Database (gnomAD)" value="0.00162">
       </allelefrequency>
       <allelefrequency source="The Genome Aggregation Database (gnomAD), exomes" value="0.00163">
       </allelefrequency>
       <allelefrequency source="Exome Aggregation Consortium (ExAC)" value="0.00170">
       </allelefrequency>
       <allelefrequency source="Trans-Omics for Precision Medicine (TOPMed)" value="0.00158">
       </allelefrequency>
       <allelefrequency source="1000 Genomes Project" value="0.00080">
       </allelefrequency>
       <allelefrequency source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" value="0.00246">
       </allelefrequency>
      </allelefrequencylist>
      <globalminorallelefrequency minorallele="G" source="1000 Genomes Project" value="0.00080">
      </globalminorallelefrequency>
     </simpleallele>
     <reviewstatus>
      reviewed by expert panel
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000034429" datelastevaluated="2017-05-15" interpretation="Conflicting interpretations of pathogenicity" reviewstatus="no assertion criteria provided" submissioncount="2" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND not provided" version="7">
       <interpretedconditionlist traitsetid="9460">
        <interpretedcondition db="MedGen" id="CN517202">
         not provided
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000113161" datelastevaluated="2015-08-10" interpretation="Benign" reviewstatus="reviewed by expert panel" submissioncount="11" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND Breast-ovarian cancer, familial 2" version="8">
       <interpretedconditionlist traitsetid="2560">
        <interpretedcondition db="MedGen" id="C2675520">
         Breast-ovarian cancer, familial 2
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000120379" datelastevaluated="2017-04-18" interpretation="Benign/Likely benign" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="7" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND not specified" version="12">
       <interpretedconditionlist traitsetid="9590">
        <interpretedcondition db="MedGen" id="CN169374">
         not specified
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000162523" datelastevaluated="2014-11-25" interpretation="Benign" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="3" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND Hereditary cancer-predisposing syndrome" version="2">
       <interpretedconditionlist traitsetid="13598">
        <interpretedcondition db="MedGen" id="C0027672">
         Hereditary cancer-predisposing syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000257910" datelastevaluated="2019-12-31" interpretation="Benign" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND Hereditary breast and ovarian cancer syndrome" version="8">
       <interpretedconditionlist traitsetid="7920">
        <interpretedcondition db="MedGen" id="C0677776">
         Hereditary breast and ovarian cancer syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000457914" datelastevaluated="2017-02-23" interpretation="Benign" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND Familial cancer of breast" version="1">
       <interpretedconditionlist traitsetid="774">
        <interpretedcondition db="MedGen" id="C0346153">
         Familial cancer of breast
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000768583" datelastevaluated="2016-02-19" interpretation="Benign" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND Breast and/or ovarian cancer" version="1">
       <interpretedconditionlist traitsetid="20192">
        <interpretedcondition db="MedGen" id="CN221562">
         Breast and/or ovarian cancer
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV001114846" datelastevaluated="2018-03-06" interpretation="Uncertain significance" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND Fanconi anemia, complementation group D1" version="1">
       <interpretedconditionlist traitsetid="2562">
        <interpretedcondition db="MedGen" id="C1838457">
         Fanconi anemia, complementation group D1
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV001282332" datelastevaluated="2019-10-31" interpretation="Benign" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000059.4(BRCA2):c.125A&gt;G (p.Tyr42Cys) AND none provided" version="1">
       <interpretedconditionlist traitsetid="23951">
        <interpretedcondition db="MedGen" id="CN235283">
         none provided
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2015-08-10" numberofsubmissions="29" numberofsubmitters="28" type="Clinical significance">
       <description>
        Benign
       </description>
       <citation type="general">
        <id source="PubMed">
         11389159
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         22703879
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         15695382
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         19200354
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         18451181
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         22713736
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         21990134
        </id>
       </citation>
       <citation type="general">
        <url>
         http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=BRCA2
        </url>
       </citation>
       <citation type="general">
        <id source="PubMed">
         21520273
        </id>
       </citation>
       <citation type="general">
        <url>
         http://hci-exlovd.hci.utah.edu/variants.php?select_db=BRCA2&amp;action=search_all&amp;search_Variant%2FDNA=c.125A%3EG
        </url>
       </citation>
       <citation type="general">
        <id source="PubMed">
         9126734
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         16489001
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         9042907
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         15290653
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         18824701
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         10699917
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         12527904
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         15876480
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         12474142
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         18607349
        </id>
       </citation>
       <conditionlist>
        <traitset id="9590" type="Disease">
         <trait id="16789" type="Disease">
          <name>
           <elementvalue type="Alternate">
            AllHighlyPenetrant
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Preferred">
            not specified
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN169374">
          </xref>
         </trait>
        </traitset>
        <traitset id="9460" type="Disease">
         <trait id="17556" type="Disease">
          <name>
           <elementvalue type="Preferred">
            not provided
           </elementvalue>
           <xref db="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre" id="13DG0619">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN517202">
          </xref>
         </trait>
        </traitset>
        <traitset id="23951" type="Finding">
         <trait id="34699" type="Finding">
          <name>
           <elementvalue type="Preferred">
            none provided
           </elementvalue>
          </name>
          <xref db="MedGen" id="CN235283">
          </xref>
         </trait>
        </traitset>
        <traitset id="2562" type="Disease">
         <trait id="1276" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Fanconi anemia, complementation group D1
           </elementvalue>
           <xref db="Genetic Alliance" id="Fanconi+anemia%2C+complementation+group+D1/8410">
           </xref>
          </name>
          <symbol>
           <elementvalue type="Alternate">
            FAD1
           </elementvalue>
           <xref db="OMIM" id="605724" type="MIM">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Preferred">
            FANCD1
           </elementvalue>
           <xref db="OMIM" id="605724" type="MIM">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="public definition">
            Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors  particularly of the head and neck, skin, gastrointestinal tract, and genitourinary tract  are more common in individuals with FA.
           </attribute>
           <xref db="GeneReviews" id="NBK1401">
           </xref>
          </attributeset>
          <citation type="Suggested Reading">
           <id source="PubMed">
            14559878
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301471
           </id>
           <id source="BookShelf">
            NBK1294
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301575
           </id>
           <id source="BookShelf">
            NBK1401
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301753
           </id>
           <id source="BookShelf">
            NBK5192
           </id>
          </citation>
          <citation abbrev="FARF, 2008" type="practice guideline">
           <url>
            http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf
           </url>
           <citationtext>
            Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008
           </citationtext>
          </citation>
          <xref db="Orphanet" id="319462">
          </xref>
          <xref db="MedGen" id="C1838457">
          </xref>
          <xref db="MONDO" id="MONDO:0011584">
          </xref>
          <xref db="OMIM" id="605724" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="2560" type="Disease">
         <trait id="636" type="Disease">
          <name>
           <elementvalue type="Alternate">
            BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
           </elementvalue>
           <xref db="OMIM" id="612555" type="MIM">
           </xref>
           <xref db="OMIM" id="600185.0005" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0006" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0012" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0007" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0008" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0010" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0003" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0004" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0009" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0016" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0001" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0002" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0011" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0014" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Breast-ovarian cancer, familial 2
           </elementvalue>
           <xref db="Genetic Alliance" id="Breast-ovarian+cancer%2C+familial+2/7866">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
           </elementvalue>
           <xref db="OMIM" id="612555">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Breast cancer, familial 2
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            BROVCA2
           </elementvalue>
           <xref db="OMIM" id="612555" type="MIM">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501744">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            BRCA2
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501818">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507864">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509692">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000519030">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520069">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520869">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520872">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530707">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021468">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325401">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000326160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501744">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501818">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509984">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520866">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520870">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551447">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569406">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509985">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512645">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520867">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017874">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000320777">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000332529">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501748">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520865">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520871">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531275">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531340">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552304">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569423">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="CAPS, 2013" type="practice guideline">
           <id source="pmc">
            3585492
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C2675520">
          </xref>
          <xref db="MONDO" id="MONDO:0012933">
          </xref>
          <xref db="OMIM" id="612555" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="13598" type="Disease">
         <trait id="18746" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Neoplastic Syndromes, Hereditary
           </elementvalue>
           <xref db="MeSH" id="D009386">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Hereditary cancer-predisposing syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="699346009">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Tumor predisposition
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Cancer predisposition
           </elementvalue>
           <xref db="Genetic Alliance" id="Hereditary+Cancer/3345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary Cancer Syndrome
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <citation abbrev="IARC, 2008" type="practice guideline">
           <id source="pmc">
            3075918
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="140162">
          </xref>
          <xref db="MedGen" id="C0027672">
          </xref>
          <xref db="MONDO" id="MONDO:0015356">
          </xref>
         </trait>
        </traitset>
        <traitset id="774" type="Disease">
         <trait id="536" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Breast cancer, familial
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            CHEK2-Related Breast Cancer
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Preferred">
            Familial cancer of breast
           </elementvalue>
           <xref db="Genetic Alliance" id="Familial+cancer+of+breast/8375">
           </xref>
           <xref db="SNOMED CT" id="254843006">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531340">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000561700">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569423">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000591268">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530707">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558503">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="Stratton and Rahman, 2008" type="review">
           <id source="PubMed">
            18163131
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <xref db="Orphanet" id="227535">
          </xref>
          <xref db="MedGen" id="C0346153">
          </xref>
          <xref db="MONDO" id="MONDO:0016419">
          </xref>
          <xref db="OMIM" id="114480" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="7920" type="Disease">
         <trait id="16761" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Hereditary breast and ovarian cancer syndrome
           </elementvalue>
           <xref db="MeSH" id="D061325">
           </xref>
           <xref db="Orphanet" id="145">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer
           </elementvalue>
           <xref db="CSER _CC_NCGL, University of Washington" id="UWMG_4506306">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer syndrome (HBOC)
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021468">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325401">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017876">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508566">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508956">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509985">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521499">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000523320">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551440">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551441">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552183">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552302">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558503">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000561859">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325409">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000502103">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509978">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000514601">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520887">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522161">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530028">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000592450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501981">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000503369">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509984">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512699">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521908">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017874">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021517">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508948">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509983">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521909">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522278">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522559">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530118">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551448">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558910">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000591268">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="ASCO, 2003" type="Position Statement">
           <id source="PubMed">
            12692171
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="Stratton and Rahman, 2008" type="review">
           <id source="PubMed">
            18163131
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C0677776">
          </xref>
          <xref db="MeSH" id="D061325">
          </xref>
          <xref db="MONDO" id="MONDO:0003582">
          </xref>
          <xref db="OMIM" id="PS604370" type="Phenotypic series">
          </xref>
         </trait>
        </traitset>
        <traitset id="20192" type="Disease">
         <trait id="32337" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Breast and/or ovarian cancer
           </elementvalue>
           <xref db="CSER _CC_NCGL, University of Washington" id="UWMG_7622958">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            Ovarian cancer is a disease that affects women. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumor. The ovaries are the female reproductive organs in which egg cells are produced. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.The most common form of ovarian cancer begins in epithelial cells, which are the cells that line the surfaces and cavities of the body. These cancers can arise in the epithelial cells on the surface of the ovary. However, researchers suggest that many or even most ovarian cancers begin in epithelial cells on the fringes (fimbriae) at the end of one of the fallopian tubes, and the cancerous cells migrate to the ovary.Cancer can also begin in epithelial cells that form the lining of the abdomen (the peritoneum). This form of cancer, called primary peritoneal cancer, resembles epithelial ovarian cancer in its origin, symptoms, progression, and treatment. Primary peritoneal cancer often spreads to the ovaries. It can also occur even if the ovaries have been removed. Because cancers that begin in the ovaries, fallopian tubes, and peritoneum are so similar and spread easily from one of these structures to the others, they are often difficult to distinguish. These cancers are so closely related that they are generally considered collectively by experts.In about 10 percent of cases, ovarian cancer develops not in epithelial cells but in germ cells, which are precursors to egg cells, or in hormone-producing ovarian cells called granulosa cells.In its early stages, ovarian cancer usually does not cause noticeable symptoms. As the cancer progresses, signs and symptoms can include pain or a feeling of heaviness in the pelvis or lower abdomen, bloating, feeling full quickly when eating, back pain, vaginal bleeding between menstrual periods or after menopause, or changes in urinary or bowel habits. However, these changes can occur as part of many different conditions. Having one or more of these symptoms does not mean that a woman has ovarian cancer.In some cases, cancerous tumors can invade surrounding tissue and spread to other parts of the body. If ovarian cancer spreads, cancerous tumors most often appear in the abdominal cavity or on the surfaces of nearby organs such as the bladder or colon. Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers.Some ovarian cancers cluster in families. These cancers are described as hereditary and are associated with inherited gene mutations. Hereditary ovarian cancers tend to develop earlier in life than non-inherited (sporadic) cases.Because it is often diagnosed at a late stage, ovarian cancer can be difficult to treat; it leads to the deaths of about 14,000 women annually in the United States, more than any other gynecological cancer. However, when it is diagnosed and treated early, the 5-year survival rate is high.
           </attribute>
           <xref db="Genetics Home Reference" id="ovarian-cancer">
           </xref>
          </attributeset>
          <xref db="MedGen" id="CN221562">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2013-03-26" datelastupdated="2020-04-18" id="98327" submissiondate="2012-07-15">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|not provided">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000043191" organizationcategory="laboratory" orgid="1160" submittername="Biesecker Lab/Clinical Genomics Section,National Institutes of Health" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2012-07-13">
        <description>
         variant of unknown significance
        </description>
        <comment>
         Converted during submission to Uncertain significance.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           no
          </affectedstatus>
          <numbertested>
           550
          </numbertested>
         </sample>
         <method>
          <nameplatform>
           Illumina GAIIx
          </nameplatform>
          <typeplatform>
           High-Throughput DNA Sequencing
          </typeplatform>
          <purpose>
           discovery
          </purpose>
          <software name="Eland" purpose="alignment">
          </software>
          <software name="Most Probable Genotype" purpose="variant calls">
          </software>
          <methodtype>
           research
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="2" type="VariantAlleles">
          </attribute>
         </observeddata>
         <comment>
          The study set was not selected for affection status in relation to any cancer. Pathogenicity categories were based on literature curation. See Pubmed ID:22703879 for details.
         </comment>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          p.Tyr42Cys
         </name>
        </othernamelist>
        <xreflist>
         <xref db="dbSNP" id="4987046" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <citation type="general">
        <id source="PubMed">
         22703879
        </id>
       </citation>
       <studyname>
        ClinSeq
       </studyname>
       <submissionnamelist>
        <submissionname>
         ClinSeq_cancer
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-06-03" datelastupdated="2020-04-18" id="410273" submissiondate="2015-05-28">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|OMIM:612555">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000223764" organizationcategory="laboratory" orgid="505209" submittername="Pathway Genomics" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2014-10-30">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          15290653
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15695382
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 2
          </elementvalue>
         </name>
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2014-03-30" datelastupdated="2020-04-18" id="263111" submissiondate="2014-03-28">
       <clinvarsubmissionid localkey="U43746.1:n.353A&gt;G|MedGen:C2675520">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000146213" organizationcategory="locus-specific database (LSDB)" orgid="504197" submittername="Breast Cancer Information Core (BIC) (BRCA2)" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion provided
       </reviewstatus>
       <interpretation>
        <description>
         not provided
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="40" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <geographicorigin>
           Ashkenazi
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <geographicorigin>
           Austria
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <geographicorigin>
           Central/Eastern European
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <geographicorigin>
           Latin American, Caribbean
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <geographicorigin>
           Western European
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="7" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Ashkenazi
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="11" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Ashkenazi, Western European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Caucasian
          </ethnicity>
          <geographicorigin>
           Denmark
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Caucasian
          </ethnicity>
          <geographicorigin>
           Germany
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Caucasian
          </ethnicity>
          <geographicorigin>
           Italy
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Caucasian
          </ethnicity>
          <geographicorigin>
           Spain
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Central/Eastern European, Jamaican
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Greek
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Latin American, Caribbean, Hispanic
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Near Eastern, Middle East
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="58" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European, Ashkenazi
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European, English
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European, French Canadian
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European, Irish, Scottish
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European, Italian
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="2" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European, Latin American, Caribbe
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European, Native American
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western Europeanan, Central/Eastern European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <genelocation>
          U43746.1:exon 3
         </genelocation>
        </location>
        <othernamelist>
         <name>
          Y42C
         </name>
        </othernamelist>
        <xreflist>
         <xref db="dbSNP" id="4987046" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          U43746.1:n.353A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 2
          </elementvalue>
         </name>
         <xref db="MedGen" id="C2675520" type="CUI">
         </xref>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-05-06" datelastupdated="2020-04-18" id="502760" submissiondate="2016-04-21">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000195945" organizationcategory="laboratory" orgid="308659" submittername="Michigan Medical Genetics Laboratories,University of Michigan" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2014-11-03">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <tissue>
           Blood
          </tissue>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <xreflist>
         <xref db="dbSNP" id="4987046" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2012-11-07" datelastupdated="2020-04-18" id="89535" submissiondate="2013-12-30">
       <clinvarsubmissionid localkey="SCRP_var_364" title="NM_000059.3:c.125A&gt;G AND Breast-ovarian cancer, familial 2">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000053920" orgabbreviation="SCRP" organizationcategory="consortium" orgid="500037" submittername="Sharing Clinical Reports Project (SCRP)" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2012-05-01">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute datevalue="2006-03-16" integervalue="1" type="ClinicalSignificanceHistory">
         Uncertain significance was amended to Benign
        </attribute>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
          <numbertested>
           2
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="VariantAlleles">
           2
          </attribute>
         </observeddata>
         <co-occurrenceset>
          <zygosity>
           SingleHeterozygote
          </zygosity>
          <alleledescset>
           <name>
            BRCA2:G1771D
           </name>
           <zygosity>
            SingleHeterozygote
           </zygosity>
           <clinicalsignificance>
            <reviewstatus>
             no assertion criteria provided
            </reviewstatus>
            <description>
             Benign
            </description>
           </clinicalsignificance>
          </alleledescset>
          <count>
           1
          </count>
         </co-occurrenceset>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <proteinchange>
         Y42C
        </proteinchange>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 2
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-01-04" datelastupdated="2020-04-18" id="952450" submissiondate="2016-11-23">
       <clinvarsubmissionid localkey="48543|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000488699" organizationcategory="laboratory" orgid="320494" submittername="Counsyl" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2016-05-24">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          15695382
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15290653
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21990134
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Counsyl Autosomal Dominant Disease Classification criteria (2015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_(2015)_v1.pdf
         </url>
         <citationtext>
          Counsyl Autosomal Dominant Disease Classification criteria (2015)
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         Counsyl2016
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-02-03" datelastupdated="2021-02-10" id="966832" submissiondate="2016-11-14">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|MedGen:C0677776" submittedassembly="hg19">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000494373" orgabbreviation="IG" organizationcategory="laboratory" orgid="500026" submittername="Integrated Genetics/Laboratory Corporation of America" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2013-10-09">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          22703879
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15695382
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21990134
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          19200354
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          11389159
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          12474142
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          16489001
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          10699917
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          9126734
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18451181
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15290653
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22713736
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18607349
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          9042907
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18824701
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         LabCorp Variant Classification Summary - May 2015
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf
         </url>
         <citationtext>
          LabCorp Variant Classification Summary - May 2015.docx
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <xreflist>
         <xref db="dbSNP" id="4987046" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MedGen" id="C0677776" type="CUI">
         </xref>
        </trait>
       </traitset>
       <studydescription>
        initial submission of 144 BRCA variants, updates to 5 previously submitted variants
       </studydescription>
       <submissionnamelist>
        <submissionname>
         BRCA_variants_111416
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-04-13" datelastupdated="2020-04-18" id="1053953" submissiondate="2017-02-23">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|Familial cancer of breast" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000541034" orgabbreviation="BCM: BMGL" organizationcategory="laboratory" orgid="1006" submittername="Baylor Genetics" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-02-23">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="ModeOfInheritance">
         Autosomal dominant inheritance
        </attribute>
       </attributeset>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           no
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Familial cancer of breast
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <studydescription>
        Variants for BRCA1/2 tests
       </studydescription>
       <submissionnamelist>
        <submissionname>
         BRCA12
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-08-25" datelastupdated="2020-08-13" id="1150142" submissiondate="2017-07-05">
       <clinvarsubmissionid localkey="NM_000059.3(BRCA2):c.125A&gt;G|not specified" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000593698" organizationcategory="laboratory" orgid="1238" submittername="Genetic Services Laboratory,University of Chicago" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-12-03">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           no
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB2843028
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-02-15" datelastupdated="2021-02-03" id="1338953" submissiondate="2017-10-26">
       <clinvarsubmissionid localkey="Db4KrQBSZeoE7-orUyypkfyT7w8mLuFYHRA9zhAgAPg|MedGen:C0027672" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000683410" organizationcategory="laboratory" orgid="505849" submittername="Color Health, Inc" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2014-11-25">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <typeplatform>
           NGS
          </typeplatform>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3163908
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2014-06-18" datelastupdated="2021-02-27" id="289320" submissiondate="2018-03-26">
       <clinvarsubmissionid localkey="GDX:7858|Not Provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000167396" orgabbreviation="GDX" organizationcategory="laboratory" orgid="26957" submittername="GeneDx" type="SCV" version="11">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2013-10-28">
        <description>
         Benign
        </description>
        <comment>
         This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         GeneDx Variant Classification (06012015)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="G" assembly="GRCh37" chr="13" referenceallele="A" start="32893271" stop="32893271" variantlength="1">
         </sequencelocation>
        </location>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3839901
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-04-18" datelastupdated="2020-04-18" id="1450833" submissiondate="2018-04-09">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000744379" organizationcategory="laboratory" orgid="506497" submittername="DNA and Cytogenetics Diagnostics Unit,Erasmus Medical Center" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-09-21">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACGS Guidelines, 2013
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/3yyso7ro/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studyname>
        VKGL Data-share Consensus
       </studyname>
       <submissionnamelist>
        <submissionname>
         SUB3885264
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-06-22" datelastupdated="2020-04-18" id="1518299" submissiondate="2018-03-09">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000778632" organizationcategory="laboratory" orgid="500068" submittername="Mayo Clinic Genetic Testing Laboratories,Mayo Clinic" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2017-05-15">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3765485
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-06-25" datelastupdated="2020-10-30" id="417086" submissiondate="2018-09-19">
       <clinvarsubmissionid localkey="30271_000000" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000228768" orgabbreviation="EGL" organizationcategory="laboratory" orgid="500060" submittername="EGL Genetic Diagnostics, Eurofins Clinical Diagnostics" type="SCV" version="5">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-05-19">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         EGL_Classification_Definitions_2015
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <gender>
           mixed
          </gender>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="2" type="VariantAlleles">
          </attribute>
         </observeddata>
         <observeddata>
          <attribute integervalue="2" type="SingleHeterozygote">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         single nucleotide variant
        </varianttype>
        <location>
         <sequencelocation alternateallele="G" assembly="GRCh37" chr="13" referenceallele="A" start="32893271" stop="32893271" variantlength="1">
         </sequencelocation>
         <genelocation>
          NM_000059.3:Ex3
         </genelocation>
        </location>
        <xreflist>
         <xref db="HGMD" id="CM970178">
         </xref>
         <xref db="dbSNP" id="4987046" type="rsNumber">
         </xref>
        </xreflist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <citation>
        <url>
         http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=BRCA2
        </url>
       </citation>
       <submissionnamelist>
        <submissionname>
         SUB4534263
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-03-28" datelastupdated="2020-04-18" id="396030" submissiondate="2018-04-30">
       <clinvarsubmissionid localkey="300004|MedGen:CN221562" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000219274" organizationcategory="laboratory" orgid="1050" submittername="CHEO Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2016-02-19">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast and/or ovarian cancer
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN221562" type="CUI">
         </xref>
        </trait>
       </traitset>
       <studyname>
        Canadian Open Genetics Repository
       </studyname>
       <submissionnamelist>
        <submissionname>
         SUB3960680
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-04-13" datelastupdated="2020-05-05" id="1073343" submissiondate="2020-01-29">
       <clinvarsubmissionid localkey="24859|MedGen:C0677776" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000560432" organizationcategory="laboratory" orgid="500031" submittername="Invitae" type="SCV" version="5">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-12-31">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Invitae Variant Classification Sherloc (09022015)
        </attribute>
        <citation>
         <id source="PubMed">
          28492532
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary breast and ovarian cancer syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0677776" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB6897608
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-09-27" datelastupdated="2021-01-27" id="1166578" submissiondate="2020-12-11">
       <clinvarsubmissionid localkey="159567|MedGen:CN235283" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000602882" organizationcategory="laboratory" orgid="25969" submittername="ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-10-31">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ARUP Molecular Germline Variant Investigation Process
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NC_000013.10:g.32893271A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Finding">
        <trait type="Finding">
         <xref db="MedGen" id="CN235283" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         2020 ARUP
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2014-06-09" datelastupdated="2020-04-18" id="281500" submissiondate="2014-05-29">
       <clinvarsubmissionid localkey="MedGen:CN169374">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000084531" organizationcategory="laboratory" orgid="504914" submittername="ITMI" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion provided
       </reviewstatus>
       <interpretation datelastevaluated="2013-09-19">
        <description>
         not provided
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Whole_cohort
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           681
          </numbertested>
         </sample>
         <method>
          <nameplatform>
           Complete Genomics
          </nameplatform>
          <typeplatform>
           next-gen sequencing
          </typeplatform>
          <purpose>
           discovery
          </purpose>
          <methodtype>
           reference population
          </methodtype>
         </method>
         <observeddata>
          <attribute type="AlleleFrequency">
           0.0022
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           African
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           43
          </numbertested>
         </sample>
         <method>
          <nameplatform>
           Complete Genomics
          </nameplatform>
          <typeplatform>
           next-gen sequencing
          </typeplatform>
          <purpose>
           discovery
          </purpose>
          <methodtype>
           reference population
          </methodtype>
         </method>
         <observeddata>
          <attribute type="AlleleFrequency">
           0
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           African_European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           46
          </numbertested>
         </sample>
         <method>
          <nameplatform>
           Complete Genomics
          </nameplatform>
          <typeplatform>
           next-gen sequencing
          </typeplatform>
          <purpose>
           discovery
          </purpose>
          <methodtype>
           reference population
          </methodtype>
         </method>
         <observeddata>
          <attribute type="AlleleFrequency">
           0
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Central_Asian
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           50
          </numbertested>
         </sample>
         <method>
          <nameplatform>
           Complete Genomics
          </nameplatform>
          <typeplatform>
           next-gen sequencing
          </typeplatform>
          <purpose>
           discovery
          </purpose>
          <methodtype>
           reference population
          </methodtype>
         </method>
         <observeddata>
          <attribute type="AlleleFrequency">
           0
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           East_Asian
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           62
          </numbertested>
         </sample>
         <method>
          <nameplatform>
           Complete Genomics
          </nameplatform>
          <typeplatform>
           next-gen sequencing
          </typeplatform>
          <purpose>
           discovery
          </purpose>
          <methodtype>
           reference population
          </methodtype>
         </method>
         <observeddata>
          <attribute type="AlleleFrequency">
           0
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           331
          </numbertested>
         </sample>
         <method>
          <nameplatform>
           Complete Genomics
          </nameplatform>
          <typeplatform>
           next-gen sequencing
          </typeplatform>
          <purpose>
           discovery
          </purpose>
          <methodtype>
           reference population
          </methodtype>
         </method>
         <observeddata>
          <attribute type="AlleleFrequency">
           0.003
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Hispanic
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           118
          </numbertested>
         </sample>
         <method>
          <nameplatform>
           Complete Genomics
          </nameplatform>
          <typeplatform>
           next-gen sequencing
          </typeplatform>
          <purpose>
           discovery
          </purpose>
          <methodtype>
           reference population
          </methodtype>
         </method>
         <observeddata>
          <attribute type="AlleleFrequency">
           0.0042
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="G" assembly="GRCh37" chr="13" referenceallele="A" start="32893271" stop="32893271" variantlength="1">
         </sequencelocation>
        </location>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           AllHighlyPenetrant
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN169374" type="CUI">
         </xref>
        </trait>
       </traitset>
       <citation type="general">
        <id source="PubMed">
         24728327
        </id>
       </citation>
       <comment>
        Please see associated publication for description of ethnicities
       </comment>
       <submissionnamelist>
        <submissionname>
         Cancer_genes_01
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-09-26" datelastupdated="2020-04-18" id="455915" submissiondate="2015-08-17">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|OMIM:612555">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000244419" orgabbreviation="ENIGMA" organizationcategory="consortium" orgid="504863" submittername="Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        reviewed by expert panel
       </reviewstatus>
       <interpretation datelastevaluated="2015-08-10">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          21990134
         </id>
        </citation>
        <citation>
         <url>
          http://hci-exlovd.hci.utah.edu/variants.php?select_db=BRCA2&amp;action=search_all&amp;search_Variant%2FDNA=c.125A%3EG
         </url>
        </citation>
        <comment>
         IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 1.22E-18. Also class 1 based on frequency &gt;1% in an outbred sampleset. Frequency 0.04021 (Asian), 0.1016 (African), 0.04749 (European), derived from 1000 genomes (2012-04-30).
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ENIGMA BRCA1/2 Classification Criteria (2015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf
         </url>
         <citationtext>
          ENIGMA BRCA1/2 Classification Criteria (2015)
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           curation
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          353A&gt;G
         </name>
         <name>
          Y42C
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 2
          </elementvalue>
         </name>
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studydescription>
        ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/
       </studydescription>
       <submissionnamelist>
        <submissionname>
         ENIGMA_2015-08-17
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-09-28" datelastupdated="2020-08-27" id="583432" submissiondate="2016-04-28">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|NOT SPECIFIED" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000301753" organizationcategory="laboratory" orgid="239772" submittername="PreventionGenetics,PreventionGenetics" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation>
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           NOT SPECIFIED
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-08-04" datelastupdated="2020-04-18" id="1139841" submissiondate="2017-08-04">
       <clinvarsubmissionid localkey="462052|not specified" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000586914" organizationcategory="laboratory" orgid="506183" submittername="Cancer Genetics and Genomics Laboratory,British Columbia Cancer Agency" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-04-18">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <studyname>
        The Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         CCG20170515
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-08-25" datelastupdated="2020-04-18" id="1148105" submissiondate="2017-04-19">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|not specified" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000591661" orgabbreviation="PLM-SHS" organizationcategory="laboratory" orgid="506152" submittername="Department of Pathology and Laboratory Medicine,Sinai Health System" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2012-11-15">
        <description>
         Benign
        </description>
        <citation>
         <id source="PubMed">
          9042907
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          11389159
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          12474142
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          12527904
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15290653
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15695382
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          16489001
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18451181
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18824701
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          19200354
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          21520273
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15876480
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          10699917
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <genelocation>
          NM_000059.3:exon 03
         </genelocation>
        </location>
        <othernamelist>
         <name>
          p.Tyr42Cys
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <studyname>
        The Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         SHS20170111
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-04-06" datelastupdated="2020-04-18" id="1414369" submissiondate="2018-04-04">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000733208" orgabbreviation="DL-UMCG" organizationcategory="laboratory" orgid="506382" submittername="Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation>
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studyname>
        VKGL Data-share Consensus
       </studyname>
       <submissionnamelist>
        <submissionname>
         SUB3868021
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-04-18" datelastupdated="2020-04-18" id="1449690" submissiondate="2018-04-17">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000743236" orgabbreviation="GDL-UMCU" organizationcategory="laboratory" orgid="274978" submittername="Genome Diagnostics Laboratory,University Medical Center Utrecht" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2014-10-09">
        <description>
         Benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACGS Guidelines, 2013
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/yggjhwfz/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studyname>
        VKGL Data-share Consensus
       </studyname>
       <submissionnamelist>
        <submissionname>
         SUB3915625
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-07-26" datelastupdated="2020-04-18" id="1537822" submissiondate="2018-03-08">
       <clinvarsubmissionid localkey="NM_000059.3:c.125A&gt;G|Hereditary cancer-predisposing syndrome" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000787917" organizationcategory="laboratory" orgid="506273" submittername="True Health Diagnostics" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2017-10-10">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3763954
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-01-07" datelastupdated="2020-04-18" id="2244748" submissiondate="2019-10-22">
       <clinvarsubmissionid localkey="NC_000013.10:g.32893271A&gt;G|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001138945" organizationcategory="laboratory" orgid="500035" submittername="Mendelics" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-05-28">
        <description>
         Likely benign
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Mendelics Assertion Criteria 2017
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NC_000013.10:g.32893271A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         MENDELICS_CLINVAR_020
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-05-23" datelastupdated="2020-06-01" id="2498887" submissiondate="2020-02-20">
       <clinvarsubmissionid localkey="149776|OMIM:605724" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001272757" organizationcategory="laboratory" orgid="504895" submittername="Illumina Clinical Services Laboratory,Illumina" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2018-03-06">
        <description>
         Uncertain significance
        </description>
        <comment>
         This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ICSL Variant Classification Criteria 13 December 2019
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/r0x0xrmc/icsl_variant_classification_criteria_13_december_2019.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="G" assembly="GRCh37" chr="13" referenceallele="A" start="32893271" stop="32893271" variantlength="1">
         </sequencelocation>
        </location>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="605724" type="MIM">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB6641900
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-12-02" datelastupdated="2020-06-01" id="697125" submissiondate="2020-02-20">
       <clinvarsubmissionid localkey="149776|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000383603" organizationcategory="laboratory" orgid="504895" submittername="Illumina Clinical Services Laboratory,Illumina" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2018-03-06">
        <description>
         Likely benign
        </description>
        <comment>
         This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ICSL Variant Classification Criteria 13 December 2019
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/r0x0xrmc/icsl_variant_classification_criteria_13_december_2019.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="G" assembly="GRCh37" chr="13" referenceallele="A" start="32893271" stop="32893271" variantlength="1">
         </sequencelocation>
        </location>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB6641900
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2015-03-21" datelastupdated="2020-12-07" id="383917" submissiondate="2020-11-30">
       <clinvarsubmissionid localkey="a7749" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000212918" organizationcategory="laboratory" orgid="61756" submittername="Ambry Genetics" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2014-11-19">
        <description>
         Benign
        </description>
        <comment>
         This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Ambry Autosomal Dominant and X-Linked criteria (10/2015)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/aH4uL7vL/mid-7377_ambry_classification_scheme_oct_2015.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.125A&gt;G
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         NonExomeUpdate_081220AmbryReport
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="583432" mappingref="Preferred" mappingtype="Name" mappingvalue="NOT SPECIFIED" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2244748" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2498887" mappingref="OMIM" mappingtype="XRef" mappingvalue="605724" traittype="Disease">
       <medgen cui="C1838457" name="Fanconi anemia, complementation group D1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1338953" mappingref="MedGen" mappingtype="XRef" mappingvalue="C0027672" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1139841" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="697125" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1166578" mappingref="MedGen" mappingtype="XRef" mappingvalue="CN235283" traittype="Finding">
       <medgen cui="CN235283" name="none provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="396030" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast and/or ovarian cancer" traittype="Disease">
       <medgen cui="CN221562" name="Breast and/or ovarian cancer">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="502760" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1150142" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="410273" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 2" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1518299" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1053953" mappingref="Preferred" mappingtype="Name" mappingvalue="Familial cancer of breast" traittype="Disease">
       <medgen cui="C0346153" name="Familial cancer of breast">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="383917" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="89535" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 2" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1073343" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary breast and ovarian cancer syndrome" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1537822" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="98327" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="281500" mappingref="Preferred" mappingtype="Name" mappingvalue="AllHighlyPenetrant" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1450833" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1414369" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="966832" mappingref="MedGen" mappingtype="XRef" mappingvalue="C0677776" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="417086" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="952450" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="263111" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 2" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="289320" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1148105" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="455915" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 2" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1449690" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
     </traitmappinglist>
     <deletedscvlist>
      <scv>
       <accession datedeleted="2018-09-06" version="1">
        SCV000804025
       </accession>
       <description>
        not specified
       </description>
      </scv>
     </deletedscvlist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000233913" datecreated="2016-05-27" datelastupdated="2021-02-25" numberofsubmissions="1" numberofsubmitters="1" recordtype="interpreted" variationid="233913" variationname="NM_000059.3(BRCA2):c.238A&gt;T (p.Ile80Leu)" variationtype="single nucleotide variant" version="3">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="234600" variationid="233913">
      <genelist>
       <gene fullname="BRCA2 DNA repair associated" geneid="675" hgnc_id="HGNC:1101" relationshiptype="within single gene" source="submitted" symbol="BRCA2">
        <location>
         <cytogeneticlocation>
          13q13.1
         </cytogeneticlocation>
         <sequencelocation accession="NC_000013.11" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="13" display_start="32315508" display_stop="32400268" start="32315508" stop="32400268" strand="+">
         </sequencelocation>
         <sequencelocation accession="NC_000013.10" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="13" display_start="32889616" display_stop="32973808" start="32889616" stop="32973808" strand="+">
         </sequencelocation>
        </location>
        <omim>
         600185
        </omim>
        <haploinsufficiency clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA2" last_evaluated="2012-07-06">
         Sufficient evidence for dosage pathogenicity
        </haploinsufficiency>
        <triplosensitivity clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA2" last_evaluated="2012-07-06">
         No evidence available
        </triplosensitivity>
        <property>
         gene_acmg_incidental_2013
        </property>
        <property>
         gene_acmg_incidental_2016
        </property>
       </gene>
      </genelist>
      <name>
       NM_000059.3(BRCA2):c.238A&gt;T (p.Ile80Leu)
      </name>
      <canonicalspdi>
       NC_000013.11:32319246:A:T
      </canonicalspdi>
      <varianttype>
       single nucleotide variant
      </varianttype>
      <location>
       <cytogeneticlocation>
        13q13.1
       </cytogeneticlocation>
       <sequencelocation accession="NC_000013.11" alternateallelevcf="T" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="13" display_start="32319247" display_stop="32319247" fordisplay="true" positionvcf="32319247" referenceallelevcf="A" start="32319247" stop="32319247" variantlength="1">
       </sequencelocation>
       <sequencelocation accession="NC_000013.10" alternateallelevcf="T" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="13" display_start="32893384" display_stop="32893384" positionvcf="32893384" referenceallelevcf="A" start="32893384" stop="32893384" variantlength="1">
       </sequencelocation>
      </location>
      <proteinchange>
       I80L
      </proteinchange>
      <hgvslist>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.32893384A&gt;T" sequenceaccession="NC_000013" sequenceaccessionversion="NC_000013.10" sequenceversion="10">
         <expression>
          NC_000013.10:g.32893384A&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.32319247A&gt;T" sequenceaccession="NC_000013" sequenceaccessionversion="NC_000013.11" sequenceversion="11">
         <expression>
          NC_000013.11:g.32319247A&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.238A&gt;T" sequenceaccession="NM_000059" sequenceaccessionversion="NM_000059.3" sequenceversion="3">
         <expression>
          NM_000059.3:c.238A&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Ile80Leu" sequenceaccession="NP_000050" sequenceaccessionversion="NP_000050.2" sequenceversion="2">
         <expression>
          NP_000050.2:p.Ile80Leu
         </expression>
        </proteinexpression>
        <molecularconsequence db="SO" id="SO:0001583" type="missense variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.238A&gt;T" sequenceaccession="LRG_293t1" sequenceaccessionversion="LRG_293t1">
         <expression>
          LRG_293t1:c.238A&gt;T
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Ile80Leu" sequenceaccession="LRG_293p1" sequenceaccessionversion="LRG_293p1">
         <expression>
          LRG_293p1:p.Ile80Leu
         </expression>
        </proteinexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.8768A&gt;T" sequenceaccession="LRG_293" sequenceaccessionversion="LRG_293">
         <expression>
          LRG_293:g.8768A&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.8768A&gt;T" sequenceaccession="NG_012772" sequenceaccessionversion="NG_012772.3" sequenceversion="3">
         <expression>
          NG_012772.3:g.8768A&gt;T
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.1117T&gt;A" sequenceaccession="NG_017006" sequenceaccessionversion="NG_017006.2" sequenceversion="2">
         <expression>
          NG_017006.2:g.1117T&gt;A
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
      <xreflist>
       <xref db="ClinGen" id="CA10579450">
       </xref>
       <xref db="dbSNP" id="876660626" type="rs">
       </xref>
      </xreflist>
     </simpleallele>
     <reviewstatus>
      criteria provided, single submitter
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000213421" datelastevaluated="2015-09-18" interpretation="Uncertain significance" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000059.3(BRCA2):c.238A&gt;T (p.Ile80Leu) AND Hereditary cancer-predisposing syndrome" version="1">
       <interpretedconditionlist traitsetid="13598">
        <interpretedcondition db="MedGen" id="C0027672">
         Hereditary cancer-predisposing syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2015-09-18" numberofsubmissions="1" numberofsubmitters="1" type="Clinical significance">
       <description>
        Uncertain significance
       </description>
       <conditionlist>
        <traitset id="13598" type="Disease">
         <trait id="18746" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Neoplastic Syndromes, Hereditary
           </elementvalue>
           <xref db="MeSH" id="D009386">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Hereditary cancer-predisposing syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="699346009">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Tumor predisposition
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Cancer predisposition
           </elementvalue>
           <xref db="Genetic Alliance" id="Hereditary+Cancer/3345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary Cancer Syndrome
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <citation abbrev="IARC, 2008" type="practice guideline">
           <id source="pmc">
            3075918
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="140162">
          </xref>
          <xref db="MedGen" id="C0027672">
          </xref>
          <xref db="MONDO" id="MONDO:0015356">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2016-05-27" datelastupdated="2020-12-07" id="514835" submissiondate="2020-11-30">
       <clinvarsubmissionid localkey="a893622" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000278381" organizationcategory="laboratory" orgid="61756" submittername="Ambry Genetics" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-09-18">
        <description>
         Uncertain significance
        </description>
        <comment>
         The p.I80L variant (also known as c.238A&gt;T), located in coding exon 2 of the BRCA2 gene, results from an A to T substitution at nucleotide position 238. The isoleucine at codon 80 is replaced by leucine, an amino acid with highly similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.001% (greater than150000alleles tested) in our clinical cohort.This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis.Since supporting evidence is limited at this time, the clinical significance of p.I80Lremains unclear.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Ambry Autosomal Dominant and X-Linked criteria (10/2015)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/aH4uL7vL/mid-7377_ambry_classification_scheme_oct_2015.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.238A&gt;T
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         NonExomeUpdate_081220AmbryReport
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="514835" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
     </traitmappinglist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE<?xml version="1.0" encoding="UTF-8" ?>
<html>
 <body>
  <clinvarresult-set>
   <variationarchive accession="VCV000009342" datecreated="2010-12-01" datelastupdated="2021-02-27" numberofsubmissions="32" numberofsubmitters="29" recordtype="interpreted" variationid="9342" variationname="NM_000059.4(BRCA2):c.658_659del" variationtype="Deletion" version="14">
    <recordstatus>
     current
    </recordstatus>
    <species>
     Homo sapiens
    </species>
    <interpretedrecord>
     <simpleallele alleleid="24381" variationid="9342">
      <genelist>
       <gene fullname="BRCA2 DNA repair associated" geneid="675" hgnc_id="HGNC:1101" relationshiptype="within single gene" source="submitted" symbol="BRCA2">
        <location>
         <cytogeneticlocation>
          13q13.1
         </cytogeneticlocation>
         <sequencelocation accession="NC_000013.11" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="13" display_start="32315508" display_stop="32400268" start="32315508" stop="32400268" strand="+">
         </sequencelocation>
         <sequencelocation accession="NC_000013.10" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="13" display_start="32889616" display_stop="32973808" start="32889616" stop="32973808" strand="+">
         </sequencelocation>
        </location>
        <omim>
         600185
        </omim>
        <haploinsufficiency clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA2" last_evaluated="2012-07-06">
         Sufficient evidence for dosage pathogenicity
        </haploinsufficiency>
        <triplosensitivity clingen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA2" last_evaluated="2012-07-06">
         No evidence available
        </triplosensitivity>
        <property>
         gene_acmg_incidental_2013
        </property>
        <property>
         gene_acmg_incidental_2016
        </property>
       </gene>
      </genelist>
      <name>
       NM_000059.4(BRCA2):c.658_659del
      </name>
      <canonicalspdi>
       NC_000013.11:32329467:TGT:T
      </canonicalspdi>
      <varianttype>
       Deletion
      </varianttype>
      <location>
       <cytogeneticlocation>
        13q13.1
       </cytogeneticlocation>
       <sequencelocation accession="NC_000013.11" alternateallelevcf="C" assembly="GRCh38" assemblyaccessionversion="GCF_000001405.38" assemblystatus="current" chr="13" display_start="32329468" display_stop="32329469" fordisplay="true" positionvcf="32329467" referenceallelevcf="CTG" start="32329468" stop="32329469" variantlength="2">
       </sequencelocation>
       <sequencelocation accession="NC_000013.10" alternateallelevcf="C" assembly="GRCh37" assemblyaccessionversion="GCF_000001405.25" assemblystatus="previous" chr="13" display_start="32903605" display_stop="32903606" positionvcf="32903604" referenceallelevcf="CTG" start="32903605" stop="32903606" variantlength="2">
       </sequencelocation>
      </location>
      <othernamelist>
       <name>
        886_887delGT
       </name>
       <name>
        886delGT
       </name>
      </othernamelist>
      <hgvslist>
       <hgvs assembly="GRCh37" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh37" change="g.32903606_32903607del" sequenceaccession="NC_000013" sequenceaccessionversion="NC_000013.10" sequenceversion="10">
         <expression>
          NC_000013.10:g.32903606_32903607del
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs assembly="GRCh38" type="genomic, top-level">
        <nucleotideexpression assembly="GRCh38" change="g.32329469_32329470del" sequenceaccession="NC_000013" sequenceaccessionversion="NC_000013.11" sequenceversion="11">
         <expression>
          NC_000013.11:g.32329469_32329470del
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.658_659del" maneselect="true" sequenceaccession="NM_000059" sequenceaccessionversion="NM_000059.4" sequenceversion="4">
         <expression>
          NM_000059.4:c.658_659del
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.657_658del" sequenceaccession="NM_000059" sequenceaccessionversion="NM_000059.3" sequenceversion="3">
         <expression>
          NM_000059.3:c.657_658del
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.658_659delGT" sequenceaccession="NM_000059" sequenceaccessionversion="NM_000059.3" sequenceversion="3">
         <expression>
          NM_000059.3:c.658_659delGT
         </expression>
        </nucleotideexpression>
        <molecularconsequence db="SO" id="SO:0001589" type="frameshift variant">
        </molecularconsequence>
       </hgvs>
       <hgvs type="coding">
        <nucleotideexpression change="c.658_659del" sequenceaccession="LRG_293t1" sequenceaccessionversion="LRG_293t1">
         <expression>
          LRG_293t1:c.658_659del
         </expression>
        </nucleotideexpression>
        <proteinexpression change="p.Val220fs" sequenceaccession="LRG_293p1" sequenceaccessionversion="LRG_293p1">
         <expression>
          LRG_293p1:p.Val220fs
         </expression>
        </proteinexpression>
       </hgvs>
       <hgvs type="non-coding">
        <nucleotideexpression change="n.886_887delGT" sequenceaccession="U43746" sequenceaccessionversion="U43746.1" sequenceversion="1">
         <expression>
          U43746.1:n.886_887delGT
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.18990_18991del" sequenceaccession="LRG_293" sequenceaccessionversion="LRG_293">
         <expression>
          LRG_293:g.18990_18991del
         </expression>
        </nucleotideexpression>
       </hgvs>
       <hgvs type="genomic">
        <nucleotideexpression change="g.18990_18991del" sequenceaccession="NG_012772" sequenceaccessionversion="NG_012772.3" sequenceversion="3">
         <expression>
          NG_012772.3:g.18990_18991del
         </expression>
        </nucleotideexpression>
       </hgvs>
      </hgvslist>
      <xreflist>
       <xref db="Breast Cancer Information Core (BIC) (BRCA2)" id="886&amp;base_change=del GT">
       </xref>
       <xref db="ClinGen" id="CA024188">
       </xref>
       <xref db="OMIM" id="600185.0027" type="Allelic variant">
       </xref>
       <xref db="dbSNP" id="80359604" type="rs">
       </xref>
      </xreflist>
     </simpleallele>
     <reviewstatus>
      reviewed by expert panel
     </reviewstatus>
     <rcvlist>
      <rcvaccession accession="RCV000009929" datelastevaluated="2007-01-01" interpretation="Pathogenic" reviewstatus="no assertion criteria provided" submissioncount="1" title="NM_000059.4(BRCA2):c.658_659del AND Fanconi anemia, complementation group D1" version="5">
       <interpretedconditionlist traitsetid="2562">
        <interpretedcondition db="MedGen" id="C1838457">
         Fanconi anemia, complementation group D1
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000009930" datelastevaluated="2007-01-01" interpretation="Pathogenic" reviewstatus="no assertion criteria provided" submissioncount="1" title="NM_000059.4(BRCA2):c.658_659del AND Wilms tumor 1" version="5">
       <interpretedconditionlist traitsetid="904">
        <interpretedcondition db="MedGen" id="CN033288">
         Wilms tumor 1
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000009931" datelastevaluated="2007-01-01" interpretation="risk factor" reviewstatus="no assertion criteria provided" submissioncount="1" title="NM_000059.4(BRCA2):c.658_659del AND Glioma susceptibility 3" version="5">
       <interpretedconditionlist traitsetid="2565">
        <interpretedcondition db="MedGen" id="C2751641">
         Glioma susceptibility 3
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000009932" datelastevaluated="2007-01-01" interpretation="Pathogenic" reviewstatus="no assertion criteria provided" submissioncount="1" title="NM_000059.4(BRCA2):c.658_659del AND Medulloblastoma" version="7">
       <interpretedconditionlist traitsetid="2566">
        <interpretedcondition db="MedGen" id="C0025149">
         Medulloblastoma
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000031637" datelastevaluated="2016-04-22" interpretation="Pathogenic" reviewstatus="reviewed by expert panel" submissioncount="10" title="NM_000059.4(BRCA2):c.658_659del AND Breast-ovarian cancer, familial 2" version="11">
       <interpretedconditionlist traitsetid="2560">
        <interpretedcondition db="MedGen" id="C2675520">
         Breast-ovarian cancer, familial 2
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000044988" datelastevaluated="2019-12-30" interpretation="Pathogenic" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="4" title="NM_000059.4(BRCA2):c.658_659del AND Hereditary breast and ovarian cancer syndrome" version="11">
       <interpretedconditionlist traitsetid="7920">
        <interpretedcondition db="MedGen" id="C0677776">
         Hereditary breast and ovarian cancer syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000074548" datelastevaluated="2020-10-23" interpretation="Pathogenic" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="7" title="NM_000059.4(BRCA2):c.658_659del AND not provided" version="15">
       <interpretedconditionlist traitsetid="9460">
        <interpretedcondition db="MedGen" id="CN517202">
         not provided
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000131858" datelastevaluated="2020-01-15" interpretation="Pathogenic" reviewstatus="criteria provided, multiple submitters, no conflicts" submissioncount="2" title="NM_000059.4(BRCA2):c.658_659del AND Hereditary cancer-predisposing syndrome" version="8">
       <interpretedconditionlist traitsetid="13598">
        <interpretedcondition db="MedGen" id="C0027672">
         Hereditary cancer-predisposing syndrome
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000210073" datelastevaluated="2015-11-20" interpretation="Pathogenic" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000059.4(BRCA2):c.658_659del AND Breast-ovarian cancer, familial 1" version="2">
       <interpretedconditionlist traitsetid="1917">
        <interpretedcondition db="MedGen" id="C2676676">
         Breast-ovarian cancer, familial 1
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000466729" datelastevaluated="2017-02-23" interpretation="Pathogenic" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000059.4(BRCA2):c.658_659del AND Familial cancer of breast" version="1">
       <interpretedconditionlist traitsetid="774">
        <interpretedcondition db="MedGen" id="C0346153">
         Familial cancer of breast
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV000735587" datelastevaluated="2019-06-11" interpretation="Pathogenic" reviewstatus="no assertion criteria provided" submissioncount="2" title="NM_000059.4(BRCA2):c.658_659del AND Breast and/or ovarian cancer" version="2">
       <interpretedconditionlist traitsetid="20192">
        <interpretedcondition db="MedGen" id="CN221562">
         Breast and/or ovarian cancer
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
      <rcvaccession accession="RCV001000010" datelastevaluated="2018-09-13" interpretation="Pathogenic" reviewstatus="criteria provided, single submitter" submissioncount="1" title="NM_000059.4(BRCA2):c.658_659del AND not specified" version="1">
       <interpretedconditionlist traitsetid="9590">
        <interpretedcondition db="MedGen" id="CN169374">
         not specified
        </interpretedcondition>
       </interpretedconditionlist>
      </rcvaccession>
     </rcvlist>
     <interpretations>
      <interpretation datelastevaluated="2016-04-22" numberofsubmissions="32" numberofsubmitters="29" type="Clinical significance">
       <description>
        Pathogenic
       </description>
       <citation type="general">
        <id source="PubMed">
         22798144
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         29492181
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         16825431
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         24156927
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         26681312
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         14647210
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         30287823
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         26657402
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         23767878
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         28724667
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         27153395
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         22535016
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         17513806
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         22009639
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         26064523
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         30350268
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         9667259
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         22923021
        </id>
       </citation>
       <citation type="Suggested Reading">
        <id source="PubMed">
         14559878
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         29339979
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         16912212
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         18465347
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         12373604
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         18703817
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         25066507
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         14670928
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         29753700
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         15689453
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         24504028
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         27831900
        </id>
       </citation>
       <citation type="general">
        <id source="PubMed">
         28324225
        </id>
       </citation>
       <conditionlist>
        <traitset id="9460" type="Disease">
         <trait id="17556" type="Disease">
          <name>
           <elementvalue type="Preferred">
            not provided
           </elementvalue>
           <xref db="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre" id="13DG0619">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN517202">
          </xref>
         </trait>
        </traitset>
        <traitset id="904" type="Disease">
         <trait id="4506" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Bilateral Wilms tumor
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Familial Wilms tumor 2
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Wilms tumor, somatic
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Preferred">
            Wilms tumor 1
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            WT1
           </elementvalue>
           <xref db="OMIM" id="194070" type="MIM">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ &lt;74) is observed in 70%; behavioral abnormalities include attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.
           </attribute>
           <xref db="GeneReviews" id="NBK1360">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301471
           </id>
           <id source="BookShelf">
            NBK1294
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301534
           </id>
           <id source="BookShelf">
            NBK1360
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            32352694
           </id>
           <id source="BookShelf">
            NBK556455
           </id>
          </citation>
          <xref db="Orphanet" id="654">
          </xref>
          <xref db="MedGen" id="CN033288">
          </xref>
          <xref db="MONDO" id="MONDO:0008679">
          </xref>
          <xref db="OMIM" id="194070" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="7920" type="Disease">
         <trait id="16761" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Hereditary breast and ovarian cancer syndrome
           </elementvalue>
           <xref db="MeSH" id="D061325">
           </xref>
           <xref db="Orphanet" id="145">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer
           </elementvalue>
           <xref db="CSER _CC_NCGL, University of Washington" id="UWMG_4506306">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary breast and ovarian cancer syndrome (HBOC)
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021468">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325401">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017876">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000500933">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508566">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508956">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509985">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521499">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000523320">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551440">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551441">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552183">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552302">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558503">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000561859">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325409">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000502103">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509978">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000514601">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520887">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522161">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530028">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000592450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501981">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000503369">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509984">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512699">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521908">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017874">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021517">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000508948">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509983">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521909">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522278">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522559">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530118">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551448">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558910">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000591268">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="ASCO, 2003" type="Position Statement">
           <id source="PubMed">
            12692171
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="Stratton and Rahman, 2008" type="review">
           <id source="PubMed">
            18163131
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C0677776">
          </xref>
          <xref db="MeSH" id="D061325">
          </xref>
          <xref db="MONDO" id="MONDO:0003582">
          </xref>
          <xref db="OMIM" id="PS604370" type="Phenotypic series">
          </xref>
         </trait>
        </traitset>
        <traitset id="2565" type="Disease">
         <trait id="6902" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Glioma susceptibility 3
           </elementvalue>
           <xref db="Genetic Alliance" id="Glioma+susceptibility+3/8470">
           </xref>
           <xref db="MONDO" id="MONDO:0013093">
           </xref>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            GLM3
           </elementvalue>
           <xref db="OMIM" id="613029" type="MIM">
           </xref>
          </symbol>
          <xref db="Orphanet" id="182067">
          </xref>
          <xref db="Orphanet" id="360">
          </xref>
          <xref db="MedGen" id="C2751641">
          </xref>
          <xref db="MONDO" id="MONDO:0013093">
          </xref>
          <xref db="OMIM" id="613029" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="2566" type="Disease">
         <trait id="2738" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Medulloblastoma
           </elementvalue>
           <xref db="Genetic Alliance" id="Medulloblastoma/4552">
           </xref>
           <xref db="Human Phenotype Ontology" id="HP:0002885">
           </xref>
           <xref db="MONDO" id="MONDO:0007959">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Medulloblastoma, somatic
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            MDB
           </elementvalue>
           <xref db="OMIM" id="155255" type="MIM">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <attributeset>
           <attribute integervalue="7005" type="GARD id">
           </attribute>
           <xref db="Office of Rare Diseases" id="7005">
           </xref>
          </attributeset>
          <xref db="Orphanet" id="616">
          </xref>
          <xref db="MedGen" id="C0025149">
          </xref>
          <xref db="MeSH" id="D008527">
          </xref>
          <xref db="MONDO" id="MONDO:0007959">
          </xref>
          <xref db="OMIM" id="155255" type="MIM">
          </xref>
          <xref db="Human Phenotype Ontology" id="HP:0002885" type="primary">
          </xref>
         </trait>
        </traitset>
        <traitset id="2562" type="Disease">
         <trait id="1276" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Fanconi anemia, complementation group D1
           </elementvalue>
           <xref db="Genetic Alliance" id="Fanconi+anemia%2C+complementation+group+D1/8410">
           </xref>
          </name>
          <symbol>
           <elementvalue type="Alternate">
            FAD1
           </elementvalue>
           <xref db="OMIM" id="605724" type="MIM">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Preferred">
            FANCD1
           </elementvalue>
           <xref db="OMIM" id="605724" type="MIM">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="public definition">
            Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors  particularly of the head and neck, skin, gastrointestinal tract, and genitourinary tract  are more common in individuals with FA.
           </attribute>
           <xref db="GeneReviews" id="NBK1401">
           </xref>
          </attributeset>
          <citation type="Suggested Reading">
           <id source="PubMed">
            14559878
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301471
           </id>
           <id source="BookShelf">
            NBK1294
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301575
           </id>
           <id source="BookShelf">
            NBK1401
           </id>
          </citation>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301753
           </id>
           <id source="BookShelf">
            NBK5192
           </id>
          </citation>
          <citation abbrev="FARF, 2008" type="practice guideline">
           <url>
            http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf
           </url>
           <citationtext>
            Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008
           </citationtext>
          </citation>
          <xref db="Orphanet" id="319462">
          </xref>
          <xref db="MedGen" id="C1838457">
          </xref>
          <xref db="MONDO" id="MONDO:0011584">
          </xref>
          <xref db="OMIM" id="605724" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="13598" type="Disease">
         <trait id="18746" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Neoplastic Syndromes, Hereditary
           </elementvalue>
           <xref db="MeSH" id="D009386">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Hereditary cancer-predisposing syndrome
           </elementvalue>
           <xref db="SNOMED CT" id="699346009">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Tumor predisposition
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            Cancer predisposition
           </elementvalue>
           <xref db="Genetic Alliance" id="Hereditary+Cancer/3345">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Hereditary Cancer Syndrome
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <citation abbrev="IARC, 2008" type="practice guideline">
           <id source="pmc">
            3075918
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <xref db="Orphanet" id="140162">
          </xref>
          <xref db="MedGen" id="C0027672">
          </xref>
          <xref db="MONDO" id="MONDO:0015356">
          </xref>
         </trait>
        </traitset>
        <traitset id="774" type="Disease">
         <trait id="536" type="Disease">
          <name>
           <elementvalue type="Alternate">
            Breast cancer, familial
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            CHEK2-Related Breast Cancer
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Preferred">
            Familial cancer of breast
           </elementvalue>
           <xref db="Genetic Alliance" id="Familial+cancer+of+breast/8375">
           </xref>
           <xref db="SNOMED CT" id="254843006">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Hereditary cancer syndrome
           </attribute>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531340">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000561700">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569423">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000591268">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530707">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000558503">
           </xref>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="Stratton and Rahman, 2008" type="review">
           <id source="PubMed">
            18163131
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <xref db="Orphanet" id="227535">
          </xref>
          <xref db="MedGen" id="C0346153">
          </xref>
          <xref db="MONDO" id="MONDO:0016419">
          </xref>
          <xref db="OMIM" id="114480" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="1917" type="Disease">
         <trait id="4711" type="Disease">
          <name>
           <elementvalue type="Alternate">
            BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
           </elementvalue>
           <xref db="OMIM" id="604370" type="MIM">
           </xref>
           <xref db="OMIM" id="113705.0003" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0005" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0006" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0008" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0010" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0015" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0023" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0026" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0028" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0030" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0033" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0004" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0012" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0017" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0019" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0020" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0025" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0029" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0032" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0035" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0037" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0041" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0007" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0009" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0013" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0014" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0024" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0036" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0038" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0040" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0001" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0002" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0016" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0018" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0021" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0027" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0031" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0034" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="113705.0042" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            OVARIAN CANCER, SUSCEPTIBILITY TO
           </elementvalue>
           <xref db="OMIM" id="602667.0001" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Breast-ovarian cancer, familial 1
           </elementvalue>
           <xref db="Genetic Alliance" id="Breast-ovarian+cancer%2C+familial+1/7865">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
           </elementvalue>
           <xref db="OMIM" id="604370">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Breast cancer, familial 1
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            BROVCA1
           </elementvalue>
           <xref db="OMIM" id="604370" type="MIM">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501743">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325409">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501817">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017876">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501743">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520866">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520867">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520870">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000521908">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501746">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507864">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509692">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509982">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512645">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520872">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569406">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000514601">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000519030">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520069">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520869">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522161">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531275">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551440">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021517">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000320777">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000332529">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509983">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512320">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520865">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520871">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552304">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569423">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000570011">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C2676676">
          </xref>
          <xref db="MONDO" id="MONDO:0011450">
          </xref>
          <xref db="OMIM" id="604370" type="MIM">
          </xref>
         </trait>
        </traitset>
        <traitset id="9590" type="Disease">
         <trait id="16789" type="Disease">
          <name>
           <elementvalue type="Preferred">
            not specified
           </elementvalue>
          </name>
          <name>
           <elementvalue type="Alternate">
            AllHighlyPenetrant
           </elementvalue>
          </name>
          <attributeset>
           <attribute type="public definition">
            The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.
           </attribute>
          </attributeset>
          <xref db="MedGen" id="CN169374">
          </xref>
         </trait>
        </traitset>
        <traitset id="20192" type="Disease">
         <trait id="32337" type="Disease">
          <name>
           <elementvalue type="Preferred">
            Breast and/or ovarian cancer
           </elementvalue>
           <xref db="CSER _CC_NCGL, University of Washington" id="UWMG_7622958">
           </xref>
          </name>
          <attributeset>
           <attribute type="public definition">
            Ovarian cancer is a disease that affects women. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumor. The ovaries are the female reproductive organs in which egg cells are produced. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.The most common form of ovarian cancer begins in epithelial cells, which are the cells that line the surfaces and cavities of the body. These cancers can arise in the epithelial cells on the surface of the ovary. However, researchers suggest that many or even most ovarian cancers begin in epithelial cells on the fringes (fimbriae) at the end of one of the fallopian tubes, and the cancerous cells migrate to the ovary.Cancer can also begin in epithelial cells that form the lining of the abdomen (the peritoneum). This form of cancer, called primary peritoneal cancer, resembles epithelial ovarian cancer in its origin, symptoms, progression, and treatment. Primary peritoneal cancer often spreads to the ovaries. It can also occur even if the ovaries have been removed. Because cancers that begin in the ovaries, fallopian tubes, and peritoneum are so similar and spread easily from one of these structures to the others, they are often difficult to distinguish. These cancers are so closely related that they are generally considered collectively by experts.In about 10 percent of cases, ovarian cancer develops not in epithelial cells but in germ cells, which are precursors to egg cells, or in hormone-producing ovarian cells called granulosa cells.In its early stages, ovarian cancer usually does not cause noticeable symptoms. As the cancer progresses, signs and symptoms can include pain or a feeling of heaviness in the pelvis or lower abdomen, bloating, feeling full quickly when eating, back pain, vaginal bleeding between menstrual periods or after menopause, or changes in urinary or bowel habits. However, these changes can occur as part of many different conditions. Having one or more of these symptoms does not mean that a woman has ovarian cancer.In some cases, cancerous tumors can invade surrounding tissue and spread to other parts of the body. If ovarian cancer spreads, cancerous tumors most often appear in the abdominal cavity or on the surfaces of nearby organs such as the bladder or colon. Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers.Some ovarian cancers cluster in families. These cancers are described as hereditary and are associated with inherited gene mutations. Hereditary ovarian cancers tend to develop earlier in life than non-inherited (sporadic) cases.Because it is often diagnosed at a late stage, ovarian cancer can be difficult to treat; it leads to the deaths of about 14,000 women annually in the United States, more than any other gynecological cancer. However, when it is diagnosed and treated early, the 5-year survival rate is high.
           </attribute>
           <xref db="Genetics Home Reference" id="ovarian-cancer">
           </xref>
          </attributeset>
          <xref db="MedGen" id="CN221562">
          </xref>
         </trait>
        </traitset>
        <traitset id="2560" type="Disease">
         <trait id="636" type="Disease">
          <name>
           <elementvalue type="Alternate">
            BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
           </elementvalue>
           <xref db="OMIM" id="612555" type="MIM">
           </xref>
           <xref db="OMIM" id="600185.0005" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0006" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0012" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0007" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0008" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0010" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0003" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0004" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0009" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0016" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0001" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0002" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0011" type="Allelic variant">
           </xref>
           <xref db="OMIM" id="600185.0014" type="Allelic variant">
           </xref>
          </name>
          <name>
           <elementvalue type="Preferred">
            Breast-ovarian cancer, familial 2
           </elementvalue>
           <xref db="Genetic Alliance" id="Breast-ovarian+cancer%2C+familial+2/7866">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
           </elementvalue>
           <xref db="OMIM" id="612555">
           </xref>
          </name>
          <name>
           <elementvalue type="Alternate">
            Breast cancer, familial 2
           </elementvalue>
          </name>
          <symbol>
           <elementvalue type="Preferred">
            BROVCA2
           </elementvalue>
           <xref db="OMIM" id="612555" type="MIM">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            HBOC
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501744">
           </xref>
          </symbol>
          <symbol>
           <elementvalue type="Alternate">
            BRCA2
           </elementvalue>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501818">
           </xref>
          </symbol>
          <attributeset>
           <attribute type="public definition">
            BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.
           </attribute>
           <xref db="GeneReviews" id="NBK1247">
           </xref>
          </attributeset>
          <attributeset>
           <attribute integervalue="273" type="disease mechanism">
            loss of function
           </attribute>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507864">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509002">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509692">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000505644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507653">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509450">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512816">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000519030">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520069">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520869">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520872">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528915">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530707">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000021468">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000325401">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000326160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000330054">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501744">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501818">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509984">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520071">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520072">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520394">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520866">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520870">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522159">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000551447">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569406">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509985">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512644">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000512645">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520867">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000528916">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552245">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000017874">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000320777">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000332529">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000501748">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000507764">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509001">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000509980">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520865">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000520871">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000522160">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000527942">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530120">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000530202">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531275">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000531340">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000552304">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000562228">
           </xref>
           <xref db="Genetic Testing Registry (GTR)" id="GTR000569423">
           </xref>
          </attributeset>
          <attributeset>
           <attribute type="keyword">
            Neoplasm
           </attribute>
          </attributeset>
          <citation abbrev="GeneReviews" type="review">
           <id source="PubMed">
            20301425
           </id>
           <id source="BookShelf">
            NBK1247
           </id>
          </citation>
          <citation abbrev="ACS, 2007" type="practice guideline">
           <id source="PubMed">
            17392385
           </id>
          </citation>
          <citation abbrev="ASCO, 2010" type="Position Statement">
           <id source="PubMed">
            20065170
           </id>
          </citation>
          <citation abbrev="NSGC, 2004" type="practice guideline">
           <id source="PubMed">
            15604628
           </id>
          </citation>
          <citation abbrev="NSGC, 2007" type="practice guideline">
           <id source="PubMed">
            17508274
           </id>
          </citation>
          <citation abbrev="ACOG, 2009" type="practice guideline">
           <id source="PubMed">
            19305347
           </id>
          </citation>
          <citation abbrev="ACMG, 2013" type="Recommendation">
           <id source="PubMed">
            23788249
           </id>
          </citation>
          <citation abbrev="NCCN, 2013" type="practice guideline">
           <url>
            http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
           </url>
           <citationtext>
            National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian
           </citationtext>
          </citation>
          <citation abbrev="Phillips et al., 2013" type="Suggested Reading">
           <id source="PubMed">
            23918944
           </id>
          </citation>
          <citation abbrev="Domchek et al., 2010" type="Suggested Reading">
           <id source="pmc">
            2948529
           </id>
          </citation>
          <citation abbrev="ASCO, 2014" type="practice guideline">
           <id source="PubMed">
            24493721
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="practice guideline">
           <id source="PubMed">
            24366376
           </id>
          </citation>
          <citation abbrev="CAPS, 2013" type="practice guideline">
           <id source="pmc">
            3585492
           </id>
          </citation>
          <citation abbrev="NSGC, 2013" type="practice guideline">
           <id source="PubMed">
            23188549
           </id>
          </citation>
          <citation abbrev="ACMG/NSGC, 2015" type="practice guideline">
           <id source="PubMed">
            25394175
           </id>
          </citation>
          <citation abbrev="USPSTF, 2014" type="Recommendation">
           <id source="PubMed">
            24366402
           </id>
          </citation>
          <citation abbrev="USPSTF, 2013" type="Recommendation">
           <id source="PubMed">
            24432435
           </id>
          </citation>
          <citation abbrev="ACMG, 2015" type="Recommendation">
           <id source="PubMed">
            25356965
           </id>
          </citation>
          <citation abbrev="ACMG, 2016" type="Recommendation">
           <id source="PubMed">
            27854360
           </id>
           <id source="DOI">
            10.1038/gim.2016.190
           </id>
          </citation>
          <xref db="Orphanet" id="145">
          </xref>
          <xref db="MedGen" id="C2675520">
          </xref>
          <xref db="MONDO" id="MONDO:0012933">
          </xref>
          <xref db="OMIM" id="612555" type="MIM">
          </xref>
         </trait>
        </traitset>
       </conditionlist>
      </interpretation>
     </interpretations>
     <clinicalassertionlist>
      <clinicalassertion datecreated="2015-03-28" datelastupdated="2020-03-26" id="397873" submissiondate="2015-03-11">
       <clinvarsubmissionid localkey="NM_000059.3(BRCA2):c.658_659delGT" localkeyissubmitted="1">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000221117" organizationcategory="laboratory" orgid="320494" submittername="Counsyl" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-02-04">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          16912212
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          17513806
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          14647210
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          16825431
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22009639
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          24504028
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22535016
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          23767878
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          9667259
         </id>
        </citation>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="ModeOfInheritance">
         Autosomal dominant inheritance
        </attribute>
       </attributeset>
       <attributeset>
        <attribute type="AssertionMethod">
         Counsyl Autosomal Dominant Disease Classification criteria (2015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_(2015)_v1.pdf
         </url>
         <citationtext>
          Counsyl Autosomal Dominant Disease Classification criteria (2015)
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 2
          </elementvalue>
         </name>
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         Counsyl_2015_03_01
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2014-03-30" datelastupdated="2020-03-26" id="264325" submissiondate="2014-03-28">
       <clinvarsubmissionid localkey="U43746.1:n.886_887delGT|MedGen:C2675520">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000147427" organizationcategory="locus-specific database (LSDB)" orgid="504197" submittername="Breast Cancer Information Core (BIC) (BRCA2)" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2002-05-29">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="7" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <geographicorigin>
           Western European
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Central/Eastern European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="7" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Latin American, Caribbean
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Latin American, Caribbean, Hispanic
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Western European
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="17" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <ethnicity>
           Latino
          </ethnicity>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <genelocation>
          U43746.1:exon 8
         </genelocation>
        </location>
        <othernamelist>
         <name>
          886delGT
         </name>
        </othernamelist>
        <xreflist>
         <xref db="dbSNP" id="80359604" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          U43746.1:n.886_887delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 2
          </elementvalue>
         </name>
         <xref db="MedGen" id="C2675520" type="CUI">
         </xref>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-03-19" datelastupdated="2020-03-26" id="498336" submissiondate="2016-03-03">
       <clinvarsubmissionid localkey="c.658_659delGT (886delGT)" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000266043" orgabbreviation="UWLABMED" organizationcategory="laboratory" orgid="506834" submittername="University of Washington Department of Laboratory Medicine, University of Washington" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-11-20">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Shirts et al. (Genet Med 2016)
        </attribute>
        <citation>
         <id source="PubMed">
          26845104
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <age age_unit="years" type="minimum">
           50
          </age>
          <age age_unit="years" type="maximum">
           59
          </age>
          <affectedstatus>
           yes
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="SampleLocalID">
           1681
          </attribute>
         </observeddata>
         <traitset type="Finding">
          <trait type="Finding">
           <name>
            <elementvalue type="Preferred">
             bilateral breast cancer
            </elementvalue>
           </name>
          </trait>
         </traitset>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <age age_unit="years" type="minimum">
           50
          </age>
          <age age_unit="years" type="maximum">
           59
          </age>
          <affectedstatus>
           yes
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="SampleLocalID">
           1689
          </attribute>
         </observeddata>
         <traitset type="Finding">
          <trait type="Finding">
           <name>
            <elementvalue type="Preferred">
             breast cancer
            </elementvalue>
           </name>
          </trait>
         </traitset>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MedGen" id="C2676676" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         GIM_BROCA
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-06-24" datelastupdated="2020-03-26" id="537161" submissiondate="2016-06-09">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659delGT|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000282430" orgabbreviation="ENIGMA" organizationcategory="consortium" orgid="504863" submittername="Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        reviewed by expert panel
       </reviewstatus>
       <interpretation datelastevaluated="2016-04-22">
        <description>
         Pathogenic
        </description>
        <comment>
         Variant allele predicted to encode a truncated non-functional protein.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ENIGMA BRCA1/2 Classification Criteria (2015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf
         </url>
         <citationtext>
          ENIGMA BRCA1/2 Classification Criteria (2015)
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           curation
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          886_887delGT
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studydescription>
        ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/
       </studydescription>
       <submissionnamelist>
        <submissionname>
         ENIGMA_2015-08-17
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-08-04" datelastupdated="2020-03-26" id="1140487" submissiondate="2017-08-04">
       <clinvarsubmissionid localkey="290182|Orphanet:ORPHA145" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000587560" organizationcategory="laboratory" orgid="506247" submittername="Research Molecular Genetics Laboratory,Women's College Hospital, University of Toronto" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2014-01-31">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           research
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name>
          NM_000059.3:c.658_659delGT
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NC_000013.10:g.32903606_32903607delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="Orphanet" id="ORPHA145">
         </xref>
        </trait>
       </traitset>
       <studyname>
        The Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         RMGL-WCRI-05152017
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-04-18" datelastupdated="2020-03-26" id="1450844" submissiondate="2018-04-09">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659delGT|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000744390" organizationcategory="laboratory" orgid="506497" submittername="DNA and Cytogenetics Diagnostics Unit,Erasmus Medical Center" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-09-21">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACGS Guidelines, 2013
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/3yyso7ro/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studyname>
        VKGL Data-share Consensus
       </studyname>
       <submissionnamelist>
        <submissionname>
         SUB3885264
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2019-02-15" datelastupdated="2020-10-06" id="1729650" submissiondate="2019-08-05">
       <clinvarsubmissionid localkey="113557|MedGen:CN169374" submittedassembly="not applicable">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000883510" organizationcategory="laboratory" orgid="25969" submittername="ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2018-09-13">
        <description>
         Pathogenic
        </description>
        <comment>
         The BRCA2 c.658_659delGT; p.Val220fs variant (rs80359604), also known as 886delGT, has been reported in multiple individuals with hereditary breast and ovarian cancer syndrome (Cunningham 2014, de Juan 2015, Frank 1998), and in patients with Fancomi anemia when found in-trans with another pathogenic variant (Hirsch 2004, Svojgr 2016). It is listed as pathogenic in ClinVar (Variation ID: 9342), and observed in the Genome Aggregation Database at an overall frequency of 0.004% (12/270878 alleles). This variant introduces a frameshift by deleting 2 nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based available information, this variant is considered pathogenic. REFERENCES Cunningham J et al. Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status. Sci Rep. 2014; 4:4026. de Juan I et al. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study. Fam Cancer. 2015; 14(4):505-13. Frank T et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998;16(7):2417-25. Hirsch B et al. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood. 2004; 103(7):2554-9. Svojgr K et al. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children. Eur J Med Genet. 2016; 59(3):152-7.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ARUP Molecular Germline Variant Investigation Process
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NC_000013.10:g.32903606_32903607delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not specified
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN169374" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         Aug 2019 ARUP
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-07-08" datelastupdated="2021-02-03" id="556584" submissiondate="2020-05-19">
       <clinvarsubmissionid localkey="Db4KrQBSZeoE7-orUyypkfOielD6TIeA2snDV1d3cy8|MedGen:C0027672" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000292146" organizationcategory="laboratory" orgid="505849" submittername="Color Health, Inc" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2020-01-15">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <typeplatform>
           NGS
          </typeplatform>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <comment>
        This variant deletes 2 nucleotides in exon 8 of the BRCA2 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been identified in 13/276414 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of BRCA2 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.
       </comment>
       <submissionnamelist>
        <submissionname>
         Color Genomics - ClinVar Submission - May2020 - SUB747
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-11-26" datelastupdated="2020-11-28" id="2858106" submissiondate="2020-10-23">
       <clinvarsubmissionid localkey="report_configuration_variant_id:188215">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001447718" orgabbreviation="IMGAG" organizationcategory="laboratory" orgid="506385" submittername="Institute of Medical Genetics and Applied Genomics, University Hospital Tbingen" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2020-10-23">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="ModeOfInheritance">
         Autosomal unknown
        </attribute>
       </attributeset>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
          <gender>
           female
          </gender>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="SampleLocalID">
           DX202188
          </attribute>
         </observeddata>
         <traitset type="Finding">
          <trait type="Finding">
           <xref db="HP" id="HP:0003002">
           </xref>
          </trait>
         </traitset>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="C" assembly="GRCh37" chr="13" referenceallele="CTG" start="32903604">
         </sequencelocation>
        </location>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2014-08-01" datelastupdated="2020-12-07" id="305428" submissiondate="2020-11-30">
       <clinvarsubmissionid localkey="a89399" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000186913" organizationcategory="laboratory" orgid="61756" submittername="Ambry Genetics" type="SCV" version="6">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2018-11-09">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          26064523
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          26657402
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          26681312
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          27153395
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          27831900
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          28324225
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          28724667
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          29339979
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          29492181
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          29753700
         </id>
        </citation>
        <comment>
         The c.658_659delGT pathogenic mutation, located in coding exon 7 of the BRCA2 gene, results from a deletion of 2 nucleotides at positions 658 to 659, causing a translational frameshift with a predicted alternate stop codon (p.V220Ifs*4). This mutation has been described in numerous HBOC families (Frank TS et al. J. Clin. Oncol. 1998 Jul;16:2417-25; Berzina D et al. BMC Med. Genet. 2013;14:61; Meisel C et al. Arch. Gynecol. Obstet. 2017 May;295:1227-1238). This mutation has also been observed in Fanconi anemia group D1 patients and was associated with brain tumors (medulloblastomas and glioblastomas) and Wilms tumor in these patients (Alter BP et al. J. Med. Genet. 2007 Jan;44:1-9; Miele E et al. Biomark Res. 2015;3:13). Of note, this alteration is also designated as 886delGT in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. However, because this variant is identified in one or more patients with Fanconi Anemia it may be hypomorphic and thus, carriers of this variant and their families may present with reduced risks, and not with the typical clinical characteristics of a high-risk pathogenic BRCA2 alteration. As risk estimates are unknown at this time, clinical correlation is advised.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Ambry Autosomal Dominant and X-Linked criteria (3/2017)
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/uwtx4ijy/ad_xl_classificationscheme_03.2017_ambry.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary cancer-predisposing syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0027672" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         NonExomeUpdate_081220AmbryReport
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-05-06" datelastupdated="2020-03-26" id="502766" submissiondate="2016-04-21">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659delGT|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000195951" organizationcategory="laboratory" orgid="308659" submittername="Michigan Medical Genetics Laboratories,University of Michigan" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2014-11-03">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <tissue>
           Blood
          </tissue>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <xreflist>
         <xref db="dbSNP" id="80359604" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2012-11-07" datelastupdated="2020-03-26" id="89859" submissiondate="2015-12-29">
       <clinvarsubmissionid localkey="SCRP_var_688" title="NM_000059.3:c.658_659delGT AND Breast-ovarian cancer, familial 2">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000054244" orgabbreviation="SCRP" organizationcategory="consortium" orgid="500037" submittername="Sharing Clinical Reports Project (SCRP)" type="SCV" version="6">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2014-01-04">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
          <numbertested>
           31
          </numbertested>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="VariantAlleles">
           31
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name type="nucleotide change">
          886delGT
         </name>
        </othernamelist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast-ovarian cancer, familial 2
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-11-04" datelastupdated="2020-03-26" id="626573" submissiondate="2016-10-28">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659del|OMIM:612555" submittedassembly="hg18">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000327465" orgabbreviation="CIMBA" organizationcategory="consortium" orgid="505954" submittername="Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-10-02">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         CIMBA Mutation Classification guidelines May 2016
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/MIHuUwlX/CIMBA_Mutation_Classification_guidelines_May16.pdf
         </url>
         <citationtext>
          CIMBA_Mutation_Classification_guidelines_May16.pdf
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <familydata numfamilieswithvariant="125">
          </familydata>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         CIMBA_20161005
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-02-03" datelastupdated="2021-02-10" id="966867" submissiondate="2016-11-14">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659delGT|MedGen:C0677776" submittedassembly="hg19">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000494408" orgabbreviation="IG" organizationcategory="laboratory" orgid="500026" submittername="Integrated Genetics/Laboratory Corporation of America" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2016-04-18">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          12373604
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18703817
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          24156927
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          18465347
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22798144
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          26657402
         </id>
        </citation>
        <comment>
         Variant summary: The c.658_659delGT variant results in a premature termination codon, predicted to cause a truncated or absent BRCA2 protein, which is a commonly known mechanism for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (c.755_758delACAG, p.Asp252fsX24; c.771_775delTCAAA, p.Asn257fsX17; c.778_779delGA, p.Glu260fsX15). The variant was observed in the large and broad cohorts of the ExAC project at an allele frequency of 0.006% which does not exceed the maximal expected allele frequency for a pathogenic variant in BRCA2 (0.075%). The variant has been reported in numerous affected individuals in the literature, including 2 siblings affected with Fanconi anemia who also carried a second pathogenic BRCA2 variant (Svojgr_2016). Mutliple reputable clinical labs have classified the variant as "Pathogenic". Taken together, this variant is classified as pathogenic.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         LabCorp Variant Classification Summary - May 2015
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf
         </url>
         <citationtext>
          LabCorp Variant Classification Summary - May 2015.docx
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <xreflist>
         <xref db="dbSNP" id="80359604" type="rsNumber">
         </xref>
        </xreflist>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MedGen" id="C0677776" type="CUI">
         </xref>
        </trait>
       </traitset>
       <studydescription>
        initial submission of 144 BRCA variants, updates to 5 previously submitted variants
       </studydescription>
       <submissionnamelist>
        <submissionname>
         BRCA_variants_111416
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-04-13" datelastupdated="2020-03-26" id="1053917" submissiondate="2017-02-23">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659delGT|Familial cancer of breast" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000540998" orgabbreviation="BCM: BMGL" organizationcategory="laboratory" orgid="1006" submittername="Baylor Genetics" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-02-23">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="ModeOfInheritance">
         Autosomal dominant inheritance
        </attribute>
       </attributeset>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Familial cancer of breast
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <studydescription>
        Variants for BRCA1/2 tests
       </studydescription>
       <submissionnamelist>
        <submissionname>
         BRCA12
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-07-27" datelastupdated="2020-03-26" id="1139203" submissiondate="2017-07-06">
       <clinvarsubmissionid localkey="13:32903604:CTG" localkeyissubmitted="1" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000584073" orgabbreviation="HA" organizationcategory="laboratory" orgid="505530" submittername="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2014-07-10">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         HA_assertions_20150911
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/suocabs5/ha_assertions_20150911.pdf
         </url>
         <citationtext>
          HA_assertions_20150911.pdf
         </citationtext>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
          <numbertested>
           1
          </numbertested>
         </sample>
         <method>
          <methodtype>
           research
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="SampleLocalID">
           13:32903604:CTG:00035
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="C" assembly="GRCh37" chr="13" referenceallele="CTG" start="32903604" stop="32903606" variantlength="3">
         </sequencelocation>
        </location>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studyname>
        CSER-HudsonAlpha
       </studyname>
       <submissionnamelist>
        <submissionname>
         SUB2844653
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2013-12-09" datelastupdated="2021-02-27" id="184150" submissiondate="2017-07-13">
       <clinvarsubmissionid localkey="GDX:7939|Not Provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000108633" orgabbreviation="GDX" organizationcategory="laboratory" orgid="26957" submittername="GeneDx" type="SCV" version="12">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2017-01-24">
        <description>
         Pathogenic
        </description>
        <comment>
         This pathogenic variant is denoted BRCA2 c.658_659delGT at the cDNA level and p.Val220IlefsX4 (V220IfsX4) at the protein level. The normal sequence, with the bases that are deleted in brackets, is AACT[delGT]ATTT. The deletion causes a frameshift, which changes a Valine to an Isoleucine at codon 220, and creates a premature stop codon at position 4 of the new reading frame. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. BRCA2 c.658_659delGT, previously reported as 886delGT using alternate nomenclature, has been reported in multiple individuals from hereditary breast and ovarian cancer families (Frank 1998, Jakubowska 2003, Machado 2007, Berzina 2013, Cunningham 2014, de Juan 2015) and has been observed in the compound heterozygous state with a second pathogenic BRCA2 variant in patients with Fanconi anemia (Alter 2007, Miele 2015). Based on currently available evidence, we consider this variant to be pathogenic.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         GeneDx Variant Classification (06012015)
        </attribute>
        <citation type="general">
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Not Provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-09-27" datelastupdated="2020-09-16" id="1169390" submissiondate="2017-10-18">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659del|MedGen:C2675520" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000605688" orgabbreviation="AMG, OUS" organizationcategory="laboratory" orgid="505260" submittername="Department of Medical Genetics, Oslo University Hospital" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-10-06">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="MedGen" id="C2675520" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3136286
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-04-06" datelastupdated="2020-03-26" id="1414377" submissiondate="2018-04-04">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659delGT|OMIM:612555" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000733216" orgabbreviation="DL-UMCG" organizationcategory="laboratory" orgid="506382" submittername="Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation>
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="OMIM" id="612555" type="MIM">
         </xref>
        </trait>
       </traitset>
       <studyname>
        VKGL Data-share Consensus
       </studyname>
       <submissionnamelist>
        <submissionname>
         SUB3868021
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-06-22" datelastupdated="2020-03-26" id="1518302" submissiondate="2018-03-09">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659del|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000778635" organizationcategory="laboratory" orgid="500068" submittername="Mayo Clinic Genetic Testing Laboratories,Mayo Clinic" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2016-12-27">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           unknown
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3765485
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-09-12" datelastupdated="2020-08-27" id="1570699" submissiondate="2018-01-29">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659delGT|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000805748" organizationcategory="laboratory" orgid="239772" submittername="PreventionGenetics,PreventionGenetics" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2014-09-03">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB3589995
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2011-01-25" datelastupdated="2020-03-26" id="30150" submissiondate="2016-09-12">
       <clinvarsubmissionid localkey="600185.0027_FANCONI ANEMIA, COMPLEMENTATION GROUP D1" title="BRCA2, 2-BP DEL, 886GT_FANCONI ANEMIA, COMPLEMENTATION GROUP D1">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000030150" organizationcategory="resource" orgid="3" submittername="OMIM" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2007-01-01">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           Fanconi Anemia
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           In 2 brothers with Fanconi anemia complementation group D1 (FANCD1; 605724), Hirsch et al. (2004) identified compound heterozygosity for mutations in the BRCA2 gene: a 2-bp deletion in exon 8 (886delGT), inherited from the father, and an 8447T-A transversion in exon 18, resulting in a leu2740-to-ter substitution (L2740X; 600185.0028), inherited from the mother.
          </attribute>
          <citation>
           <id source="PubMed">
            14670928
           </id>
          </citation>
          <xref db="OMIM" id="605724" type="MIM">
          </xref>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           Wilms Tumor/Medulloblastoma/Glioblastoma
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           In 2 brothers who developed Wilms tumor (WT1; 194070) and brain tumors, Reid et al. (2005) identified 2 truncating BRCA2 mutations: a paternally inherited 886delGT, predicted to truncate the protein at codon 223 before the 8 BRC repeats, and a maternally inherited 5873C-A transversion in exon 11, resulting in a ser1882-to-ter substitution (S1882X; 600185.0031) predicted to truncate the protein such that BRC7 and BRC8 would be missing. One boy developed a glioblastoma (GLM3; 613029); the other had recurrent medulloblastoma (MDB; 155255) as well as pre-B-cell acute lymphoblastic leukemia. Neither child had the typical clinical features of Fanconi anemia. No first- or second-degree relative had cancer when the family presented; however, after the boys died their mother developed breast cancer at age 45 as did a paternal aunt at age 48.
          </attribute>
          <citation>
           <id source="PubMed">
            15689453
           </id>
          </citation>
          <xref db="OMIM" id="194070" type="MIM">
          </xref>
          <xref db="OMIM" id="613029" type="MIM">
          </xref>
          <xref db="OMIM" id="155255" type="MIM">
          </xref>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           Alter et al. (2007) included this mutation in an analysis of the clinical and molecular features associated with the BRCA2 mutations identified in FANCD1 patients. They noted that the 886delGT mutation is associated with brain tumors. They also concluded that small group of patients with biallelic mutations in BRCA2 is distinctive in the severity of the phenotype, with early onset and high rates of leukaemia and specific solid tumours. These features may comprise an extreme variant of Fanconi anemia.
          </attribute>
          <citation>
           <id source="PubMed">
            16825431
           </id>
          </citation>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <name>
         BRCA2, 2-BP DEL, 886GT
        </name>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name type="NonHGVS">
          2-BP DEL, 886GT
         </name>
        </othernamelist>
        <xreflist>
         <xref db="OMIM" id="600185.0027" type="Allelic variant">
         </xref>
        </xreflist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           FANCONI ANEMIA, COMPLEMENTATION GROUP D1
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2011-01-25" datelastupdated="2020-03-26" id="30151" submissiondate="2016-09-12">
       <clinvarsubmissionid localkey="600185.0027_WILMS TUMOR" title="BRCA2, 2-BP DEL, 886GT_WILMS TUMOR">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000030151" organizationcategory="resource" orgid="3" submittername="OMIM" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2007-01-01">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to included disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           Fanconi Anemia
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           In 2 brothers with Fanconi anemia complementation group D1 (FANCD1; 605724), Hirsch et al. (2004) identified compound heterozygosity for mutations in the BRCA2 gene: a 2-bp deletion in exon 8 (886delGT), inherited from the father, and an 8447T-A transversion in exon 18, resulting in a leu2740-to-ter substitution (L2740X; 600185.0028), inherited from the mother.
          </attribute>
          <citation>
           <id source="PubMed">
            14670928
           </id>
          </citation>
          <xref db="OMIM" id="605724" type="MIM">
          </xref>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           Wilms Tumor/Medulloblastoma/Glioblastoma
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           In 2 brothers who developed Wilms tumor (WT1; 194070) and brain tumors, Reid et al. (2005) identified 2 truncating BRCA2 mutations: a paternally inherited 886delGT, predicted to truncate the protein at codon 223 before the 8 BRC repeats, and a maternally inherited 5873C-A transversion in exon 11, resulting in a ser1882-to-ter substitution (S1882X; 600185.0031) predicted to truncate the protein such that BRC7 and BRC8 would be missing. One boy developed a glioblastoma (GLM3; 613029); the other had recurrent medulloblastoma (MDB; 155255) as well as pre-B-cell acute lymphoblastic leukemia. Neither child had the typical clinical features of Fanconi anemia. No first- or second-degree relative had cancer when the family presented; however, after the boys died their mother developed breast cancer at age 45 as did a paternal aunt at age 48.
          </attribute>
          <citation>
           <id source="PubMed">
            15689453
           </id>
          </citation>
          <xref db="OMIM" id="194070" type="MIM">
          </xref>
          <xref db="OMIM" id="613029" type="MIM">
          </xref>
          <xref db="OMIM" id="155255" type="MIM">
          </xref>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           Alter et al. (2007) included this mutation in an analysis of the clinical and molecular features associated with the BRCA2 mutations identified in FANCD1 patients. They noted that the 886delGT mutation is associated with brain tumors. They also concluded that small group of patients with biallelic mutations in BRCA2 is distinctive in the severity of the phenotype, with early onset and high rates of leukaemia and specific solid tumours. These features may comprise an extreme variant of Fanconi anemia.
          </attribute>
          <citation>
           <id source="PubMed">
            16825431
           </id>
          </citation>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <name>
         BRCA2, 2-BP DEL, 886GT
        </name>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name type="NonHGVS">
          2-BP DEL, 886GT
         </name>
        </othernamelist>
        <xreflist>
         <xref db="OMIM" id="600185.0027" type="Allelic variant">
         </xref>
        </xreflist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="included">
           WILMS TUMOR
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2011-01-25" datelastupdated="2020-03-26" id="30152" submissiondate="2016-09-12">
       <clinvarsubmissionid localkey="600185.0027_GLIOMA SUSCEPTIBILITY 3" title="BRCA2, 2-BP DEL, 886GT_GLIOMA SUSCEPTIBILITY 3">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000030152" organizationcategory="resource" orgid="3" submittername="OMIM" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2007-01-01">
        <description>
         risk factor
        </description>
       </interpretation>
       <assertion>
        variation to included disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           Fanconi Anemia
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           In 2 brothers with Fanconi anemia complementation group D1 (FANCD1; 605724), Hirsch et al. (2004) identified compound heterozygosity for mutations in the BRCA2 gene: a 2-bp deletion in exon 8 (886delGT), inherited from the father, and an 8447T-A transversion in exon 18, resulting in a leu2740-to-ter substitution (L2740X; 600185.0028), inherited from the mother.
          </attribute>
          <citation>
           <id source="PubMed">
            14670928
           </id>
          </citation>
          <xref db="OMIM" id="605724" type="MIM">
          </xref>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           Wilms Tumor/Medulloblastoma/Glioblastoma
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           In 2 brothers who developed Wilms tumor (WT1; 194070) and brain tumors, Reid et al. (2005) identified 2 truncating BRCA2 mutations: a paternally inherited 886delGT, predicted to truncate the protein at codon 223 before the 8 BRC repeats, and a maternally inherited 5873C-A transversion in exon 11, resulting in a ser1882-to-ter substitution (S1882X; 600185.0031) predicted to truncate the protein such that BRC7 and BRC8 would be missing. One boy developed a glioblastoma (GLM3; 613029); the other had recurrent medulloblastoma (MDB; 155255) as well as pre-B-cell acute lymphoblastic leukemia. Neither child had the typical clinical features of Fanconi anemia. No first- or second-degree relative had cancer when the family presented; however, after the boys died their mother developed breast cancer at age 45 as did a paternal aunt at age 48.
          </attribute>
          <citation>
           <id source="PubMed">
            15689453
           </id>
          </citation>
          <xref db="OMIM" id="194070" type="MIM">
          </xref>
          <xref db="OMIM" id="613029" type="MIM">
          </xref>
          <xref db="OMIM" id="155255" type="MIM">
          </xref>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           Alter et al. (2007) included this mutation in an analysis of the clinical and molecular features associated with the BRCA2 mutations identified in FANCD1 patients. They noted that the 886delGT mutation is associated with brain tumors. They also concluded that small group of patients with biallelic mutations in BRCA2 is distinctive in the severity of the phenotype, with early onset and high rates of leukaemia and specific solid tumours. These features may comprise an extreme variant of Fanconi anemia.
          </attribute>
          <citation>
           <id source="PubMed">
            16825431
           </id>
          </citation>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <name>
         BRCA2, 2-BP DEL, 886GT
        </name>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name type="NonHGVS">
          2-BP DEL, 886GT
         </name>
        </othernamelist>
        <xreflist>
         <xref db="OMIM" id="600185.0027" type="Allelic variant">
         </xref>
        </xreflist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="included">
           GLIOMA SUSCEPTIBILITY 3
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2011-01-25" datelastupdated="2020-03-26" id="30153" submissiondate="2016-09-12">
       <clinvarsubmissionid localkey="600185.0027_MEDULLOBLASTOMA" title="BRCA2, 2-BP DEL, 886GT_MEDULLOBLASTOMA">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000030153" organizationcategory="resource" orgid="3" submittername="OMIM" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2007-01-01">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to included disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species>
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           literature only
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           Fanconi Anemia
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           In 2 brothers with Fanconi anemia complementation group D1 (FANCD1; 605724), Hirsch et al. (2004) identified compound heterozygosity for mutations in the BRCA2 gene: a 2-bp deletion in exon 8 (886delGT), inherited from the father, and an 8447T-A transversion in exon 18, resulting in a leu2740-to-ter substitution (L2740X; 600185.0028), inherited from the mother.
          </attribute>
          <citation>
           <id source="PubMed">
            14670928
           </id>
          </citation>
          <xref db="OMIM" id="605724" type="MIM">
          </xref>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           Wilms Tumor/Medulloblastoma/Glioblastoma
          </attribute>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           In 2 brothers who developed Wilms tumor (WT1; 194070) and brain tumors, Reid et al. (2005) identified 2 truncating BRCA2 mutations: a paternally inherited 886delGT, predicted to truncate the protein at codon 223 before the 8 BRC repeats, and a maternally inherited 5873C-A transversion in exon 11, resulting in a ser1882-to-ter substitution (S1882X; 600185.0031) predicted to truncate the protein such that BRC7 and BRC8 would be missing. One boy developed a glioblastoma (GLM3; 613029); the other had recurrent medulloblastoma (MDB; 155255) as well as pre-B-cell acute lymphoblastic leukemia. Neither child had the typical clinical features of Fanconi anemia. No first- or second-degree relative had cancer when the family presented; however, after the boys died their mother developed breast cancer at age 45 as did a paternal aunt at age 48.
          </attribute>
          <citation>
           <id source="PubMed">
            15689453
           </id>
          </citation>
          <xref db="OMIM" id="194070" type="MIM">
          </xref>
          <xref db="OMIM" id="613029" type="MIM">
          </xref>
          <xref db="OMIM" id="155255" type="MIM">
          </xref>
         </observeddata>
         <observeddata>
          <attribute type="Description">
           Alter et al. (2007) included this mutation in an analysis of the clinical and molecular features associated with the BRCA2 mutations identified in FANCD1 patients. They noted that the 886delGT mutation is associated with brain tumors. They also concluded that small group of patients with biallelic mutations in BRCA2 is distinctive in the severity of the phenotype, with early onset and high rates of leukaemia and specific solid tumours. These features may comprise an extreme variant of Fanconi anemia.
          </attribute>
          <citation>
           <id source="PubMed">
            16825431
           </id>
          </citation>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <name>
         BRCA2, 2-BP DEL, 886GT
        </name>
        <varianttype>
         Variation
        </varianttype>
        <othernamelist>
         <name type="NonHGVS">
          2-BP DEL, 886GT
         </name>
        </othernamelist>
        <xreflist>
         <xref db="OMIM" id="600185.0027" type="Allelic variant">
         </xref>
        </xreflist>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="included">
           MEDULLOBLASTOMA
          </elementvalue>
         </name>
        </trait>
       </traitset>
      </clinicalassertion>
      <clinicalassertion datecreated="2018-12-20" datelastupdated="2020-03-26" id="1688931" submissiondate="2018-07-18">
       <clinvarsubmissionid localkey="NM_000059.3:c.658_659delGT|MedGen:CN221562" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000863725" orgabbreviation="WDFlab" organizationcategory="laboratory" orgid="500086" submittername="Foulkes Cancer Genetics LDI, Lady Davis Institute for Medical Research" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2016-12-04">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast and/or ovarian cancer
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN221562" type="CUI">
         </xref>
        </trait>
       </traitset>
       <studyname>
        The Canadian Open Genetics Repository (COGR)
       </studyname>
       <submissionnamelist>
        <submissionname>
         SUB4310295
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2017-09-27" datelastupdated="2020-10-07" id="1169482" submissiondate="2019-03-21">
       <clinvarsubmissionid localkey="56658059|Orphanet:ORPHA145" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000605780" organizationcategory="laboratory" orgid="21766" submittername="Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine" type="SCV" version="2">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-04-17">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          9667259
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          14559878
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          14670928
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          15689453
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          23767878
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          25066507
         </id>
        </citation>
        <comment>
         The p.Val220fs variant in BRCA2 has been identified in &gt;50 individuals with BRCA 2-associated cancers (Frank 1998, Berzina 2013, Breast Cancer Information Core ( BIC) database) and in 3 compound heterozygous individuals with Fanconi anemia (O ffit 2003, Hirsch 2004, Reid 2005). This variant has been identified in 4/51064 of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs80359604). This variant is predicted to cause a frame shift, which alters the protein?s amino acid sequence beginning at position 220 and leads to a premature termination codon 4 amino acids downstream. This altera tion is then predicted to lead to a truncated or absent protein. In summary, thi s variant meets our criteria to be classified as pathogenic for hereditary breas t and ovarian cancer in an autosomal dominant manner based on the low frequency in controls and the predicted impact to the protein.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="ModeOfInheritance">
         Autosomal dominant inheritance
        </attribute>
       </attributeset>
       <attributeset>
        <attribute type="AssertionMethod">
         LMM Criteria
        </attribute>
        <citation>
         <id source="PubMed">
          24033266
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           not provided
          </affectedstatus>
          <familydata numfamilieswithvariant="2">
          </familydata>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="2" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <genelocation>
          NM_000059.3:EXON 8
         </genelocation>
        </location>
        <othernamelist>
         <name>
          NM_000059.3:c.658_659delGT
         </name>
         <name>
          p.Val220IlefsX4
         </name>
        </othernamelist>
        <attributeset>
         <attribute type="HGVS">
          NC_000013.10:g.32903606_32903607delGT
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <xref db="Orphanet" id="ORPHA145">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB5348977
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2016-07-29" datelastupdated="2020-03-26" id="574309" submissiondate="2020-03-06">
       <clinvarsubmissionid localkey="2396369|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000296738" organizationcategory="laboratory" orgid="500110" submittername="Quest Diagnostics Nichols Institute San Juan Capistrano" type="SCV" version="4">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-02-22">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          25066507
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22923021
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22798144
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          16825431
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          23767878
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          26657402
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          24504028
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          30287823
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          29492181
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          29339979
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          30350268
         </id>
        </citation>
        <comment>
         The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one symptomatic patient, and found in general population data that is consistent with pathogenicity.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Quest Diagnostics Criteria
        </attribute>
        <citation>
         <id source="PubMed">
          26467025
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <citation type="general">
        <id source="PubMed">
         26295337
        </id>
       </citation>
       <submissionnamelist>
        <submissionname>
         SUB6975398
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2013-07-02" datelastupdated="2020-04-15" id="120931" submissiondate="2020-02-06">
       <clinvarsubmissionid localkey="248701|MedGen:C0677776" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV000073001" organizationcategory="laboratory" orgid="500031" submittername="Invitae" type="SCV" version="11">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-12-30">
        <description>
         Pathogenic
        </description>
        <citation>
         <id source="PubMed">
          24504028
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          9667259
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          23767878
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          26657402
         </id>
        </citation>
        <citation>
         <id source="PubMed">
          22923021
         </id>
        </citation>
        <comment>
         This sequence change creates a premature translational stop signal (p.Val220Ilefs*4) in the BRCA2 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs768580992, ExAC 0.01%). This variant has been observed in individual(s) affected with hereditary breast and ovarian cancer (PMID: 9667259, 22923021, 23767878, 24504028), and Fanconi anemia (PMID: 26657402). This variant is also known as 886delGT in the literature. ClinVar contains an entry for this variant (Variation ID: 9342). Loss-of-function variants in BRCA2 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic.
        </comment>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Invitae Variant Classification Sherloc (09022015)
        </attribute>
        <citation>
         <id source="PubMed">
          28492532
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           unknown
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute type="Description">
           not provided
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.658_659del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Hereditary breast and ovarian cancer syndrome
          </elementvalue>
         </name>
         <xref db="MedGen" id="C0677776" type="CUI">
         </xref>
        </trait>
       </traitset>
       <citation type="general">
        <id source="PubMed">
         28492532
        </id>
       </citation>
       <submissionnamelist>
        <submissionname>
         SUB6933801
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-05-08" datelastupdated="2021-02-25" id="2469234" submissiondate="2020-07-06">
       <clinvarsubmissionid localkey="102082|MedGen:CN517202" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001247635" orgabbreviation="PHGT" organizationcategory="laboratory" orgid="505870" submittername="CeGaT Praxis fuer Humangenetik Tuebingen" type="SCV" version="3">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2019-04-01">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria
        </attribute>
        <citation>
         <url>
          https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf
         </url>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="7" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <varianttype>
         Variation
        </varianttype>
        <location>
         <sequencelocation alternateallele="C" assembly="GRCh37" chr="13" referenceallele="CTG" start="32903604" stop="32903606" variantlength="3">
         </sequencelocation>
        </location>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN517202" type="CUI">
         </xref>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         2020-07
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-12-09" datelastupdated="2020-12-12" id="2862699" submissiondate="2020-11-26">
       <clinvarsubmissionid localkey="NM_000059.4:c.658_659del|not provided" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001449833" orgabbreviation="KLINGEN-KUS" organizationcategory="laboratory" orgid="505315" submittername="Clinical Genetics Karolinska University Hospital,Karolinska University Hospital" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        criteria provided, single submitter
       </reviewstatus>
       <interpretation datelastevaluated="2015-11-18">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <attributeset>
        <attribute type="AssertionMethod">
         ACMG Guidelines, 2015
        </attribute>
        <citation>
         <id source="PubMed">
          25741868
         </id>
        </citation>
       </attributeset>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="3" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.4:c.658_659del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           not provided
          </elementvalue>
         </name>
        </trait>
       </traitset>
       <submissionnamelist>
        <submissionname>
         SUB8639822
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
      <clinicalassertion datecreated="2020-12-23" datelastupdated="2020-12-26" id="2866962" submissiondate="2019-06-13">
       <clinvarsubmissionid localkey="NM_000059.3:c.657_658del|MedGen:CN221562" submittedassembly="GRCh37">
       </clinvarsubmissionid>
       <clinvaraccession accession="SCV001451877" organizationcategory="consortium" orgid="507065" submittername="CZECANCA consortium" type="SCV" version="1">
       </clinvaraccession>
       <recordstatus>
        current
       </recordstatus>
       <reviewstatus>
        no assertion criteria provided
       </reviewstatus>
       <interpretation datelastevaluated="2019-06-11">
        <description>
         Pathogenic
        </description>
       </interpretation>
       <assertion>
        variation to disease
       </assertion>
       <observedinlist>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Slavic
          </ethnicity>
          <geographicorigin>
           Czech Republic
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           no
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           case-control
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="1" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
        <observedin>
         <sample>
          <origin>
           germline
          </origin>
          <ethnicity>
           Slavic
          </ethnicity>
          <geographicorigin>
           Czech Republic
          </geographicorigin>
          <species taxonomyid="9606">
           human
          </species>
          <affectedstatus>
           yes
          </affectedstatus>
         </sample>
         <method>
          <methodtype>
           clinical testing
          </methodtype>
         </method>
         <observeddata>
          <attribute integervalue="6" type="VariantAlleles">
          </attribute>
         </observeddata>
        </observedin>
       </observedinlist>
       <simpleallele>
        <genelist>
         <gene symbol="BRCA2">
         </gene>
        </genelist>
        <varianttype>
         Variation
        </varianttype>
        <attributeset>
         <attribute type="HGVS">
          NM_000059.3:c.657_658del
         </attribute>
        </attributeset>
       </simpleallele>
       <traitset type="Disease">
        <trait type="Disease">
         <name>
          <elementvalue type="Preferred">
           Breast and/or ovarian cancer
          </elementvalue>
         </name>
         <xref db="MedGen" id="CN221562" type="CUI">
         </xref>
        </trait>
       </traitset>
       <citation type="general">
        <id source="PubMed">
         32295079
        </id>
       </citation>
       <submissionnamelist>
        <submissionname>
         SUB5822876
        </submissionname>
       </submissionnamelist>
      </clinicalassertion>
     </clinicalassertionlist>
     <traitmappinglist>
      <traitmapping clinicalassertionid="1169482" mappingref="Orphanet" mappingtype="XRef" mappingvalue="ORPHA145" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1570699" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1053917" mappingref="Preferred" mappingtype="Name" mappingvalue="Familial cancer of breast" traittype="Disease">
       <medgen cui="C0346153" name="Familial cancer of breast">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2866962" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast and/or ovarian cancer" traittype="Disease">
       <medgen cui="CN221562" name="Breast and/or ovarian cancer">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="498336" mappingref="Preferred" mappingtype="Name" mappingvalue="bilateral breast cancer" traittype="Finding">
       <medgen cui="CN235586" name="bilateral breast cancer">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2862699" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2858106" mappingref="HP" mappingtype="XRef" mappingvalue="HP:0003002" traittype="Finding">
       <medgen cui="C0678222" name="Breast carcinoma">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1414377" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="502766" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1688931" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast and/or ovarian cancer" traittype="Disease">
       <medgen cui="CN221562" name="Breast and/or ovarian cancer">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="264325" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 2" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="30153" mappingref="Alternate" mappingtype="Name" mappingvalue="MEDULLOBLASTOMA" traittype="Disease">
       <medgen cui="C0025149" name="Medulloblastoma">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2469234" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="30152" mappingref="Alternate" mappingtype="Name" mappingvalue="GLIOMA SUSCEPTIBILITY 3" traittype="Disease">
       <medgen cui="C2751641" name="Glioma susceptibility 3">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="626573" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="966867" mappingref="MedGen" mappingtype="XRef" mappingvalue="C0677776" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1518302" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="2858106" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="305428" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1139203" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="537161" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1450844" mappingref="OMIM" mappingtype="XRef" mappingvalue="612555" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="89859" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 2" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="30151" mappingref="Alternate" mappingtype="Name" mappingvalue="WILMS TUMOR" traittype="Disease">
       <medgen cui="C0027708" name="Nephroblastoma">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="397873" mappingref="Preferred" mappingtype="Name" mappingvalue="Breast-ovarian cancer, familial 2" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="120931" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary breast and ovarian cancer syndrome" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1140487" mappingref="Orphanet" mappingtype="XRef" mappingvalue="ORPHA145" traittype="Disease">
       <medgen cui="C0677776" name="Hereditary breast and ovarian cancer syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="184150" mappingref="Preferred" mappingtype="Name" mappingvalue="Not Provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1729650" mappingref="Preferred" mappingtype="Name" mappingvalue="not specified" traittype="Disease">
       <medgen cui="CN169374" name="not specified">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="574309" mappingref="Preferred" mappingtype="Name" mappingvalue="not provided" traittype="Disease">
       <medgen cui="CN517202" name="not provided">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="498336" mappingref="MedGen" mappingtype="XRef" mappingvalue="C2676676" traittype="Disease">
       <medgen cui="C2676676" name="Breast-ovarian cancer, familial 1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="30150" mappingref="Preferred" mappingtype="Name" mappingvalue="FANCONI ANEMIA, COMPLEMENTATION GROUP D1" traittype="Disease">
       <medgen cui="C1838457" name="Fanconi anemia, complementation group D1">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="1169390" mappingref="MedGen" mappingtype="XRef" mappingvalue="C2675520" traittype="Disease">
       <medgen cui="C2675520" name="Breast-ovarian cancer, familial 2">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="556584" mappingref="Preferred" mappingtype="Name" mappingvalue="Hereditary cancer-predisposing syndrome" traittype="Disease">
       <medgen cui="C0027672" name="Hereditary cancer-predisposing syndrome">
       </medgen>
      </traitmapping>
      <traitmapping clinicalassertionid="498336" mappingref="Preferred" mappingtype="Name" mappingvalue="breast cancer" traittype="Finding">
       <medgen cui="C0006142" name="Malignant tumor of breast">
       </medgen>
      </traitmapping>
     </traitmappinglist>
     <deletedscvlist>
      <scv>
       <accession datedeleted="2015-11-13" version="2">
        SCV000030154
       </accession>
      </scv>
     </deletedscvlist>
    </interpretedrecord>
   </variationarchive>
  </clinvarresult-set>
 </body>
</html>BREAKHERE